Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3004119	vb-hb	g/l (g/l)	13164	48632	0.00%
3004119	vb-thb	g/l (g/l)	11220	30890	0.00%
3004119	vb-hb	— (—)	962	2616	100.00%	Distribution not available
3004119	vb-hb-vt	g/l (g/l)	451	728	0.00%
3004119	vb-thb	— (—)	270	293	100.00%	Distribution not available
3004119	vb-hb-vt	— (—)	88	113	100.00%	Distribution not available
3004119	vb-hblask	g/l (g/l)	57	63	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, unspecified (mode), excluding more controls

2348

7370

2.49

323.31

3.9

2.6

129.75

132.52

g/l

6.70

2292

7228

Diarrhoea and gastroenteritis of presumed infectious origin

3448

15517

2.09

322.19

5.4

3.1

127.19

130.20

g/l

11.41

3355

15163

Symptoms and signs involving the circulatory and respiratory systems

4364

11310

1.99

321.24

4.0

3.2

131.08

129.84

g/l

2.67

4262

11056

Intestinal infectious diseases

4464

18345

1.91

317.74

5.3

3.1

126.59

130.08

g/l

19.02

4341

17937

GASTRO-related operations

3431

8172

2.17

316.41

4.3

2.5

127.58

134.95

g/l

55.15

3348

8001

Any gastric operation

3431

8172

2.17

316.41

4.3

2.5

127.58

134.95

g/l

55.15

3348

8001

Hypo-osmolality and hyponatraemia

1190

3693

3.58

314.78

5.1

2.9

122.38

127.83

g/l

13.64

1171

3611

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1553

3264

3.12

314.22

4.6

2.2

128.33

134.85

g/l

19.66

1515

3188

Symptoms and signs involving the digestive system and abdomen

4634

12376

1.94

313.60

4.2

3.3

129.63

130.12

g/l

0.66

4523

12084

Caries of dentine

1434

4845

3.14

311.48

7.7

3.1

120.54

131.40

g/l

48.68

1405

4749

Syncope and collapse

2267

8307

2.46

309.92

3.8

2.9

128.04

130.08

g/l

3.84

2213

8122

Viral Sepsis

1499

4285

3.95

307.65

6.6

2.7

122.03

130.60

g/l

34.77

1448

4186

Abnormalities of breathing

4310

11280

2.31

307.65

4.3

3.2

129.39

129.79

g/l

0.48

4196

11027

Condition for Implicit Sepsis (Organ dysfunction codes)

4952

14047

2.57

307.65

5.1

2.7

124.51

132.41

g/l

90.24

4806

13765

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4814

15282

2.14

307.65

5.8

2.8

122.78

131.90

g/l

120.07

4688

14963

Heart failure and coronary heart disease

2758

7146

3.00

307.65

5.5

2.9

121.93

129.70

g/l

49.64

2678

6998

Other septicaemia

2753

8550

3.44

307.65

7.1

2.7

116.64

130.89

g/l

168.83

2675

8327

Implicit viral Sepsis

1496

4276

3.95

307.65

6.6

2.7

121.99

130.61

g/l

35.17

1445

4178

Complications of procedures, not elsewhere classified

3940

16781

2.03

307.65

4.6

3.1

123.42

130.61

g/l

64.51

3834

16411

Type 1 diabetes, wide definition

1262

3909

3.50

307.65

5.7

3.6

124.13

132.28

g/l

26.32

1225

3819

Type 2 diabetes, definitions combined

4557

12467

2.24

307.65

3.7

2.9

128.85

130.59

g/l

4.84

4459

12176

Type 2 diabetes, wide definition

4938

11464

2.97

307.65

4.4

2.9

126.13

130.39

g/l

26.11

4829

11203

Covid-19 confirmed case

2341

8442

3.03

307.65

5.5

3.3

123.85

128.45

g/l

17.57

2284

8226

Septicaemia

3038

9290

3.38

307.65

6.9

2.7

116.97

131.02

g/l

181.23

2955

9058

Covid-19 suspected case

2081

3713

6.67

307.65

3.8

3.5

134.75

130.79

g/l

11.70

2067

3619

Certain infectious and parasitic diseases

4436

10829

2.12

307.65

4.6

2.6

126.68

133.07

g/l

54.65

4341

10579

Type 2 diabetes, definitions combined, including avohilmo

4519

12326

2.23

307.65

3.7

2.9

129.12

130.53

g/l

3.33

4427

12034

Antihypertensive medication - note that there are other indications

2345

4266

3.03

307.65

4.5

2.7

130.49

134.47

g/l

10.98

2284

4184

Erysipelas

3015

11766

2.40

307.65

4.7

2.7

125.24

132.11

g/l

45.76

2951

11487

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5319

16064

2.38

307.65

5.0

3.1

124.43

131.53

g/l

81.85

5181

15720

Hypertension

3909

8070

2.88

307.65

5.0

2.7

128.07

132.59

g/l

21.87

3816

7892

Hypertensive diseases (excluding secondary)

2657

3549

4.65

307.65

5.4

2.5

128.37

135.40

g/l

31.48

2598

3468

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5250

12791

2.61

307.65

4.2

3.1

127.73

130.79

g/l

14.91

5133

12494

Anaemias

1263

876

10.24

307.65

7.7

2.0

115.13

140.61

g/l

148.75

1234

862

Type 1 diabetes, wide definition, subgroup 1

1236

3580

3.77

307.65

5.6

3.5

124.18

132.75

g/l

28.20

1199

3498

Hard cardiovascular diseases

4405

10840

2.56

307.65

4.7

3.0

126.32

131.53

g/l

34.77

4291

10627

Dialysis

526

678

11.28

307.65

15.1

3.6

106.08

132.22

g/l

96.91

521

665

Acute tubulo-interstitial nephritis

3452

12070

2.62

307.65

5.1

2.6

122.79

131.50

g/l

87.69

3365

11783

Other heart diseases, wide

4807

11064

2.80

307.65

4.7

3.0

129.60

131.33

g/l

4.62

4689

10839

Type 1 diabetes

1509

4576

3.59

307.65

5.7

3.5

124.02

132.11

g/l

29.65

1465

4462

Depression medications

998

964

5.41

307.65

3.6

1.8

134.76

141.64

g/l

12.98

974

949

Implicit viral Sepsis

1896

6360

3.28

307.65

5.9

2.7

123.10

130.29

g/l

32.74

1835

6219

Non-invasive ventilation

1554

2108

7.33

307.65

6.1

2.7

120.64

131.14

g/l

40.28

1432

2078

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5118

16872

2.19

307.65

5.6

3.0

117.60

132.86

g/l

307.65

4996

16492

Malaise and fatigue

3281

8704

3.28

307.65

4.6

2.9

126.50

130.03

g/l

13.95

3212

8509

Pain in throat and chest

4219

11043

2.40

307.65

3.7

3.1

131.01

129.78

g/l

2.59

4117

10794

Headache

2842

10383

2.27

307.65

3.7

2.8

131.23

131.30

g/l

0.06

2775

10153

Implicit bacterial Sepsis

3117

8849

3.48

307.65

6.5

2.7

119.66

130.37

g/l

107.56

3024

8651

Nausea and vomiting

1667

5449

3.25

307.65

6.0

3.3

125.07

128.20

g/l

6.46

1626

5323

Pneumonias (Asthma/COPD co-morbidities)

5442

15956

2.41

307.65

5.0

3.0

124.57

131.70

g/l

83.53

5300

15612

Hypothyroidism, levothyroxine purchases

837

913

5.39

307.65

4.4

1.9

131.53

141.00

g/l

20.16

816

899

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4848

12324

2.51

307.65

4.8

2.8

124.61

131.03

g/l

59.51

4722

12066

Implicit bacterial Sepsis

3310

9350

3.39

307.65

6.3

2.7

120.03

130.50

g/l

108.89

3210

9144

Any reimbursement code in KELA

2230

3564

3.26

307.65

4.2

2.0

130.92

136.91

g/l

22.18

2178

3488

Cardiovascular diseases

2412

3970

3.40

307.65

4.6

2.9

130.26

135.83

g/l

20.45

2358

3875

Other heart diseases

2794

3670

5.39

307.65

5.3

2.8

129.79

135.42

g/l

20.64

2723

3587

Type 2 diabetes

5092

12772

2.45

307.65

4.2

2.9

127.95

130.74

g/l

12.22

4978

12476

Complications of surgical and medical care, not elsewhere classified

4996

17288

2.07

307.65

4.6

3.1

123.39

130.79

g/l

84.05

4863

16911

Metabolic disorders

5572

12938

2.80

307.65

4.7

3.0

127.63

130.58

g/l

14.53

5438

12639

Cerebrovascular diseases (FINNGEN)

1627

2489

4.99

307.65

4.2

2.2

128.18

134.15

g/l

15.26

1589

2442

Persons encountering health services for specific procedures and health care

6180

14562

2.69

307.65

5.2

2.8

124.49

132.45

g/l

111.21

6040

14218

Hyperlipidaemia, other/unspecified

2201

8401

2.59

307.65

4.3

2.8

128.90

129.03

g/l

0.09

2176

8204

Diabetes, varying definitions

5352

13304

2.48

307.65

4.3

3.1

128.17

130.85

g/l

11.86

5227

12997

Other bacterial diseases

6025

14639

2.78

307.65

5.5

2.7

122.79

132.97

g/l

175.80

5889

14302

Heart failure, strict

3758

10802

2.66

307.65

5.3

3.0

122.61

129.74

g/l

56.95

3651

10554

Endocrine, nutritional and metabolic diseases

3562

7104

2.64

307.65

4.3

2.9

130.33

132.44

g/l

5.01

3474

6942

All-cause Heart Failure

3695

10650

2.66

307.65

5.2

3.0

122.49

129.67

g/l

57.08

3589

10404

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3404

10811

2.73

307.65

4.2

3.2

125.59

128.92

g/l

12.60

3330

10550

Other (not insulin) diabetes medications

4751

13459

2.19

307.65

3.7

3.0

128.61

130.28

g/l

4.69

4646

13139

Dialysis, with operation codes

1572

2533

8.35

307.65

13.6

2.8

106.75

132.86

g/l

307.51

1550

2471

All chronic kidney diseases

4134

10136

3.71

307.65

7.6

2.6

116.64

131.90

g/l

285.13

4040

9900

Presence of cardiac and vascular implants and grafts

2794

8934

2.51

307.65

4.8

2.8

122.87

130.12

g/l

46.24

2701

8748

4848

12324

2.51

307.65

4.8

2.8

124.61

131.03

g/l

59.51

4722

12066

All pneumoniae

5475

15989

2.41

307.65

4.9

3.1

124.63

131.63

g/l

80.91

5329

15646

Angina pectoris

3270

8854

2.64

307.65

4.4

2.8

126.49

130.45

g/l

16.76

3185

8683

Other bacterial diseases

6087

14808

2.97

307.65

5.6

2.7

122.00

132.66

g/l

195.82

5954

14464

Speech therapy

2052

5973

3.92

307.65

3.9

3.5

129.61

128.17

g/l

2.07

2028

5828

Type 2 diabetes, strict (exclude DM1)

4573

12555

2.23

307.65

3.7

2.9

128.82

130.54

g/l

4.75

4474

12261

Implicit Sepsis

4996

13873

2.82

307.65

5.3

2.7

123.76

131.92

g/l

97.21

4856

13587

Diabetes medication

5418

14177

2.38

307.65

4.1

3.2

128.01

130.54

g/l

10.98

5286

13846

General symptoms and signs

5389

11745

2.40

307.65

4.2

2.9

128.66

131.43

g/l

12.50

5260

11480

Kidney transplant status

821

927

14.11

307.65

13.5

3.7

106.95

132.46

g/l

125.25

814

908

All kidney diseases

6241

14931

3.07

307.65

5.8

2.6

122.00

132.90

g/l

209.01

6099

14583

Erysipelas

3710

12965

2.30

307.65

4.6

2.7

125.44

132.60

g/l

59.42

3622

12665

Care involving dialysis

1115

1420

11.38

307.65

14.1

3.1

105.74

132.11

g/l

200.82

1105

1374

Hypertension, essential

3896

7894

2.95

307.65

4.4

2.5

128.94

132.55

g/l

14.31

3809

7718

Ischaemic heart disease, wide definition

3935

11626

2.21

307.65

4.5

2.9

125.83

130.53

g/l

27.00

3835

11385

Heart failure,strict

3494

8642

3.13

307.65

5.4

2.6

122.65

131.91

g/l

83.94

3398

8457

Bacterial infection, other or unspecified

4004

11348

3.27

307.65

6.3

2.7

119.41

131.50

g/l

185.65

3907

11080

Nephropathy related operations

1590

2560

8.58

307.65

13.6

3.0

106.78

131.40

g/l

276.73

1567

2493

Percutaneous Coronary Intervention

4306

11153

2.51

307.65

4.8

3.0

125.33

131.18

g/l

43.02

4185

10942

L04AD Calcineurin inhibitors

1091

1993

6.88

307.65

13.1

3.7

109.54

132.26

g/l

158.12

1074

1946

Other disorders of fluid, electrolyte and acid-base balance

2370

6524

3.90

307.65

5.7

2.9

122.42

128.47

g/l

29.95

2318

6365

Atrial fibrillation and flutter with reimbursement

1827

1831

7.16

307.65

3.9

2.1

134.39

133.43

g/l

0.68

1790

1797

Care involving use of rehabilitation procedures

4042

13052

3.07

307.65

4.5

2.8

127.57

131.77

g/l

24.84

3944

12746

Bacterial Sepsis

3470

9648

3.41

307.65

6.3

2.7

119.79

130.73

g/l

123.15

3367

9434

Atrial fibrillation and flutter

2120

2347

6.51

307.65

4.5

2.1

133.59

134.71

g/l

0.95

2073

2301

Bacterial pneumoniae

2403

8664

2.62

307.65

5.4

2.9

123.15

130.40

g/l

41.05

2319

8456

Pure hypercholesterolaemia

3697

11239

2.25

307.65

4.0

2.9

127.76

130.05

g/l

6.61

3591

10988

Provisional assignment of new diseases of uncertain etiology

4204

11789

3.99

307.65

4.5

3.3

129.27

129.07

g/l

0.22

4137

11492

Other CVD (FINNGEN)

712

957

6.47

307.65

4.8

2.0

124.97

131.91

g/l

10.01

692

939

Codes for special purposes

4208

11814

3.99

307.65

4.5

3.3

129.28

129.05

g/l

0.25

4141

11517

Other arrhythmias

2896

9299

2.46

307.65

3.7

2.8

132.01

130.58

g/l

2.63

2834

9112

Valvular heart disease excluding rheumatic fever

2646

6871

2.99

307.65

5.1

2.9

121.67

129.89

g/l

51.28

2572

6734

Explicit Sepsis

3101

9569

3.33

307.65

6.8

2.7

117.20

130.69

g/l

171.89

3016

9353

Complications of medical and surgical care

3767

17014

2.14

307.65

5.0

3.1

122.98

129.94

g/l

59.79

3653

16644

Cardiac arrhythmias

3013

5137

4.06

307.65

4.1

2.8

133.36

132.23

g/l

1.50

2943

5029

Major coronary heart disease event

4500

11951

2.40

307.65

4.7

3.0

125.75

131.03

g/l

37.31

4377

11723

Acute renal failure

1882

5080

4.33

307.65

7.8

2.7

115.02

130.48

g/l

129.43

1830

4950

Glomerular diseases

1396

4035

3.97

307.65

10.1

3.3

113.56

130.56

g/l

127.19

1372

3936

Bleeding

4465

15277

2.19

307.65

4.7

3.3

123.67

130.41

g/l

60.38

4358

14940

Coronary revascularization (ANGIO or CABG)

4287

11160

2.49

307.65

4.8

3.0

125.44

131.17

g/l

41.28

4167

10949

Fever of other and unknown origin

3318

10223

3.09

307.65

5.5

2.9

122.61

130.80

g/l

70.39

3248

9993

Renal tubulo-interstitial diseases

5937

14664

3.27

307.65

6.1

2.6

119.98

132.44

g/l

268.55

5798

14333

Disorders of lipoprotein metabolism and other lipidaemias

4438

11821

2.46

307.65

4.1

2.9

128.66

130.29

g/l

4.14

4334

11555

Hypertensive heart and/or renal disease

1661

3689

3.69

307.65

5.7

2.6

123.51

129.58

g/l

17.38

1642

3616

Dyspnoea

4836

16583

2.27

307.65

4.4

3.2

127.74

129.37

g/l

4.95

4720

16206

Renal failure

4052

10425

3.95

307.65

7.8

2.7

114.85

130.51

g/l

304.57

3950

10171

Hypertensive Heart Disease

1437

3488

3.53

307.65

5.0

2.6

125.34

129.32

g/l

7.10

1424

3422

Dental caries

1597

5515

3.02

307.65

7.9

3.1

120.35

131.46

g/l

57.59

1566

5407

Chronic kidney disease

2759

7467

4.22

307.65

9.3

2.7

112.57

130.17

g/l

284.69

2695

7284

Diseases of arteries, arterioles and capillaries (FINNGEN)

1440

1854

5.92

307.65

6.2

2.2

121.21

133.75

g/l

50.16

1402

1819

Diabetes, insulin treatment (Kela reimbursement)

5581

14404

2.47

307.65

4.1

3.2

127.49

130.40

g/l

14.62

5456

14060

Hypothyroidism and >3 levothyroxin purchases

837

913

5.39

307.65

4.4

1.9

131.53

141.00

g/l

20.16

816

899

STROKE

2809

6795

2.99

307.65

4.1

2.5

128.80

132.48

g/l

11.67

2743

6672

Bacterial pneumonia, not elsewhere classified

2290

8224

2.63

307.65

5.4

2.9

122.91

130.29

g/l

40.70

2207

8030

Pneumonia, organism unspecified

4811

15013

2.36

307.65

4.9

3.0

124.36

131.59

g/l

77.65

4697

14695

Glomerular disorders in diseases classified elsewhere

993

2481

4.76

307.65

10.4

3.1

111.13

130.58

g/l

116.97

976

2410

Insulin, combination of fast acting with intermediate-acting or long-acting

4013

14291

2.77

307.65

5.0

3.2

124.92

129.96

g/l

33.02

3914

13958

Infections, IBD-co-morbidities

962

1304

5.77

307.65

7.8

2.9

118.82

130.19

g/l

28.06

937

1280

Bacterial infection, other or unspecified

3751

10883

3.29

307.65

6.5

2.7

119.04

131.34

g/l

181.74

3663

10621

Hypothyroidism (congenital or acquired)

861

920

5.51

307.65

4.6

1.9

131.64

140.94

g/l

19.56

837

906

Substance abuse, excluding more controls

2803

10852

2.31

307.65

3.7

3.3

130.22

130.25

g/l

0.02

2722

10600

Insulin, fast-acting

2368

8132

3.19

307.65

5.8

3.4

124.28

130.62

g/l

31.02

2307

7934

Insulin medication

4001

11510

3.18

307.65

5.0

3.3

124.93

130.35

g/l

35.99

3902

11240

Insulin, fast-acting or short human

2377

8710

2.97

307.65

5.8

3.4

124.23

130.16

g/l

27.70

2316

8497

Paroxysmal tachycardia

1068

2066

4.64

307.65

4.3

2.4

131.02

133.75

g/l

3.06

1046

2026

Non-rheumatic valve diseases

2620

6818

2.98

307.65

5.1

2.8

121.78

129.91

g/l

49.82

2546

6682

Ischemic heart diseases

4308

11439

2.39

307.65

4.8

3.0

126.21

131.28

g/l

32.99

4190

11222

Biguanides

4645

14143

2.09

307.65

3.6

3.2

128.71

129.73

g/l

2.03

4544

13807

Implicit Sepsis

4834

13313

2.95

307.65

5.4

2.7

123.19

131.72

g/l

102.93

4697

13039

Transplanted organ and tissue status

1104

1767

8.17

307.65

12.9

3.2

108.47

133.45

g/l

187.02

1086

1721

Hypertensive diseases

3917

8073

2.89

307.65

5.0

2.7

128.10

132.59

g/l

21.65

3824

7895

Insulin, intermediate and long-acting

3687

13401

2.91

307.65

4.9

3.2

125.34

130.02

g/l

26.49

3598

13086

Diabetes mellitus

5389

13285

2.49

307.65

4.3

3.1

128.18

130.86

g/l

11.94

5262

12980

Influenza and pneumonia

5662

15675

2.42

307.65

5.0

3.0

125.08

131.72

g/l

75.10

5515

15339

Secondary hypertension

604

780

8.95

307.65

9.8

2.8

113.28

134.28

g/l

64.53

594

768

Major coronary heart disease event excluding revascularizations

3105

9596

2.28

307.65

4.6

2.8

124.86

130.56

g/l

31.49

3019

9411

Heart failure and antihypertensive medication

1734

2028

6.29

307.65

6.3

2.5

122.42

131.37

g/l

29.84

1683

2000

Cardiovascular diseases (excluding rheumatic etc)

2806

4490

3.78

307.65

5.0

2.8

129.76

135.60

g/l

25.09

2741

4388

Extracorporeal dialysis

865

1257

10.32

307.65

15.3

3.1

105.66

130.80

g/l

158.45

858

1221

Condition for Implicit Sepsis (Organ dysfunction codes)

4997

13941

2.69

307.65

5.3

2.7

123.87

132.09

g/l

98.47

4852

13658

Emergency coronary revascularization (for ACS)

4708

12559

2.41

307.65

4.7

3.0

125.13

130.67

g/l

43.01

4578

12320

Heart failure, not strict

5170

11369

3.39

307.65

5.9

2.6

121.67

132.48

g/l

161.21

5038

11141

Bacterial pneumonia (organism specified)

2530

10445

2.33

305.61

5.5

3.2

122.92

129.13

g/l

33.33

2444

10191

Abdominal and pelvic pain

4587

12373

1.92

303.71

4.0

3.3

130.43

130.11

g/l

0.38

4476

12081

L04AA Selective immunosuppressants

1319

4464

3.24

302.30

9.6

3.2

113.62

131.29

g/l

129.66

1292

4354

Coronary atherosclerosis

3132

9568

2.18

299.87

4.6

2.8

123.82

130.76

g/l

45.05

3055

9386

First line medication for Crohn's disease

5019

15181

1.84

297.54

5.5

2.9

125.13

131.81

g/l

67.09

4906

14837

ILD medications: prednisolone, methylprednisolone, prednisone

5005

15705

1.84

297.28

5.5

2.8

125.45

131.20

g/l

50.46

4891

15348

Asthma, excluding more controls

3159

7811

2.18

296.56

3.8

2.6

130.96

132.93

g/l

4.43

3090

7655

Symptoms and signs involving cognition, perception, emotional state and behaviour

4481

16828

1.88

295.81

3.8

3.3

129.30

129.42

g/l

0.12

4367

16443

Parasetamol

3227

7810

2.16

294.28

3.9

2.9

129.40

133.12

g/l

13.72

3142

7646

Intracranial trauma

2560

8115

2.31

294.14

3.6

3.4

130.35

129.17

g/l

1.70

2509

7938

Diseases of arteries, arterioles and capillaries

3521

13421

2.04

292.45

5.1

3.1

121.77

129.69

g/l

69.39

3423

13127

Diseases of oesophagus, stomach and duodenum

4857

16353

1.84

289.94

4.0

3.3

126.38

130.60

g/l

27.11

4741

15981

Non-ischemic cardiomyopathy

1706

5326

2.78

287.26

4.7

2.7

123.84

130.26

g/l

21.39

1657

5209

Other nutritional deficiencies

2988

13975

2.10

286.15

4.2

3.4

130.27

129.70

g/l

0.65

2914

13649

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1261

4239

3.14

284.87

3.2

131.14

131.13

g/l

0.00

1222

4152

Other diseases of intestines

4652

14713

1.85

284.83

4.3

3.3

128.51

130.76

g/l

8.19

4542

14372

Other medical care

2314

9387

2.34

284.03

4.8

2.7

118.14

130.49

g/l

115.41

2248

9149

Tramadol

3653

11628

2.00

283.76

4.3

3.0

126.68

131.53

g/l

26.62

3565

11389

ILD medications

5111

15896

1.80

279.33

5.7

2.9

125.73

131.27

g/l

47.77

4999

15536

Poisoning by medicine

1156

3798

3.29

276.75

3.3

3.5

132.09

131.24

g/l

0.63

1120

3710

Poisoning by drugs, medicaments and biological substances

1249

4287

3.13

276.63

3.3

3.6

131.99

131.25

g/l

0.56

1211

4193

Heart failure and bmi 25plus

2049

5873

2.55

275.49

5.2

2.9

122.79

130.18

g/l

32.74

1986

5722

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1411

2293

3.20

274.71

3.7

2.5

131.44

133.73

g/l

2.37

1379

2237

Asthma, unspecified (mode)

2437

8418

2.27

273.89

3.9

2.7

129.46

131.39

g/l

3.73

2379

8249

Aplastic and other anaemias

2565

11486

2.21

272.67

6.1

3.2

111.00

129.90

g/l

297.20

2498

11203

Asthma (only as main-diagnosis), excluding more controls

2865

7811

2.17

271.94

3.8

2.6

130.44

132.93

g/l

6.32

2802

7655

Hypothyroidism, drug reimbursement

503

547

6.84

269.31

3.9

1.8

129.31

139.47

g/l

14.79

484

541

Abnormalities of heart beat

1746

7026

2.57

269.30

3.6

3.0

131.94

128.29

g/l

9.31

1707

6857

Valvular operations

928

2753

3.76

265.95

5.6

3.0

115.05

129.88

g/l

58.83

879

2693

COPD/asthma/ILD related infections

4419

12328

1.85

260.46

4.4

2.8

127.31

131.03

g/l

20.17

4308

12070

COPD/asthma related infections

4419

12328

1.85

260.46

4.4

2.8

127.31

131.03

g/l

20.17

4308

12070

Obesity

2785

13513

2.07

258.81

4.1

3.3

130.55

129.65

g/l

1.19

2719

13201

Mental and behavioural disorders due to psychoactive substance use

2879

13558

2.06

258.65

3.7

3.5

130.27

130.58

g/l

0.28

2797

13246

Diverticular disease of intestine

3470

11708

1.97

258.36

3.8

3.1

127.23

129.62

g/l

7.07

3398

11446

Obesity and other hyperalimentation

2795

13567

2.07

258.33

4.1

3.3

130.50

129.64

g/l

1.13

2729

13254

Pain in limb

3723

13500

1.91

257.67

4.5

3.3

128.09

129.50

g/l

3.15

3636

13203

Myocardial infarction

2444

8106

2.24

255.89

4.7

2.7

123.35

130.64

g/l

40.88

2370

7947

Substance abuse

2803

13376

2.06

253.11

3.7

3.5

130.22

130.62

g/l

0.38

2722

13070

Asthma

3315

8928

2.01

252.39

3.8

2.8

130.80

131.86

g/l

1.64

3242

8745

Dizziness and giddiness

3499

15060

1.91

250.00

3.7

3.3

128.99

128.79

g/l

0.21

3417

14720

ILD medications: immunosuppressive drugs

2889

13836

2.02

248.19

7.4

2.8

120.54

131.67

g/l

113.97

2825

13520

Obesity due to excess calories

2135

9909

2.26

248.13

4.3

3.3

130.13

129.83

g/l

0.23

2089

9686

Diseases of the digestive system

2426

11858

2.15

244.79

4.9

3.4

119.66

129.38

g/l

69.31

2365

11576

GI-bleeding

1878

8371

2.41

244.74

4.9

3.4

117.99

129.17

g/l

67.22

1833

8163

Hypokalaemia

795

2259

3.96

243.94

5.4

2.8

124.08

128.43

g/l

5.63

775

2201

Unstable angina pectoris

1975

6955

2.39

243.65

4.5

2.8

126.14

129.78

g/l

9.42

1909

6812

Other diseases of the digestive system

1866

8321

2.40

243.02

4.9

3.4

117.78

129.15

g/l

68.90

1821

8110

Convulsions, not elsewhere classified

1167

4083

3.00

242.01

4.4

3.0

129.54

132.02

g/l

2.94

1139

3987

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2916

15111

1.99

241.19

5.1

3.1

122.09

129.76

g/l

56.40

2822

14786

Other soft tissue disorders, not elsewhere classified

4152

13814

1.82

239.85

4.4

3.3

128.71

129.64

g/l

1.71

4050

13506

Examination and observation for other reasons

2765

7924

2.10

239.75

4.0

2.8

126.38

131.03

g/l

18.66

2732

7736

Other anaemias

2345

10911

2.17

238.02

5.7

3.2

110.96

129.70

g/l

267.68

2283

10636

Sub-endpoint used in defining T1D endpoints

1591

6561

2.54

236.09

5.7

3.6

123.91

130.21

g/l

20.91

1543

6411

Other and unspecified anaemias

2325

10850

2.17

235.87

5.7

3.2

110.86

129.69

g/l

267.71

2263

10576

Cardiodefibrillation

2059

9695

2.28

234.53

3.8

3.4

135.57

127.29

g/l

45.51

2021

9446

Oedema, not elsewhere classified

1567

6449

2.54

234.32

4.7

2.8

124.73

129.74

g/l

13.86

1527

6305

Personality disorders, excluding more controls

1101

3855

3.01

232.89

3.2

131.77

132.04

g/l

0.14

1079

3782

Disorders of gallbladder, biliary tract and pancreas

4425

16378

1.76

231.84

4.2

3.3

127.93

129.36

g/l

3.63

4322

16009

Unspecified kidney failure

773

2248

3.96

231.49

7.6

2.7

114.65

129.55

g/l

61.18

757

2193

Fall on same level

4906

16046

1.71

229.87

4.0

3.4

128.16

130.68

g/l

10.85

4798

15656

Other neurological diseases

3473

15201

1.87

229.43

3.9

3.3

128.79

128.34

g/l

0.53

3394

14852

Injuries to the head

4854

17976

1.71

229.02

3.5

3.6

129.50

129.52

g/l

0.02

4748

17553

Pacemaker

1963

8795

2.30

227.38

5.3

3.2

122.62

127.37

g/l

16.44

1878

8591

Asthma (only as main-diagnosis)

2976

8928

1.99

226.60

3.8

2.8

130.09

131.86

g/l

3.65

2912

8745

Autoimmune diseases excluding thyroid diseases

4629

14975

1.74

225.69

4.6

3.2

126.42

130.92

g/l

29.79

4522

14638

Pain, not elsewhere classified

1280

4937

2.74

225.63

4.9

2.8

128.89

130.92

g/l

2.36

1245

4822

Statin medication

2697

7603

2.06

223.40

4.3

2.8

129.48

131.97

g/l

5.71

2627

7432

Asthma, hospital admission 2, infections

2744

14161

1.98

223.32

4.2

3.6

128.81

128.80

g/l

0.01

2673

13831

Asthma-related infections

2744

14161

1.98

223.32

4.2

3.6

128.81

128.80

g/l

0.01

2673

13831

2757

13135

1.98

221.63

3.7

3.5

129.27

130.67

g/l

2.23

2676

12836

2856

13405

1.95

220.95

3.6

3.5

129.39

130.67

g/l

1.99

2771

13100

Oxycodone

2031

8724

2.23

220.42

4.6

3.1

119.46

130.21

g/l

76.44

1967

8548

Autoimmune diseases excluding thyroid diseases, strict definition

4476

14500

1.74

220.10

4.5

3.2

126.40

130.84

g/l

28.07

4378

14180

Asthma (mode)

3173

9031

1.94

220.01

3.6

2.8

130.73

131.92

g/l

1.96

3104

8847

Oral corticosteroids

4656

16608

1.71

219.82

4.2

3.1

127.48

130.22

g/l

11.99

4534

16244

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

859

2725

3.41

218.48

3.4

132.92

131.76

g/l

0.81

832

2669

Mental and behavioural disorders due to alcohol

2454

12069

2.04

218.04

3.6

3.5

130.09

130.66

g/l

0.57

2382

11797

Cerebrovascular diseases

3552

14135

1.84

217.70

4.0

3.3

126.95

128.72

g/l

4.29

3475

13802

Concussion

2075

8041

2.18

216.64

3.6

3.4

131.01

129.11

g/l

3.33

2033

7866

Inflammatory bowel disease treatment related agents

4930

16917

1.67

212.34

4.7

3.2

127.41

130.31

g/l

13.87

4806

16547

Neurological diseases, wide definition

1121

1869

3.12

210.27

4.0

3.3

132.02

131.14

g/l

0.52

1093

1826

Alcohol use disorder, Swedish definition

2610

12627

1.98

209.99

3.7

3.5

128.92

130.75

g/l

3.34

2527

12345

Myocardial infarction, strict

2214

7737

2.14

209.47

4.6

2.7

123.71

130.56

g/l

33.30

2144

7593

Any mental disorder

4695

14203

1.70

208.85

3.8

3.5

130.00

129.27

g/l

1.25

4580

13883

Low back pain

3285

13263

1.84

204.62

3.5

3.3

129.66

129.40

g/l

0.27

3202

12976

All influenza

1320

5444

2.59

203.93

5.5

3.1

126.16

131.03

g/l

11.86

1279

5322

Symptoms and signs involving the urinary system

3522

15565

1.79

200.78

4.5

3.2

126.97

129.30

g/l

7.51

3432

15215

Intestinal infectious diseases

4939

17612

1.64

199.50

4.7

3.1

127.29

129.93

g/l

12.00

4810

17214

Asthma-related pneumonia

1881

9062

2.19

199.16

4.5

3.5

126.11

127.53

g/l

1.87

1835

8840

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2157

10873

2.07

199.11

3.7

3.5

129.63

130.90

g/l

1.61

2090

10624

Asthma, hospital admissions 3, pneumonia

1883

9076

2.19

199.08

4.5

3.5

126.11

127.53

g/l

1.88

1837

8853

Asthma-related pneumonia or sepsis

1883

9076

2.19

199.08

4.5

3.5

126.11

127.53

g/l

1.88

1837

8853

Any death

3042

12138

1.88

199.00

5.1

3.0

118.37

131.41

g/l

153.38

2964

11844

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1261

5131

2.59

198.77

3.2

3.4

131.14

131.33

g/l

0.11

1222

5017

Opioids

4030

12342

1.74

197.39

4.1

3.0

128.34

131.81

g/l

15.75

3929

12089

Alcohol abuse, main dg, excluding more controls

823

2712

3.30

196.90

3.5

3.4

133.18

131.42

g/l

1.26

804

2654

Volume depletion

652

1884

3.90

195.47

5.5

3.0

122.74

127.53

g/l

5.36

634

1837

Dorsalgia

4229

13610

1.71

195.22

3.4

3.3

130.61

129.51

g/l

2.23

4120

13314

Disorders resulting from impaired renal tubular function

372

718

6.77

194.59

13.3

3.7

108.42

128.69

g/l

53.77

367

705

Other functional intestinal disorders

2117

9912

2.07

194.21

4.5

3.4

126.72

128.93

g/l

4.73

2058

9674

Paralytic ileus and intestinal obstruction

1393

6021

2.47

194.11

4.3

3.2

125.07

128.48

g/l

5.97

1344

5876

Suicide or other Intentional self-harm

1145

4554

2.67

190.41

3.4

131.07

131.31

g/l

0.13

1111

4452

Lower back pain or/and sciatica

4489

18215

1.65

190.22

3.4

129.73

129.36

g/l

0.50

4377

17803

Polyarthropathies

3024

11020

1.85

190.14

4.6

3.3

124.39

130.24

g/l

33.28

2946

10791

Alcohol use disorder, ICD-based

1993

10006

2.09

188.95

3.7

3.5

129.80

130.98

g/l

1.35

1931

9777

Adjustment and management of implanted device

1072

4179

2.79

188.66

4.6

2.8

128.27

129.48

g/l

0.96

1053

4066

Other disorders of urethra and urinary system

3021

12299

1.83

186.84

4.3

3.2

125.12

128.91

g/l

16.74

2955

11990

Continuous positive airway pressure

708

1786

3.52

186.38

5.0

3.6

130.15

130.80

g/l

0.27

695

1763

Gastrointestinal diseases

2228

5506

2.08

186.05

4.0

2.5

129.32

133.67

g/l

13.41

2173

5369

Nutritional anaemias

2376

12253

1.95

185.46

4.7

3.3

114.63

129.28

g/l

163.46

2317

11953

Infections of the skin and subcutaneous tissue

2568

13937

1.89

185.25

5.2

3.4

126.13

130.84

g/l

19.59

2508

13618

Mood disorders, excluding more controls

3837

13690

1.72

185.11

3.7

3.3

130.49

129.51

g/l

1.79

3737

13381

Other pulmonary diagnosis

3206

9013

1.83

184.27

4.2

2.8

128.72

131.88

g/l

10.52

3123

8827

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4773

16414

1.62

180.47

4.4

3.2

128.60

129.77

g/l

2.70

4696

16014

Pain (limb, back, neck, head abdominally)

3075

8593

1.84

180.32

3.9

3.3

130.16

129.53

g/l

0.72

3005

8398

Constipation

3882

16405

1.69

179.07

3.9

3.5

127.10

129.13

g/l

6.57

3772

16046

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2609

14527

1.87

178.95

5.1

3.2

122.13

129.43

g/l

46.30

2525

14205

Iron deficiency anaemia

2050

10461

2.03

177.45

4.8

3.3

114.04

129.25

g/l

153.86

2001

10210

Codeine

3749

12166

1.72

177.23

3.7

3.0

129.22

131.77

g/l

8.37

3631

11914

Excluding asthma or asthma-COPD overlap

3173

9013

1.81

176.23

4.1

2.8

128.93

131.88

g/l

9.20

3095

8827

Coronary artery bypass grafting

1427

4746

2.40

174.80

4.7

2.7

117.97

129.89

g/l

62.23

1368

4653

Stroke, including SAH

2980

12440

1.81

174.31

4.0

3.3

127.16

128.28

g/l

1.77

2915

12142

Hyperkalaemia

456

1121

4.79

174.25

8.8

2.9

115.88

128.24

g/l

23.78

441

1092

Conduction disorders

1354

4819

2.40

173.27

4.5

2.8

125.61

129.26

g/l

6.96

1307

4718

Falls/tendency to fall

4397

13720

1.64

173.06

3.8

3.4

129.03

130.57

g/l

3.94

4303

13386

Amiodarone users

723

2424

3.43

172.94

4.5

3.3

135.22

128.20

g/l

11.73

711

2357

Certain infectious and parasitic diseases

3011

8470

1.83

172.53

4.0

2.6

127.95

133.05

g/l

24.81

2943

8269

Medical observation and evaluation for suspected diseases and conditions

2836

8022

1.86

172.17

4.2

2.9

129.91

130.92

g/l

1.34

2782

7832

Disorders of thyroid, IBD co-morbidities

666

1372

3.56

170.89

3.4

2.5

133.24

129.69

g/l

3.03

648

1343

Schizophrenia or delusion, excluding more controls

1265

5454

2.40

170.69

3.0

3.3

130.68

130.77

g/l

0.05

1236

5341

Diarrhoea and gastroenteritis of presumed infectious origin

4236

17571

1.63

170.51

4.8

3.1

128.14

129.91

g/l

5.16

4128

17175

COPD differential diagnosis

3154

9033

1.79

170.42

4.1

2.8

128.94

131.92

g/l

9.28

3074

8849

Other disorders of skin and subcutaneous tissue

3077

16116

1.76

170.07

4.9

3.2

123.07

129.32

g/l

43.86

3005

15746

ILD differential diagnosis

3150

9031

1.79

169.58

4.1

2.8

128.96

131.92

g/l

9.19

3071

8847

Peripheral artery disease

2257

9716

1.95

166.29

5.6

3.0

119.19

128.87

g/l

71.19

2194

9483

Myocardial infarction, without ST-elevation

2121

10353

1.97

165.25

4.8

3.2

121.89

128.30

g/l

31.11

2047

10118

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1276

5687

2.37

164.84

4.1

3.3

132.79

130.93

g/l

1.98

1254

5546

Glucagon-like peptide-1 (GLP-1) analogues

1276

5687

2.37

164.84

4.1

3.3

132.79

130.93

g/l

1.98

1254

5546

Haemorrhage from respiratory passages

1613

7079

2.15

163.05

4.8

3.1

125.90

128.16

g/l

3.36

1561

6912

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2973

15739

1.75

162.77

4.1

3.3

126.09

128.82

g/l

8.60

2916

15369

Other antidepressants

4368

14162

1.62

162.72

3.7

3.3

130.32

129.22

g/l

2.30

4261

13858

Gout

1540

6513

2.22

162.61

5.5

3.2

121.44

129.12

g/l

28.30

1494

6364

AV-block

947

3217

2.77

162.50

4.3

2.8

123.89

128.53

g/l

7.65

910

3151

4692

15626

1.59

161.75

4.2

3.1

128.78

129.28

g/l

0.75

4573

15271

Unspecified mental disorder

1707

8566

2.08

160.84

3.3

3.5

130.83

130.68

g/l

0.10

1669

8376

Stroke, excluding SAH

2823

11966

1.79

160.39

4.1

3.3

127.05

128.09

g/l

1.49

2762

11677

Hernia of abdominal wall, postoperative

889

3429

2.76

157.77

5.2

2.5

124.05

134.64

g/l

30.39

874

3358

1904

9915

1.98

157.15

4.3

3.7

130.07

129.26

g/l

0.82

1853

9697

Bronchitis

4427

18031

1.58

157.02

4.3

3.2

128.81

129.47

g/l

1.11

4327

17607

Substance use, excluding alcohol

915

3591

2.71

156.64

3.8

3.4

132.83

131.76

g/l

0.68

890

3510

Used for control exclusion in common control thyroid runs

4334

13952

1.61

156.08

4.4

3.2

128.63

130.79

g/l

7.10

4227

13644

Nerve, nerve root and plexus disorders

4427

17563

1.58

155.42

3.9

3.3

128.98

129.35

g/l

0.49

4299

17186

Glomerulonephritis

627

2046

3.43

155.01

10.1

3.4

116.81

129.63

g/l

34.05

619

1987

Intestinal stricture

1565

7786

2.13

153.56

4.3

3.6

124.38

128.08

g/l

7.65

1515

7599

Asthma (diagnoses ohter than nonallergic)

3618

18845

1.63

153.33

3.9

3.5

129.81

129.08

g/l

1.13

3534

18406

Calcific aortic valvular stenosis, operated

1648

8118

2.10

152.81

5.0

3.2

118.87

127.64

g/l

43.50

1598

7914

Calcific aortic valvular stenosis

1648

8118

2.10

152.81

5.0

3.2

118.87

127.64

g/l

43.50

1598

7914

Calcific aortic valvular stenosis, diagnosis (helper)

1645

8106

2.10

152.36

5.0

3.2

118.88

127.64

g/l

43.23

1595

7902

Operations 2 for CAVS

1645

8106

2.10

152.36

5.0

3.2

118.88

127.64

g/l

43.23

1595

7902

Personality disorders

1101

4763

2.42

151.50

3.2

3.5

131.77

131.87

g/l

0.05

1079

4654

Vocal cord dysfunction

469

1109

3.98

151.45

3.7

2.7

127.62

131.72

g/l

2.83

450

1087

Other or unspecified ileus, impaction or obstruction

1002

4186

2.57

151.38

4.3

3.3

124.71

128.33

g/l

4.89

967

4090

Neurological diseases

3335

10069

1.70

150.96

3.9

3.5

131.41

128.78

g/l

8.16

3249

9847

Calcific aortic valvular stenosis, including rheumatic fever

1646

8131

2.09

150.92

5.0

3.2

118.91

127.62

g/l

42.75

1596

7926

Persons encountering health services in other circumstances, wide

4866

16551

1.55

150.16

4.4

3.2

129.16

129.70

g/l

0.84

4762

16148

Psychiatric diseases

4054

12852

1.62

149.86

3.7

3.5

130.02

129.29

g/l

1.13

3951

12564

Anxiety disorders, excluding more controls

3160

12404

1.70

149.74

4.1

3.3

131.35

129.62

g/l

3.96

3087

12131

Obesity, other/unspecified

1374

6539

2.19

149.57

4.2

3.3

130.18

129.90

g/l

0.17

1343

6393

Other disorders of kidney and ureter

782

2938

2.94

149.47

9.2

3.4

116.64

128.87

g/l

39.94

770

2862

Alcohol abuse, main dg

823

3166

2.80

148.14

3.5

133.18

131.32

g/l

1.42

804

3088

Diabetic maculopathy, excluding more controls

611

2005

3.34

148.11

6.2

2.9

117.68

131.55

g/l

36.88

593

1951

Episodal and paroxysmal disorders

4403

14521

1.58

147.53

3.9

3.4

131.48

128.46

g/l

14.12

4297

14172

COPD (mode)

1485

5671

2.16

147.41

4.4

2.7

127.33

130.35

g/l

4.79

1444

5550

Genitourinary diseases

2422

6711

1.86

146.60

5.0

2.8

129.11

134.66

g/l

21.27

2360

6561

Problems related to lifestyle

562

1760

3.47

146.60

3.9

3.2

134.07

132.53

g/l

0.77

547

1714

Insulin, fast-acting (human)

701

2488

3.02

146.40

6.4

3.1

122.05

132.48

g/l

23.78

683

2426

Autoimmune diseases

4522

15043

1.56

145.50

4.5

3.2

127.76

130.92

g/l

15.02

4411

14705

Disorders of adult personality and behaviour

1134

5057

2.34

145.14

3.2

3.5

131.68

131.88

g/l

0.11

1106

4944

Diabetic nephropathy, excluding more controls

965

3302

2.67

144.98

9.0

3.1

114.14

131.08

g/l

88.66

941

3227

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

499

960

3.94

144.75

5.0

2.9

125.80

128.50

g/l

1.42

480

940

Atherosclerosis, excluding cerebral and coronary sclerosis

2091

9161

1.90

143.17

5.5

3.0

119.26

128.62

g/l

62.27

2035

8940

Other acute lower respiratory infections

2343

12846

1.80

142.77

4.7

3.6

127.92

129.08

g/l

1.67

2287

12546

Intracranial injury

2520

13989

1.76

142.56

3.5

3.6

129.21

129.30

g/l

0.07

2468

13655

Combinations of oral blood glucose lowering drugs

1334

6431

2.20

142.41

3.3

129.11

129.78

g/l

0.47

1317

6270

Other reaction to severe stress, and adjustment disorders

1351

6506

2.15

141.80

4.1

3.3

129.95

130.98

g/l

0.90

1315

6362

Transient ischemic attack

2435

11445

1.79

141.09

3.8

3.3

128.56

127.69

g/l

1.08

2387

11154

Alcohol dependence

1299

6219

2.21

140.91

3.9

3.5

129.98

130.49

g/l

0.32

1269

6073

Benign neoplasm of colon, rectum, anus and anal canal

2857

15081

1.71

140.86

4.2

3.2

125.26

128.78

g/l

12.71

2794

14747

Other special examinations and investigations of persons without complaint or reported diagnosis

2730

8025

1.77

140.60

4.2

2.9

128.82

130.91

g/l

4.39

2665

7835

Other dorsopathies, not elsewhere classified

4043

13642

1.59

139.53

3.5

3.3

130.74

129.52

g/l

2.60

3935

13344

Viral pneumonia

692

2528

2.96

137.92

6.3

3.2

124.86

131.01

g/l

9.10

665

2467

Cholelithiasis, broad definition with cholecystitis

3554

15229

1.61

137.23

3.7

3.2

128.71

128.87

g/l

0.16

3473

14884

Cardiomyopathy

818

3249

2.69

137.10

5.2

2.9

128.77

130.49

g/l

1.13

792

3176

Gastroduodenal ulcer

1336

6524

2.16

136.66

4.5

3.2

119.09

128.49

g/l

35.11

1310

6368

Chronic lower respiratory diseases

4824

17316

1.51

136.23

3.8

3.5

130.11

129.47

g/l

1.08

4708

16917

Acute alcohol intoxication, ICD10

991

4317

2.44

135.93

3.5

3.6

133.37

131.29

g/l

2.04

967

4219

Ulcer of lower limb, not elsewhere classified

855

3519

2.66

135.41

6.9

3.2

115.47

128.75

g/l

51.47

843

3438

Other and unspecified iron deficiency

1561

8089

2.02

135.22

4.6

3.3

114.17

129.20

g/l

119.43

1526

7898

Specific personality disorders

939

3988

2.47

134.83

3.2

3.6

131.50

131.52

g/l

0.01

917

3899

Gout, FINNGEN

1540

7974

2.04

134.38

5.5

3.2

121.44

129.30

g/l

30.63

1494

7777

Sciatica+with lumbago

2108

11004

1.82

133.78

3.5

3.3

130.20

129.17

g/l

1.27

2055

10768

Other retinal disorders

2867

13704

1.69

133.67

4.8

3.2

124.81

128.80

g/l

16.69

2784

13391

Abnormal findings on examination of blood, without diagnosis

2187

11567

1.81

133.27

5.2

3.4

124.42

129.79

g/l

21.12

2131

11299

Osteopathies and chondropathies

2382

13079

1.76

132.85

5.0

3.3

124.22

129.07

g/l

21.45

2323

12782

Implicit fungal Sepsis

428

1214

3.99

132.44

8.5

2.6

118.65

129.56

g/l

16.15

415

1181

Acute alcohol intoxication

1221

5861

2.20

131.30

3.5

131.89

130.19

g/l

1.74

1189

5722

Obesity related asthma

1490

7677

2.03

131.18

4.6

3.5

131.13

129.23

g/l

2.46

1457

7496

Factors influencing health status and contact with health services

1243

2810

2.29

130.50

3.5

2.2

129.39

135.08

g/l

11.49

1213

2758

Codeine or tramadol medication

4542

16724

1.52

130.21

3.7

3.2

128.94

129.79

g/l

1.52

4399

16373

Depression

3709

16354

1.57

129.81

3.8

3.3

130.86

129.74

g/l

2.24

3613

15984

Viral hepatitis, IBD co-morbidity

246

450

5.90

129.78

4.0

2.5

130.52

133.51

g/l

0.90

240

441

Unspecified haematuria

1998

9320

1.85

129.74

4.7

3.3

126.02

129.37

g/l

8.46

1959

9086

Ischaemic Stroke, excluding all haemorrhages

2588

11590

1.73

129.60

4.1

3.3

126.88

127.94

g/l

1.43

2530

11301

Mood disorders

4049

17358

1.54

129.31

3.7

3.3

130.62

129.56

g/l

2.17

3942

16965

Benign neoplasm: Colon

2452

14086

1.73

128.07

4.3

3.3

125.27

128.47

g/l

9.31

2399

13754

Mood [affective] disorders

4033

17346

1.54

127.85

3.7

3.3

130.64

129.56

g/l

2.26

3927

16954

Kela-code for severe mental illness

1496

7783

2.00

127.31

3.2

3.5

130.53

130.72

g/l

0.13

1459

7605

Disorders of other endocrine glands

1851

10135

1.86

127.16

6.3

3.5

124.96

128.94

g/l

11.36

1809

9907

Cholelithiasis

3380

14993

1.59

125.24

3.6

3.2

128.71

128.80

g/l

0.08

3304

14652

Anxiety (asthma-related co-morbidities)

2104

9303

1.79

125.21

4.1

3.5

132.41

130.80

g/l

2.64

2059

9096

Disorders of choroid and retina

3441

15861

1.58

124.40

4.6

3.2

125.72

129.29

g/l

15.72

3348

15511

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

392

1093

3.98

123.49

3.8

3.6

131.99

130.37

g/l

0.73

381

1067

Other bacterial intestinal infections

911

3995

2.43

123.33

7.1

3.0

119.57

128.77

g/l

26.53

887

3899

Misadventures to patients during surgical and medical care

731

2916

2.70

122.43

5.1

2.9

122.87

129.28

g/l

10.83

713

2847

Streptococcal septicaemia

507

1675

3.34

122.10

5.3

2.8

117.66

131.40

g/l

27.79

495

1627

Fungal Sepsis

303

717

4.99

121.85

9.8

2.5

115.75

129.58

g/l

17.71

296

699

Venous thromboembolism

2387

13969

1.71

121.10

4.3

3.2

125.61

128.41

g/l

7.47

2336

13630

External causes of morbidity and mortality

2458

7230

1.74

121.05

3.6

3.3

129.14

131.14

g/l

3.75

2391

7073

Other CVD

1085

5176

2.25

120.33

4.6

3.3

123.79

127.12

g/l

5.62

1048

5051

Epilepsy

1361

6974

2.03

120.26

4.2

3.7

129.34

127.99

g/l

1.40

1331

6806

Unspecified fall

2175

12718

1.74

119.45

4.2

3.6

128.18

128.83

g/l

0.67

2127

12420

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

777

3115

2.58

118.94

7.6

4.6

121.33

130.90

g/l

22.33

760

3036

Retention of urine

1681

7567

1.91

118.94

4.3

3.2

124.98

129.08

g/l

10.68

1633

7364

Explicit bacterial Sepsis

566

2017

3.05

118.37

5.5

2.9

117.80

130.83

g/l

28.83

552

1967

Emotionally unstable personality disorder

501

1657

3.21

118.07

3.1

132.64

132.70

g/l

0.02

489

1619

Other external causes of accidental injury

3140

9913

1.62

117.97

3.9

3.4

129.12

130.07

g/l

1.37

3065

9678

Disorders of lens

2798

10868

1.66

117.82

4.9

3.2

124.78

130.31

g/l

27.74

2719

10657

General examination and investigation of persons without complaint and reported diagnosis

2554

7997

1.71

117.80

4.3

2.9

128.37

130.96

g/l

6.02

2486

7807

Sequelae of external causes of morbidity and mortality

1204

5997

2.12

117.67

4.7

3.5

122.44

128.96

g/l

17.98

1176

5850

Disorders of mineral metabolism

459

1461

3.46

117.46

7.2

2.9

120.17

129.67

g/l

14.86

448

1423

Cutaneous abscess, furuncle and carbuncle

1114

5420

2.15

115.18

5.8

3.5

125.44

131.10

g/l

12.26

1086

5301

Disorders of calcium metabolism

381

1096

3.90

115.12

7.6

2.8

118.18

128.84

g/l

15.78

373

1065

Acute peritonitis

427

1328

3.65

115.11

10.6

3.3

113.22

128.18

g/l

29.27

421

1293

Other diseases of urinary system

3945

14912

1.52

114.19

4.2

3.3

126.87

129.86

g/l

13.04

3857

14556

Implicit fungal Sepsis

278

648

5.07

114.02

9.9

2.5

115.91

129.59

g/l

15.88

271

631

Liquid cancers, helper endpoint

1746

8582

1.85

113.88

4.9

3.3

118.77

130.98

g/l

83.55

1700

8380

Accidents

3113

9913

1.61

112.82

3.8

3.4

129.18

130.07

g/l

1.25

3036

9678

Exposure to unspecified factor

3932

19245

1.50

112.81

3.8

3.5

129.13

129.52

g/l

0.49

3858

18776

Schizophrenia or delusion

1265

6482

2.03

112.64

3.0

3.5

130.68

131.17

g/l

0.33

1236

6335

Soft tissue disorders

4021

13972

1.51

112.01

4.4

3.4

129.79

129.70

g/l

0.08

3922

13658

Spondylopathies

3193

12353

1.58

111.93

3.3

128.96

128.99

g/l

0.02

3105

12091

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

803

3366

2.46

111.61

7.4

4.5

121.51

130.73

g/l

21.55

784

3279

Pulmonary heart disease, diseases of pulmonary circulation

1507

8234

1.92

111.61

4.4

3.3

125.84

127.59

g/l

2.10

1466

8035

Early onset COPD, excluding more controls

895

4048

2.33

111.47

4.7

2.7

129.97

132.08

g/l

1.77

871

3965

Schizophrenia, schizotypal and delusional disorders

1269

6539

2.02

111.17

3.0

3.5

130.65

131.13

g/l

0.32

1239

6393

Cardiac arrest

302

621

4.49

109.98

6.5

2.4

122.85

133.65

g/l

10.87

284

614

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

353

988

3.90

109.80

3.5

3.4

136.14

135.17

g/l

0.32

342

974

Benzodiazepine use

3969

18702

1.49

109.46

3.6

3.4

129.37

129.40

g/l

0.03

3869

18284

Hypertensive Renal Disease

253

561

5.20

109.46

8.3

2.5

111.02

128.83

g/l

25.64

248

550

Cholecystectomy

2846

15813

1.59

109.37

3.6

3.3

129.51

128.08

g/l

2.79

2782

15443

Neurotic, stress-related and somatoform disorders

3287

15173

1.55

108.56

4.1

3.4

131.43

129.88

g/l

3.53

3214

14823

Type 1 diabetes, definitions combined

417

1298

3.42

108.45

4.4

4.7

131.32

135.23

g/l

2.86

405

1269

Type 1 diabetes, strict (exclude DM2)

414

1287

3.42

107.93

4.4

4.9

131.27

135.05

g/l

2.69

402

1259

Autoimmune diseases related-to ILD

3312

18894

1.53

107.72

4.3

3.3

128.11

129.75

g/l

3.88

3228

18473

Diseases of liver

1497

8247

1.89

107.55

4.5

3.4

123.07

129.80

g/l

21.18

1459

8044

Other bacterial intestinal infections

1033

5032

2.16

106.86

6.7

3.1

120.53

128.98

g/l

25.98

1008

4915

DVT of lower extremities and pulmonary embolism

1876

11008

1.76

106.72

4.2

3.2

126.13

127.99

g/l

2.96

1838

10737

Hydronephrosis

583

2233

2.82

106.15

5.1

2.6

118.15

131.36

g/l

34.24

570

2174

Anxiety disorders

3316

15360

1.54

105.69

4.1

3.4

131.50

129.83

g/l

4.07

3241

15002

Other anxiety disorders

1567

7536

1.85

105.34

3.7

3.4

132.23

131.21

g/l

1.05

1535

7368

Non-allergic asthma (mode), excluding more controls

766

3288

2.41

104.87

3.6

2.8

128.89

131.28

g/l

2.06

750

3224

Gout, idiopatic and unspecified

1267

6708

2.00

104.77

5.6

3.3

122.01

129.04

g/l

20.40

1231

6535

Unspecified acute lower respiratory infection

744

3218

2.47

104.09

5.7

3.4

126.98

130.48

g/l

3.77

729

3144

Bacterial intestinal infections, IBD co-morbidities

904

4240

2.27

104.05

7.1

3.3

119.71

128.50

g/l

24.41

879

4136

Asthma, hospital admissions , main diagnosis only

3179

18705

1.53

103.79

3.8

3.5

129.74

129.29

g/l

0.54

3109

18262

All anxiety disorders

2131

10185

1.69

103.75

4.1

3.4

132.44

130.83

g/l

2.69

2086

9945

Asthma/COPD (KELA code 203)

3696

17287

1.50

103.50

3.7

3.4

130.19

129.47

g/l

1.11

3609

16888

Cystic kidney disease

254

599

5.09

103.25

8.8

3.7

111.28

129.01

g/l

25.68

249

591

Other diseases of pleura

2077

11074

1.71

102.99

5.1

3.3

123.68

128.31

g/l

15.41

2013

10804

Congenital malformations of the urinary system

350

1042

3.77

100.57

8.5

4.5

115.01

130.04

g/l

24.69

342

1015

Dermatitis

2441

15497

1.61

100.57

4.1

3.3

126.77

129.23

g/l

6.14

2385

15141

Cystic kidney disease

261

646

4.79

99.35

8.6

3.7

111.57

128.88

g/l

25.37

255

636

Cough

1504

8000

1.83

98.76

4.3

3.3

129.35

128.63

g/l

0.60

1470

7819

Status post-ami

1212

4822

2.01

98.56

4.1

2.7

125.59

129.80

g/l

8.30

1182

4728

Hypotension

925

4485

2.21

98.53

4.6

3.2

124.33

126.92

g/l

3.19

903

4377

Other intervertebral disc disorders

3198

12824

1.53

98.46

3.6

3.3

130.07

129.21

g/l

1.24

3094

12549

Enterocolitis due to Clostridium difficile

600

2442

2.67

97.08

7.8

3.1

116.61

127.51

g/l

25.06

580

2378

Congenital malformations of the urinary system

361

1121

3.59

96.89

8.3

4.5

115.43

129.90

g/l

23.80

352

1092

Elevated blood glucose level

468

1686

3.05

96.77

7.5

3.4

125.67

129.80

g/l

3.17

456

1637

Finngen Rheumatological endpoints

3611

14038

1.49

96.54

3.9

3.3

129.12

130.71

g/l

3.65

3511

13732

Dorsopathies

3907

13718

1.47

96.49

3.7

3.4

130.84

129.51

g/l

2.95

3805

13417

Asthma, including avohilmo

4569

18331

1.42

96.08

3.6

3.5

130.59

129.20

g/l

3.71

4466

17903

Chronic pancreatitis

641

2703

2.56

95.81

4.9

3.4

123.88

130.16

g/l

9.03

625

2641

Viral and other specified intestinal infections

810

3635

2.26

95.79

6.9

3.3

126.74

132.39

g/l

9.54

783

3552

Pulmonary embolism

1345

7441

1.89

95.71

4.4

3.3

125.44

127.68

g/l

2.90

1313

7263

Abnormal findings on diagnostic imaging of lung

2094

12503

1.66

95.37

4.2

3.3

125.70

128.48

g/l

6.49

2056

12191

Superficial injury of head

1040

5293

2.06

95.07

3.4

3.5

128.39

128.82

g/l

0.26

1016

5168

Vascular disorders of the intestines

423

1461

3.22

94.87

5.4

3.0

115.89

128.26

g/l

21.15

410

1426

Disorder of lipoprotein metabolism, unspecified

655

2795

2.51

94.85

4.6

2.8

127.78

128.51

g/l

0.34

644

2726

Viral and other specified intestinal infections

1011

4896

2.06

94.30

6.2

3.3

127.35

132.23

g/l

8.81

978

4780

Pulmonary heart disease

1345

7483

1.88

93.97

4.4

3.3

125.44

127.70

g/l

2.94

1313

7301

Diseases of the respiratory system

2400

7510

1.63

93.80

3.7

2.8

128.37

131.06

g/l

6.22

2335

7361

Delirium, not induced by alcohol and other psychoactive substances

664

2870

2.50

93.66

4.5

3.2

125.54

126.69

g/l

0.64

650

2792

Sulfonylureas

1540

7025

1.82

93.45

4.5

3.1

121.82

127.73

g/l

19.90

1507

6837

Amputation

588

2418

2.66

93.42

7.7

3.2

113.46

128.52

g/l

45.23

574

2359

Other disorders of glucose regulation and pancreatic internal secretion

464

1693

2.99

93.39

5.8

3.7

124.28

129.27

g/l

4.50

451

1646

Diabetic retinopathy, excluding more controls

1352

4107

1.96

93.29

6.0

3.1

122.11

131.01

g/l

32.29

1319

4011

COPD

1998

10060

1.68

93.21

4.5

3.3

127.76

127.91

g/l

0.10

1943

9821

Persons encountering health services for examination and investigation

2526

8025

1.61

93.07

3.6

2.9

129.42

130.91

g/l

2.35

2468

7835

Diseases of the skin and subcutaneous tissue

3888

13549

1.46

93.01

4.3

3.1

128.08

130.68

g/l

9.45

3794

13224

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

894

4376

2.17

92.40

3.6

3.2

118.36

130.56

g/l

50.31

878

4259

Cardiomyopathies, Primary/intrinsic

552

2199

2.68

92.32

5.7

2.9

129.19

130.41

g/l

0.53

532

2149

Nonorganic sleeping disorders, excluding more controls

697

3066

2.37

92.23

3.8

3.4

132.84

130.53

g/l

1.99

683

3000

Peripheral artery operations in Hilmo

684

3018

2.43

91.92

7.1

3.0

113.85

129.05

g/l

55.32

671

2950

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

463

1700

2.96

91.82

5.7

3.1

126.30

129.87

g/l

2.79

449

1664

Open wound of head

2225

13659

1.61

91.56

3.5

3.7

128.46

129.40

g/l

1.12

2176

13343

Senile cataract

2524

9970

1.59

91.44

4.5

3.2

124.86

129.93

g/l

21.65

2450

9777

ILD medications: azathioprine

630

2680

2.48

90.86

9.6

2.8

121.31

132.53

g/l

27.24

616

2620

Benign neoplasms

3737

14342

1.46

90.21

3.9

3.3

129.35

130.47

g/l

2.07

3643

14021

Congenital malformations, deformations and chromosomal abnormalities

2051

12221

1.64

90.06

5.1

3.5

127.60

131.03

g/l

9.08

1999

11941

Other symptoms and signs involving cognitive functions and awareness

1919

10778

1.67

89.95

3.5

3.3

127.93

128.00

g/l

0.04

1871

10513

Hernia

3603

16867

1.46

89.10

4.1

3.4

126.92

129.93

g/l

11.58

3531

16470

Acute upper respiratory infections of multiple and unspecified sites

2792

13794

1.53

88.89

4.3

3.3

130.14

129.41

g/l

0.95

2738

13468

Other headache syndromes

1498

8692

1.77

88.61

3.6

3.2

131.47

127.96

g/l

8.22

1464

8494

Injuries to the thorax

1913

11884

1.66

88.24

4.0

3.4

128.31

129.18

g/l

0.92

1875

11602

Cardiomyopathy (excluding other)

568

2343

2.58

88.23

5.7

2.9

129.08

130.56

g/l

0.70

547

2291

Acute bronchitis

1677

9868

1.72

88.22

4.5

3.6

128.10

128.40

g/l

0.21

1634

9637

Other gastritis (incl. Duodenitis)

1010

5236

2.02

87.99

4.3

3.2

123.84

129.10

g/l

9.94

990

5112

Other infectious diseases

501

1963

2.78

87.88

6.0

3.3

123.07

128.19

g/l

5.34

495

1910

Disorders of parathyroid gland

970

4909

2.06

87.71

6.8

3.0

119.52

126.47

g/l

19.75

949

4785

Cytomegalovirus infection, IBD co-morbidity

188

398

5.81

87.69

11.6

3.7

108.87

129.63

g/l

27.13

179

393

Other/unspecified dorsalgia

1461

8389

1.78

87.55

3.6

3.3

129.22

128.47

g/l

0.64

1424

8202

Hyperparathyroidism

881

4327

2.13

87.07

6.8

3.0

119.27

126.54

g/l

19.18

863

4217

Functional dyspepsia

1057

5568

1.98

87.06

4.0

3.2

130.83

129.35

g/l

1.44

1033

5447

Cytomegaloviral disease

188

400

5.71

86.92

11.6

3.6

108.87

129.01

g/l

25.78

179

394

Peripheral arterial reconstruction

899

4528

2.12

86.45

6.1

3.3

116.55

127.47

g/l

39.38

872

4415

Non-allergic asthma (mode)

767

3571

2.22

86.37

3.6

2.9

128.86

129.99

g/l

0.67

751

3500

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

221

533

4.66

85.54

8.3

3.0

120.20

135.41

g/l

14.18

215

524

Osteoporosis

1175

6024

1.91

85.33

5.2

3.0

123.11

126.62

g/l

6.82

1143

5879

Gastric ulcer

859

4260

2.13

85.29

4.7

3.2

118.52

128.50

g/l

27.11

840

4154

Sequelae with surgical and medical care as external cause

928

4734

2.07

85.20

4.7

3.4

121.38

128.60

g/l

17.02

906

4618

Bipolar affective disorders

677

3049

2.31

84.79

2.8

3.3

131.93

131.36

g/l

0.28

662

2987

Other chronic obstructive pulmonary disease

1898

9744

1.66

84.73

4.5

3.3

127.75

127.83

g/l

0.05

1845

9517

Hypoglycaemia, other or unspecified

382

1327

3.16

84.42

6.0

3.9

123.90

129.05

g/l

3.93

372

1295

Neoplasms

2701

9443

1.54

84.23

4.9

3.3

128.46

133.48

g/l

21.73

2635

9235

Injuries to the abdomen, lower back, lumbar spine and pelvis

1653

9909

1.71

84.20

3.8

3.4

126.86

128.59

g/l

2.46

1620

9666

Other and unspecified drugs and medicaments

446

1685

2.88

84.05

5.7

3.3

126.07

128.85

g/l

1.80

433

1644

Other and unspecified nonorganic psychotic disorders

721

3354

2.24

83.53

2.9

3.5

132.35

132.46

g/l

0.05

705

3275

Use of hypnotics and sedatives

4066

16765

1.42

83.49

3.9

3.3

128.12

129.94

g/l

5.32

3968

16387

Injury, poisoning and certain other consequences of external causes

1938

5921

1.67

83.26

3.6

3.3

128.80

130.88

g/l

3.29

1888

5782

Other and unspecified dermatitis

1993

12689

1.61

82.63

4.0

3.3

127.00

129.16

g/l

4.08

1949

12394

Azathioprine

630

2797

2.37

82.41

9.6

3.2

121.31

131.59

g/l

23.26

616

2733

Diseases of peritoneum

524

2168

2.61

81.77

9.2

3.1

115.98

128.61

g/l

26.57

515

2112

Transport accidents

1630

8458

1.70

81.58

3.3

3.2

131.43

130.61

g/l

0.73

1589

8260

Other cataract

1802

8427

1.67

81.43

4.9

3.2

124.08

129.57

g/l

18.62

1756

8248

Injuries to the hip and thigh

2010

11629

1.61

81.35

4.0

3.4

124.51

128.52

g/l

12.64

1968

11346

Type 1 diabetes, strict definition, subgroup 1

291

868

3.55

81.07

4.2

5.1

132.70

136.59

g/l

2.07

281

851

Organic, including symptomatic, mental disorders

2221

10264

1.59

81.05

3.6

3.4

127.00

127.26

g/l

0.21

2171

10003

Gout, strict definition

926

4823

2.04

80.93

5.8

3.3

122.01

128.62

g/l

13.71

899

4699

Gout, unspecified

1010

5417

1.97

80.46

5.5

3.3

121.88

128.94

g/l

16.53

980

5276

Ascites

394

1428

3.01

80.43

7.0

2.8

113.26

128.97

g/l

34.00

385

1383

Dysphagia

997

5294

1.96

80.32

4.0

3.1

126.29

128.30

g/l

2.04

967

5164

Panic disorder

510

2079

2.56

80.09

3.8

3.0

132.98

131.74

g/l

0.60

496

2037

Mycoses

1092

5986

1.90

79.86

5.7

3.4

125.11

129.56

g/l

8.13

1067

5838

Symptoms and signs concerning food and fluid intake

465

1829

2.70

79.47

5.8

2.9

125.20

129.98

g/l

4.46

447

1779

Cellulitis

926

4844

2.00

78.39

5.4

3.4

124.19

130.49

g/l

13.37

903

4735

Type 1 diabetes, strict definition

302

950

3.36

77.18

4.4

5.4

132.84

136.45

g/l

1.89

292

930

Intestinal adhesions without obstruction

439

1718

2.77

77.01

3.8

3.2

126.86

129.15

g/l

1.24

422

1676

Other viral diseases

1054

5744

1.89

76.97

6.9

4.0

125.75

131.47

g/l

12.16

1026

5612

Non-selective monoamine reuptake inhibitors

1494

8697

1.71

76.63

3.9

3.2

127.63

127.92

g/l

0.20

1444

8509

Diabetic nephropathy

971

5198

2.00

76.61

9.0

3.5

114.18

128.87

g/l

74.59

946

5077

Focal epilepsy

910

4780

1.99

76.10

3.9

3.8

129.54

129.45

g/l

0.04

893

4661

COPD related to multimorbidity

1747

9287

1.65

75.31

4.7

3.3

127.50

127.76

g/l

0.17

1698

9057

Shoulder lesions

2936

12316

1.47

74.92

3.5

3.1

130.36

129.31

g/l

1.59

2842

12042

Viral infections characterized by skin and mucous membrane lesions

1613

9996

1.66

74.87

5.3

3.5

127.28

129.61

g/l

3.85

1565

9769

Conductive and sensorineural hearing loss

3133

14899

1.45

74.36

3.7

3.4

127.39

128.90

g/l

3.11

3047

14573

Acute sinusitis

1774

10398

1.62

73.96

4.3

3.3

131.03

130.11

g/l

0.95

1728

10160

Enlarged lymph nodes

591

2668

2.31

73.87

4.2

3.0

126.67

131.26

g/l

4.81

579

2608

Cervicobrachial syndrome

835

4317

2.01

72.71

3.2

3.4

131.88

128.61

g/l

4.17

815

4216

Iron deficiency anaemia secondary to blood loss (chronic)

750

3755

2.11

72.70

5.5

3.2

111.18

129.15

g/l

69.15

727

3669

Acute pancreatitis

855

4475

2.00

72.55

4.6

3.4

128.32

129.68

g/l

0.86

827

4366

Anaemia in chronic diseases classified elsewhere

187

462

4.86

71.85

13.3

3.1

107.12

129.53

g/l

37.66

182

448

Sensorineural hearing loss

3010

14402

1.45

71.61

3.6

3.4

127.35

128.73

g/l

2.59

2925

14091

Malignant neoplasm

3123

13044

1.44

71.30

4.6

3.4

124.21

132.00

g/l

61.07

3059

12740

Congenital malformations, deformations and chromosomal abnormalities

2175

13384

1.53

71.06

5.0

3.4

127.90

130.82

g/l

7.14

2117

13064

Depression or dysthymia

2514

9376

1.51

71.05

3.7

3.4

130.68

128.95

g/l

3.16

2441

9174

Symptoms and signs involving the skin and subcutaneous tissue

2598

17639

1.47

70.85

4.4

3.4

129.39

128.94

g/l

0.48

2532

17227

Tobacco use

284

923

3.39

70.63

3.7

3.2

133.88

130.75

g/l

1.27

278

906

Presence of other functional implants

2280

10612

1.53

70.35

4.2

2.8

125.23

129.86

g/l

18.26

2217

10394

Amputation of toe

413

1652

2.75

70.17

8.2

3.1

112.87

128.02

g/l

34.21

404

1605

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

700

3471

2.15

70.16

5.0

3.6

115.89

129.95

g/l

39.74

686

3387

Decubitus ulcer and pressure area

365

1373

2.94

70.12

7.2

3.1

116.68

127.69

g/l

14.56

357

1340

Other diseases of pericardium

247

741

3.70

70.04

6.8

2.8

116.67

129.64

g/l

14.53

239

720

Certain disorders involving the immune mechanism

790

4078

2.03

69.85

8.6

3.5

122.98

129.93

g/l

13.21

770

3975

Hernia of abdominal wall

1818

11800

1.59

69.78

4.4

3.4

126.91

129.50

g/l

4.83

1777

11519

Ventral hernia

1015

5681

1.86

69.59

4.2

3.3

125.19

128.90

g/l

5.42

988

5540

Malignant neoplasm, wide definition for exclusion

3185

13307

1.43

68.89

4.7

3.4

124.47

132.08

g/l

59.07

3113

12998

All influenza (not pneumonia)

603

2828

2.23

68.88

5.8

3.0

127.57

132.53

g/l

6.09

580

2763

Other viral diseases

1258

7410

1.73

68.76

6.4

3.9

126.82

131.55

g/l

10.35

1220

7237

Thiazolidinediones

546

2486

2.35

68.37

4.2

3.3

125.87

128.96

g/l

2.24

536

2422

Other chronic obstructive pulmonary disease, including avohilmo

2218

12399

1.52

68.22

4.3

3.3

128.39

128.17

g/l

0.16

2161

12114

Traumatic subdural haemorrhage

622

2849

2.21

67.96

4.0

3.2

125.89

126.51

g/l

0.28

606

2783

Schizophrenia

638

3076

2.17

67.92

3.2

3.5

130.98

131.68

g/l

0.33

622

3006

Post-traumatic stress disorder

277

896

3.24

67.71

4.8

3.1

132.85

131.84

g/l

0.34

268

880

Cystitis

3048

12876

1.43

67.08

4.1

3.2

127.20

129.10

g/l

4.93

2986

12548

Spinal stenosis

2040

10298

1.54

67.06

3.4

3.3

126.59

128.02

g/l

2.11

1995

10082

Other complications of surgical and medical care, not elsewhere classified

432

1790

2.57

66.68

4.8

2.8

126.20

129.93

g/l

2.67

417

1746

KRA_PSY_EATING, excluding more controls

241

718

3.48

66.49

5.6

3.4

128.57

130.74

g/l

0.84

234

702

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1204

7158

1.74

66.19

4.3

3.5

129.22

130.00

g/l

0.59

1176

6990

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

691

3492

2.09

65.47

3.6

3.4

120.06

131.08

g/l

29.90

678

3401

Noninfective enteritis and colitis

1707

11048

1.58

65.47

4.8

3.6

127.43

129.78

g/l

4.08

1667

10786

Mental and behavioural disorders due to sedatives or hypnotics

314

1127

3.00

64.91

3.4

3.1

132.83

131.74

g/l

0.36

306

1100

Fracture of rib(s), sternum and thoracic spine

1271

7721

1.71

64.84

4.0

3.4

128.72

129.02

g/l

0.18

1245

7526

Gastro-oesophageal reflux disease

2464

14811

1.46

64.60

4.0

3.3

128.23

130.19

g/l

4.09

2392

14479

Assault

498

2217

2.35

64.59

3.5

3.7

134.34

134.00

g/l

0.12

487

2175

Acute upper respiratory infections

3841

17592

1.37

64.52

4.0

3.3

129.97

128.86

g/l

2.26

3744

17186

Other metabolic disorders

468

2029

2.41

64.51

5.1

2.9

128.64

129.62

g/l

0.42

452

1977

Other specified and unspecified personality disorders

368

1433

2.73

64.47

3.2

130.41

132.14

g/l

0.74

359

1400

Other blood glucose lowering drugs, excl. Insulins

695

3541

2.07

64.07

4.1

3.3

126.29

128.68

g/l

1.91

676

3443

Focal epilepsy, strict definition

826

4455

1.94

63.85

3.9

3.7

129.62

129.29

g/l

0.16

813

4345

Focal epilepsy, mode (most common among epilepsy diagnosis)

787

4182

1.97

63.72

3.5

3.7

129.85

129.25

g/l

0.32

774

4080

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

383

1540

2.69

63.69

5.3

3.0

122.33

128.15

g/l

5.16

377

1498

Spondylosis

2047

11240

1.52

63.62

3.1

3.3

130.12

128.66

g/l

2.13

1992

11005

Other and unspecified local infections of skin and subcutaneous tissue

447

1925

2.48

63.58

6.9

3.5

122.91

129.70

g/l

7.16

439

1871

Recurrent or chronic depression

1296

5476

1.70

63.57

3.7

3.3

132.61

130.28

g/l

3.09

1266

5365

Myocarditis

177

446

4.23

63.47

6.1

2.3

130.24

136.50

g/l

2.69

171

439

Schizoaffective disorder

326

1207

2.89

63.33

2.9

3.1

130.80

132.04

g/l

0.48

317

1178

Diseases of the eye and adnexa

2789

9807

1.45

63.09

4.3

3.3

129.69

131.70

g/l

4.20

2717

9609

Other local infections of skin and subcutaneous tissue

466

2056

2.41

62.61

6.8

3.5

123.24

129.94

g/l

7.29

458

1998

Allergic asthma (mode), excluding more controls

685

3393

2.03

62.41

3.6

2.8

131.69

133.30

g/l

1.02

671

3334

ILD, hospital admission 2, with pulmonary infections

465

2055

2.42

62.40

5.2

2.7

125.16

129.13

g/l

3.30

449

2003

Endocarditis

203

579

3.92

62.36

7.4

3.2

112.12

130.48

g/l

16.39

196

564

COPD, early/later onset

1906

10746

1.54

62.33

4.5

3.3

127.78

127.94

g/l

0.11

1853

10488

Later onset COPD, excluding more controls

937

4045

1.87

62.19

4.4

2.7

125.54

128.69

g/l

3.66

910

3950

Other and unspecified effects of external causes

953

5404

1.82

61.80

3.8

131.38

130.37

g/l

0.72

935

5280

Other disorders of ear

3422

16512

1.38

61.78

3.7

3.5

128.60

129.25

g/l

0.90

3336

16140

Postprocedural endocrine and metabolic disorders, not elsewhere classified

432

1851

2.44

61.23

4.4

2.7

129.04

129.73

g/l

0.26

417

1804

Other diseases of the respiratory system

913

5154

1.85

61.20

5.5

3.6

126.54

127.66

g/l

0.72

872

5030

Other respiratory disorders and diseases

913

5154

1.85

61.20

5.5

3.6

126.54

127.66

g/l

0.72

872

5030

Migraine

1480

7574

1.61

61.09

3.2

3.3

133.24

128.80

g/l

13.24

1437

7402

COPD, hospital admissions

1881

10674

1.53

60.55

4.5

3.3

127.80

127.94

g/l

0.09

1829

10415

Noninfectious colitis NAS

580

2826

2.16

60.40

5.0

3.5

125.60

128.90

g/l

2.90

571

2757

Diseases of the musculoskeletal system and connective tissue

1887

6203

1.55

60.00

4.3

3.4

130.29

131.27

g/l

0.97

1839

6070

Other infectious diseases

391

1635

2.58

59.84

6.7

3.1

123.28

128.15

g/l

4.01

385

1590

Other noninfective gastroenteritis and colitis

952

5457

1.81

59.69

5.2

3.7

125.12

128.92

g/l

5.82

936

5325

Nonischemic cardiomyopathy

433

1889

2.44

59.56

4.9

3.0

129.54

130.54

g/l

0.35

416

1848

Left ventricular outflow tract obstruction (LVOTO), broad definition

450

2002

2.40

59.39

7.1

4.2

123.26

132.16

g/l

11.13

440

1957

Acute pancreatitis (for exclusion)

855

4785

1.87

58.91

4.6

3.4

128.32

129.56

g/l

0.75

827

4668

Visual disturbances

1781

11935

1.53

58.67

4.5

3.4

130.06

128.74

g/l

1.72

1728

11658

Acidosis

148

356

4.89

58.57

6.5

2.9

122.90

130.18

g/l

2.85

143

347

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

461

2096

2.35

57.96

5.5

3.2

120.07

128.76

g/l

11.61

447

2041

Other viral diseases, not elsewhere classified

691

3613

1.98

57.94

7.2

3.8

127.49

130.68

g/l

3.02

676

3523

Polyneuropathies and other disorders of the peripheral nervous system

938

5428

1.81

57.79

5.7

3.4

124.82

128.72

g/l

5.83

915

5286

Candidiasis

550

2676

2.16

57.50

6.9

3.1

121.35

129.10

g/l

12.21

539

2605

Mental and behavioural disorders due to opioids

177

485

3.98

57.10

3.7

3.1

131.35

134.85

g/l

1.05

170

476

Sequelae of cerebrovascular disease

1506

8433

1.59

56.94

4.1

3.3

125.75

127.68

g/l

2.62

1472

8217

Irritable bowel syndrome

909

5212

1.79

56.64

3.5

3.1

132.14

129.73

g/l

3.07

889

5100

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1195

7389

1.66

56.37

4.1

3.5

132.12

128.56

g/l

6.46

1148

7227

Visual disturbances and blindness

1917

13142

1.49

56.18

4.6

3.4

129.52

128.53

g/l

1.18

1860

12838

Selective serotonin reuptake inhibitors

3638

14241

1.35

55.99

3.6

3.4

130.95

129.23

g/l

4.38

3545

13934

Other diseases of anus and rectum

1142

6990

1.68

55.66

4.2

3.2

125.32

128.94

g/l

5.71

1113

6820

Solid cancers, helper endpoint

2985

12885

1.39

55.61

4.0

3.4

124.85

131.95

g/l

49.64

2921

12584

Early onset COPD

895

5166

1.80

55.40

4.7

3.4

129.97

129.38

g/l

0.31

871

5033

Vascular diseases of the intestine

236

799

3.30

55.28

5.2

2.7

119.27

127.93

g/l

6.98

230

782

Pain in thoracic spine

566

2817

2.09

55.20

3.2

3.3

130.90

128.95

g/l

1.23

550

2749

Myalgia

806

4500

1.85

55.13

3.8

3.1

131.62

129.18

g/l

2.62

789

4406

Lumbar disc prolapse

2234

12051

1.45

54.67

3.6

3.3

130.28

129.39

g/l

1.03

2161

11789

Sleep apnoea

3379

16391

1.36

54.66

3.9

3.3

133.27

128.80

g/l

24.15

3303

16005

Toxic effects of substances chiefly nonmedicinal as to source

465

2169

2.26

54.28

3.5

132.08

130.85

g/l

0.58

459

2117

Fitting and adjustment of other devices

1321

7599

1.61

54.10

3.7

2.7

127.72

129.54

g/l

2.36

1299

7396

Other and unspecified polyneuropathies, also in other diseases

827

4710

1.84

54.01

5.1

3.4

124.57

128.54

g/l

5.54

806

4589

Injuries to the shoulder and upper arm

3109

18674

1.36

53.90

3.7

3.4

128.97

129.47

g/l

0.57

3030

18256

Other skin changes

774

4322

1.87

53.86

5.0

3.4

126.41

128.01

g/l

1.18

758

4211

Any event in cancer register

3228

14140

1.36

53.75

4.5

3.4

124.72

131.66

g/l

50.83

3156

13814

Nonorganic sleeping disorders

697

3772

1.91

52.92

3.8

3.5

132.84

130.51

g/l

2.09

683

3683

Chronic ulcer of skin, not elsewhere classified

357

1518

2.55

52.89

6.8

3.0

118.26

128.27

g/l

13.49

351

1478

COPD, hospital admission 2, with asthma infections

1348

7444

1.60

52.86

5.1

3.3

127.08

127.81

g/l

0.54

1309

7253

Injuries to the knee and lower leg

4287

18440

1.31

52.74

3.7

3.4

129.37

129.44

g/l

0.07

4188

18007

Undetermined asthma, excluding more controls

450

2089

2.24

52.53

4.9

2.5

131.48

131.44

g/l

0.01

438

2044

Viral pneumonia (unknown virus, not influenza)

319

1287

2.66

52.52

6.1

3.4

125.79

130.05

g/l

2.42

311

1253

Allergic asthma (mode)

685

3599

1.91

52.51

3.6

2.9

131.69

132.52

g/l

0.41

671

3532

ILD, hospital admissions 3, with pneumonia sepsis

408

1840

2.37

52.45

5.6

2.8

124.18

128.95

g/l

4.15

393

1792

Malignant neoplasm of digestive organs

1557

8168

1.55

52.08

3.3

119.71

130.50

g/l

58.22

1519

7968

Disturbances of skin sensation

922

5440

1.74

52.02

3.2

3.4

132.77

130.15

g/l

3.33

893

5307

Speech and linguistic disorders, excluding more controls

277

971

2.81

51.88

5.5

6.2

131.31

129.87

g/l

0.47

270

949

Other degenerative diseases of the nervous system

1023

4583

1.71

51.74

3.2

3.0

129.30

126.97

g/l

2.63

997

4481

Other diseases of pancreas

385

1705

2.42

51.74

5.3

3.2

124.31

128.93

g/l

3.40

378

1659

Aortic valve malfunction, age under 60 years

408

1847

2.35

51.73

7.0

3.8

122.22

132.20

g/l

12.59

399

1803

Periodontitis

3500

17793

1.34

51.56

4.3

3.2

128.15

129.65

g/l

3.31

3414

17386

Phobic anxiety disorders

394

1740

2.34

51.53

4.9

3.2

133.24

133.10

g/l

0.04

384

1708

Aortic aneurysm

982

5813

1.72

51.52

4.3

3.2

125.74

129.95

g/l

6.11

954

5670

Exclusions for E4_PCOS_BROAD

644

3441

1.95

51.11

6.8

4.0

130.24

130.12

g/l

0.05

624

3352

Carpal tunnel syndrome

2147

13438

1.44

51.03

3.5

3.2

128.78

128.87

g/l

0.06

2094

13152

Alcohol withdrawal state with delirium

347

1481

2.54

51.00

4.4

3.5

129.05

130.87

g/l

0.68

337

1449

Chronic periodontitis, including avohilmo

3488

17799

1.33

50.83

4.3

3.2

128.13

129.65

g/l

3.38

3403

17393

Systemic connective tissue disorders

1297

8385

1.59

50.82

4.9

3.3

124.18

127.79

g/l

7.70

1267

8184

Migraine with aura

701

3845

1.87

50.48

2.7

3.2

133.90

129.13

g/l

7.65

682

3761

Somatoform disorder

563

2889

2.02

50.33

3.7

3.3

131.17

129.35

g/l

1.21

546

2820

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

819

4653

1.78

50.31

6.8

3.4

128.47

130.84

g/l

2.45

794

4541

Injuries to the ankle and foot

2302

14730

1.41

50.22

4.2

3.5

129.91

130.57

g/l

0.71

2255

14365

Abnormal findings on diagnostic imaging of other body structures

557

2862

2.04

50.21

4.5

3.2

124.97

128.58

g/l

3.24

546

2787

Other viral diseases, not elsewhere classified

874

5104

1.75

50.08

6.5

4.1

128.67

131.01

g/l

2.27

850

4987

Unspecified dementia

552

2535

2.06

49.87

3.6

3.2

125.53

124.22

g/l

0.85

544

2474

Diaphragmatic hernia

1374

9041

1.56

49.81

3.6

3.2

123.54

128.34

g/l

11.88

1354

8814

Fibrosis and cirrhosis of liver

369

1653

2.40

48.43

5.7

3.2

114.56

128.75

g/l

23.19

361

1606

Duodenal ulcer

507

2558

2.09

48.41

4.1

3.2

118.53

128.88

g/l

15.05

497

2496

Coxarthrosis [arthrosis of hip](FG)

2088

10433

1.44

48.19

3.4

3.2

127.77

129.23

g/l

2.16

2040

10214

Candidiasis

976

5972

1.68

48.07

5.6

3.2

125.09

128.96

g/l

6.04

956

5830

Other and unspecified mood [affective] disorders

243

888

2.87

48.01

2.6

2.9

130.99

132.38

g/l

0.46

237

871

Diseases of the ear and mastoid process

4073

15938

1.30

47.01

3.6

3.5

130.52

129.69

g/l

1.43

3978

15573

Vitreous haemorrhage

453

2224

2.16

46.81

6.1

3.2

120.11

128.71

g/l

10.63

440

2161

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

970

5916

1.68

46.62

3.2

3.3

117.89

130.65

g/l

53.68

953

5763

Pneumonitis due to solids and liquids

407

1924

2.26

46.60

4.9

3.2

124.38

127.59

g/l

2.11

390

1880

Chronic gastritis

1059

6692

1.63

46.05

3.8

3.2

122.55

127.90

g/l

10.94

1033

6534

Fracture of femur

1137

6610

1.61

45.95

4.3

3.3

121.09

126.95

g/l

15.75

1115

6446

Fracture of lumbar spine and pelvis

914

5575

1.70

45.90

3.9

3.3

125.14

127.46

g/l

2.44

895

5443

Osteomyelitis

313

1337

2.52

45.86

7.9

3.3

113.99

129.50

g/l

27.04

308

1308

Benign neoplasm: Colon, unspecified

1018

6392

1.65

45.85

4.8

3.3

125.80

128.16

g/l

2.59

993

6235

Disorders of eyelid, lacrimal system and orbit

3048

17609

1.33

45.62

3.7

3.4

128.61

128.76

g/l

0.14

2975

17201

COPD, hospital admissions 3, with asthma pneumonia sepsis

1147

6299

1.61

45.54

5.3

3.3

125.86

127.39

g/l

1.37

1113

6137

Sleep apnoea, including avohilmo

3478

16628

1.31

45.20

3.8

3.4

133.24

128.76

g/l

25.05

3390

16241

Cirrhosis of liver, NAS

286

1188

2.64

45.07

6.3

3.2

112.47

129.06

g/l

24.89

281

1157

Undefined dementia

561

2754

1.97

44.97

3.6

3.0

125.47

124.71

g/l

0.41

553

2690

Migraine without aura

532

2772

1.97

44.96

3.6

3.3

132.63

129.77

g/l

2.42

514

2711

Coxarthrosis

1931

9026

1.44

44.93

3.4

3.2

127.89

129.25

g/l

1.78

1885

8846

Other arthritis (FG)

1086

6933

1.61

44.86

4.0

3.3

125.95

129.87

g/l

6.64

1061

6781

Diagnoses used for exclusion with ILD

999

6269

1.65

44.81

4.5

3.4

126.33

128.63

g/l

2.42

966

6118

Other diseases of intestine

562

3010

1.95

44.65

5.5

3.4

121.30

129.41

g/l

11.20

546

2943

Rotator cuff syndrome

2222

11601

1.40

44.42

3.6

3.1

129.96

129.05

g/l

1.06

2155

11350

Gonarthrosis [arthrosis of knee](FG)

2753

11973

1.36

44.37

3.1

3.2

129.67

129.93

g/l

0.22

2682

11716

Cervicalgia

736

4282

1.77

43.99

4.0

3.3

129.95

128.06

g/l

1.43

714

4185

Undetermined asthma

450

2240

2.08

43.82

4.9

2.6

131.48

130.50

g/l

0.44

438

2191

Congenital malformations of heart and great arteries

481

2396

2.03

42.97

6.4

5.0

126.43

130.69

g/l

3.52

471

2336

Type of accident

1041

6661

1.61

42.73

4.2

3.5

128.77

129.84

g/l

0.85

1017

6505

Other viral hepatitis

245

959

2.71

42.72

4.8

3.3

130.84

134.07

g/l

1.23

239

942

Other problems related to primary support group, including family circumstances

360

1617

2.25

42.54

10.9

3.4

127.39

131.55

g/l

3.25

353

1578

Other respiratory diseases principally affecting the interstitium

764

4566

1.74

42.08

5.1

3.3

123.60

127.70

g/l

5.27

738

4450

Disorders of the thyroid gland

3312

16722

1.31

41.98

3.8

3.4

129.09

128.95

g/l

0.13

3219

16353

Zoster [herpes zoster]

723

4255

1.77

41.92

4.2

3.3

125.51

127.77

g/l

1.98

703

4144

Type1 diabetes, definitions combined, early onset

224

840

2.79

41.87

5.2

6.0

131.15

135.80

g/l

2.30

218

822

Arthrosis

2577

10549

1.36

41.81

3.3

3.2

130.72

130.22

g/l

0.49

2502

10326

Sleep disorders (combined)

4009

16635

1.28

41.80

3.6

3.3

132.06

128.40

g/l

19.61

3908

16238

Haemorrhage, not elsewhere classified

197

703

3.06

41.72

4.9

2.7

119.64

128.59

g/l

5.90

192

686

Colectomy operation

695

4058

1.79

41.68

4.1

3.4

120.38

128.54

g/l

15.16

680

3961

Soft tissue disorders related to use, overuse and pressure

965

6112

1.62

41.42

3.7

3.1

129.36

128.71

g/l

0.40

949

5974

Fentanyl

455

2329

2.05

41.38

4.2

3.0

117.99

128.56

g/l

20.31

443

2276

Idiopathic gout

447

2297

2.07

41.07

5.8

3.3

123.34

128.84

g/l

4.75

435

2245

Unspecified misadventure during surgical and medical care

264

1100

2.60

41.01

5.4

3.1

123.44

128.59

g/l

2.84

254

1069

Fracture of lower leg, including ankle

1920

13797

1.40

40.82

3.8

3.4

127.33

129.38

g/l

3.59

1873

13483

COPD-related respiratory insufficiency

527

2859

1.94

40.77

6.6

3.2

126.47

127.70

g/l

0.55

502

2788

Other pleural conditions

465

2424

2.03

40.65

6.2

3.2

117.65

127.30

g/l

16.29

450

2355

Diseases of the myoneural junction and muscle

511

2745

1.95

40.58

5.7

3.4

128.01

128.28

g/l

0.09

501

2673

Arthropathies

3095

12025

1.32

40.54

3.9

3.4

129.99

130.73

g/l

0.97

3012

11767

Congenital malformations of the circulatory system

521

2719

1.93

40.54

6.5

4.7

127.18

130.81

g/l

2.87

509

2648

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3429

17186

1.29

40.37

4.1

3.3

127.72

129.52

g/l

4.47

3347

16795

Acute and transient psychotic disorders

415

2073

2.09

40.35

2.9

3.3

131.11

131.47

g/l

0.11

401

2027

Periapical abscess

1528

10696

1.46

40.31

4.2

3.5

130.94

130.29

g/l

0.53

1492

10445

Other specified/unspecified arthritis

946

6006

1.62

40.13

3.9

3.3

126.17

129.47

g/l

4.23

924

5876

Pain in joint

1776

8034

1.43

40.05

3.7

3.2

129.74

129.71

g/l

0.01

1734

7848

Other diseases of liver

652

3775

1.79

39.94

3.8

3.4

126.69

130.10

g/l

3.06

641

3681

Dermatitis and eczema

3891

19176

1.27

39.90

4.0

3.5

128.13

129.73

g/l

4.26

3799

18728

Benign neoplasm of other and ill-defined parts of digestive system

692

4083

1.76

39.85

4.0

3.3

123.66

128.13

g/l

5.58

674

3968

severe traumatic brain injury, does not include concussion

911

5761

1.64

39.81

3.7

3.5

126.61

128.26

g/l

1.41

890

5613

Assault by bodily force

276

1179

2.45

39.71

3.3

3.5

134.93

134.82

g/l

0.03

268

1157

COPD, hospital admissions 1, only main diagnosis

1379

8118

1.49

39.67

4.9

3.3

128.53

127.66

g/l

0.70

1340

7910

Use of disulfiram, acamprosate or naltrexone

352

1671

2.22

39.60

3.7

3.5

132.89

133.48

g/l

0.18

342

1635

Thoracic aortic aneurysm

593

3363

1.85

39.59

4.5

3.2

127.00

130.79

g/l

3.25

574

3285

Coagulation defects, purpura and other haemorrhagic conditions

712

4239

1.74

39.39

5.8

3.5

120.50

129.38

g/l

18.58

694

4141

Alcohol-induced chronic pancreatitis

296

1321

2.40

39.26

4.5

3.7

127.01

131.32

g/l

2.14

286

1292

Abnormal serum enzyme levels

1212

7977

1.53

39.07

4.3

3.5

126.02

130.00

g/l

7.13

1184

7780

Other and unspecified myopathies

395

1975

2.12

39.02

6.0

3.1

127.24

128.25

g/l

0.36

386

1921

Left ventricular outflow tract obstruction, narrow definition

224

884

2.73

38.90

6.5

5.1

122.45

132.00

g/l

7.47

217

865

Artificial opening status

258

1092

2.55

38.71

5.9

3.3

120.16

130.18

g/l

8.63

253

1059

Other symptoms and signs involving general sensations and perceptions

200

752

2.89

38.38

3.4

3.3

129.68

127.61

g/l

0.66

195

736

Diabetic neuropathy

617

3585

1.83

38.23

6.3

4.0

121.52

127.84

g/l

10.05

600

3507

Other diseases of biliary tract

381

1895

2.13

38.07

4.8

3.3

120.77

127.43

g/l

6.79

370

1846

Extreme obesity with alveolar hypoventilation

200

759

2.87

37.82

4.8

3.0

134.94

128.37

g/l

3.09

190

741

Cholecystitis

564

3192

1.84

37.59

4.2

3.2

125.78

128.01

g/l

1.35

553

3115

Cholangitis (primary sclerosing, PSC)

279

1235

2.41

37.58

5.8

3.3

120.23

128.57

g/l

7.35

271

1208

Other disorders of adrenal gland

204

782

2.81

37.56

9.9

4.0

127.71

129.17

g/l

0.40

199

765

Respiratory insufficiency

344

1652

2.19

37.25

5.4

2.7

131.93

128.44

g/l

1.85

324

1612

Amputation of foot

161

554

3.30

37.23

8.3

3.3

110.84

127.69

g/l

18.43

156

541

Acute gastritis

326

1541

2.24

37.23

4.1

2.9

127.06

128.98

g/l

0.80

312

1499

Diabetic retinopathy

1674

7497

1.44

37.01

5.7

3.6

122.09

128.40

g/l

22.90

1630

7325

Other diseases of arteries and capillaries

368

1825

2.12

36.94

5.8

3.1

119.54

129.10

g/l

11.97

357

1778

Intentional self-harm by sharp object

116

322

3.92

36.90

3.4

2.9

132.81

133.63

g/l

0.16

110

315

Primary_lymphoid and hematopoietic malignant neoplasms

940

6101

1.59

36.72

6.0

3.4

116.64

128.92

g/l

47.54

919

5946

Arthropod-borne viral fevers and viral haemorrhagic fevers

664

3961

1.74

36.53

3.2

3.9

131.24

129.33

g/l

1.32

652

3856

Other eating disorders

156

520

3.14

36.47

4.6

4.1

129.97

130.87

g/l

0.21

151

513

Eating disorder

242

1008

2.48

36.38

5.6

3.7

128.61

131.40

g/l

1.30

235

988

Chronic viral hepatitis

198

756

2.78

36.37

4.1

3.3

131.83

134.73

g/l

0.90

192

742

L04AX Other immunosuppressants

1841

13529

1.38

36.31

5.8

3.4

125.07

129.90

g/l

16.58

1791

13221

Second line medication for Crohn's disease

1880

13864

1.38

36.23

5.7

3.4

125.23

129.91

g/l

15.95

1830

13548

Open wound of ankle and foot

398

2045

2.04

35.96

5.3

3.4

122.91

130.83

g/l

8.32

393

1987

Exclusions for E4_PCOS_CONSORTIUM

2175

10175

1.36

35.80

4.0

3.4

128.52

128.55

g/l

0.02

2111

9952

Gonarthrosis

2330

10004

1.35

35.70

3.1

3.2

129.94

129.81

g/l

0.10

2269

9796

Disorders of skin appendages

1493

10638

1.43

35.28

4.7

3.4

128.58

130.34

g/l

2.29

1464

10387

Purpura and other haemorrhagic conditions

519

2929

1.85

35.03

5.8

3.4

119.58

129.25

g/l

16.13

508

2852

Urolithiasis

1205

8308

1.49

34.92

4.0

3.5

131.40

129.10

g/l

2.87

1182

8097

Hyperkinetic disorders, excluding more controls

246

1003

2.40

34.73

4.8

4.6

133.08

133.98

g/l

0.26

239

985

Total colectomy operation

192

744

2.79

34.71

5.4

3.2

124.54

129.98

g/l

2.14

186

730

Total colectomy

192

744

2.79

34.71

5.4

3.2

124.54

129.98

g/l

2.14

186

730

Fracture of skull and facial bones

732

4529

1.66

34.71

4.2

3.6

131.12

130.59

g/l

0.25

707

4422

Psychotic depression

220

904

2.55

34.56

3.4

3.1

132.67

128.96

g/l

1.63

213

882

Disorders of vitreous body and globe

1787

12676

1.38

34.34

4.0

3.3

128.06

128.04

g/l

0.01

1743

12376

Diabetic retinopathy, strict definition

848

4837

1.63

34.25

7.4

3.7

118.78

129.37

g/l

33.49

824

4723

Obsessive-compulsive disorder

196

764

2.67

34.15

5.0

3.1

131.45

132.33

g/l

0.23

191

753

Viral hepatitis

265

1191

2.34

34.09

4.7

3.3

130.72

133.06

g/l

0.83

259

1166

Injuries to the wrist and hand

3388

18749

1.27

34.07

3.5

131.63

129.30

g/l

7.34

3309

18314

Congenital malformations of aortic and mitral valves

189

734

2.78

34.02

6.4

4.4

121.20

131.80

g/l

7.78

183

718

Migraine with aura and triptan purchases

417

2205

1.94

34.00

2.7

3.4

134.10

129.91

g/l

4.15

406

2152

Viral haemorrhagic fevers, not elsewhere classified/unspecified

588

3463

1.76

34.00

3.1

3.9

131.34

129.40

g/l

1.26

581

3372

Impacted teeth

497

2459

1.84

33.73

4.2

3.5

134.68

133.88

g/l

0.37

488

2409

Other arthrosis

1874

9610

1.37

33.62

3.2

128.94

129.87

g/l

0.98

1822

9416

Aneurysms, operations, SAH

602

3584

1.74

33.49

3.3

127.07

128.04

g/l

0.47

590

3500

Eating disorders

299

1412

2.18

33.43

4.7

3.4

129.17

130.53

g/l

0.53

290

1382

Hypothyroidism, strict autoimmune

2378

11968

1.32

33.41

3.8

3.0

127.60

129.79

g/l

4.86

2312

11713

Disorders of vitreous body

1734

12368

1.38

33.40

4.0

3.3

128.30

128.06

g/l

0.17

1691

12075

Other systemic involvement of connective tissue (FG)

888

5721

1.57

33.40

4.0

3.2

125.65

128.06

g/l

2.93

865

5602

Alcoholic liver disease

417

2240

1.96

33.32

4.1

3.4

117.87

130.50

g/l

18.56

406

2192

Paralytic ileus

189

744

2.75

33.20

5.5

3.0

125.15

129.84

g/l

1.85

179

726

Superficial injury of lower leg

819

5260

1.60

33.13

3.8

3.3

128.90

129.31

g/l

0.21

808

5144

Lung diseases due to external agents

574

3391

1.76

33.05

4.4

3.3

125.67

127.70

g/l

1.33

555

3306

Any dementia, excluding more controls

1406

6870

1.44

32.97

3.3

3.2

126.88

126.26

g/l

0.50

1377

6690

Disorders of psychological development

365

1727

2.02

32.80

4.2

5.7

132.12

131.86

g/l

0.08

355

1687

Pleural effusion

636

3874

1.71

32.69

5.3

3.2

117.60

127.93

g/l

24.83

621

3770

Open wound of lower leg

559

3283

1.76

32.69

5.1

3.3

125.71

129.30

g/l

2.91

545

3205

Nontraumatic intracranial haemmorrhage

775

4948

1.62

32.52

3.7

3.3

126.90

127.38

g/l

0.24

761

4827

Other embolism and thrombosis

509

2927

1.81

32.27

4.6

3.3

124.50

128.67

g/l

3.75

498

2857

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

504

2541

1.80

32.14

4.6

4.9

133.43

133.96

g/l

0.21

492

2490

Cerebral cysts

224

963

2.46

32.12

4.8

3.5

129.58

129.32

g/l

0.05

215

940

Generalized anxiety disorder

412

2210

1.91

32.12

2.7

3.1

133.60

131.50

g/l

1.15

407

2164

Other ulcerative colitis

227

982

2.45

32.12

5.1

3.2

129.62

131.15

g/l

0.46

216

956

Other necrotizing vasculopathies

315

1560

2.15

32.10

6.7

3.0

120.26

127.94

g/l

7.14

309

1517

Viral warts

347

1768

2.05

32.10

6.8

3.3

125.79

130.23

g/l

2.71

334

1725

Calculus of kidney and ureter

1102

7595

1.49

32.07

4.0

3.5

131.26

129.17

g/l

2.25

1083

7401

Hypothyroidism, other/unspecified

2980

15536

1.28

31.83

3.8

3.4

128.46

128.72

g/l

0.26

2887

15199

Unspecified privation

408

2204

1.93

31.81

4.8

3.3

125.57

129.57

g/l

2.63

401

2140

Superficial injury of hip and thigh

566

3363

1.74

31.71

4.0

3.2

125.82

128.43

g/l

2.01

557

3279

Complications of internal orthopaedic prosthetic devices, implants and grafts

837

5471

1.58

31.69

3.8

3.0

122.46

128.06

g/l

10.16

814

5341

Infective dermatitis

432

2385

1.89

31.41

4.6

3.2

125.14

129.66

g/l

3.85

424

2318

Adverse effects, not elsewhere classified

605

3663

1.70

31.26

4.2

3.7

129.93

129.61

g/l

0.13

594

3574

Other congenital malformations of the digestive system

188

752

2.66

31.24

10.5

6.2

123.60

129.26

g/l

2.58

183

737

Status epilepticus

177

695

2.75

31.24

5.9

3.5

125.34

127.72

g/l

0.63

172

678

Heartburn

363

1894

1.99

31.18

4.3

2.9

130.50

130.31

g/l

0.05

352

1842

Parkinson's disease, excluding more controls

496

2682

1.80

31.16

3.3

3.1

127.62

126.35

g/l

0.68

482

2618

Symptoms and signs involving the nervous and musculoskeletal systems

1972

14997

1.34

30.99

4.2

3.5

129.48

128.74

g/l

0.79

1915

14663

Injuries to the neck

730

4640

1.61

30.95

2.9

3.5

131.29

130.55

g/l

0.39

715

4533

419

2300

1.88

30.65

7.0

3.0

124.30

130.51

g/l

6.38

411

2236

Superficial injury of abdomen, lower back and pelvis

523

3070

1.76

30.55

4.1

3.4

129.70

130.01

g/l

0.11

514

2991

Abnormal involuntary movements

494

2860

1.79

30.54

4.4

3.4

129.01

128.98

g/l

0.01

483

2788

Tubulo-interstitial nephritis, not specified as acute or chronic

262

1229

2.24

30.41

5.2

2.7

122.07

130.24

g/l

7.14

256

1199

Hypothyreosis and Thyroxine purchase for inclusion criteria

3075

16139

1.26

30.36

3.8

3.4

128.49

128.76

g/l

0.28

2981

15792

Other symptoms and signs involving the digestive system and abdomen

509

2965

1.76

30.36

5.2

3.1

124.61

127.98

g/l

2.83

492

2891

Leisure time condition

635

3939

1.66

30.05

4.1

3.4

129.51

129.59

g/l

0.03

623

3843

Other pulmonary heart/vessel disease

223

1001

2.40

29.46

5.4

3.3

129.81

125.86

g/l

1.53

213

974

Vitamin deficiency, wide

202

868

2.48

29.21

5.2

3.2

128.05

127.18

g/l

0.20

194

842

Vitamin deficiency

202

868

2.48

29.21

5.2

3.2

128.05

127.18

g/l

0.20

194

842

Secondary right heart disease

206

898

2.48

29.21

5.5

3.1

128.77

125.71

g/l

0.96

196

874

Phlebitis and thrombophlebitis (not including DVT)

797

5246

1.56

29.15

4.9

3.4

126.93

128.94

g/l

1.80

784

5134

Arterial embolism and thrombosis

260

1242

2.22

29.09

6.7

2.9

119.77

128.54

g/l

7.14

250

1210

Persistent mood disorders

600

3694

1.67

29.06

4.0

3.2

129.08

129.46

g/l

0.16

581

3613

Speech and linguistic disorders

286

1350

2.11

28.86

6.6

5.9

131.32

131.26

g/l

0.01

279

1317

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

298

1499

2.10

28.84

3.4

3.1

128.36

126.73

g/l

0.60

292

1462

Suppurative and necrotic conditions of lower respiratory tract

248

1170

2.26

28.83

5.7

3.3

120.30

128.95

g/l

6.48

240

1139

Parkinson's disease, strict definition, excluding more controls

461

2530

1.80

28.67

3.3

3.1

128.17

126.17

g/l

1.27

448

2469

Myocardial infarction, with ST-elevation

712

4603

1.60

28.56

4.5

3.4

124.53

128.14

g/l

3.94

694

4485

Benign neoplasm: Sigmoid colon

714

4620

1.60

28.51

3.8

3.5

124.68

128.40

g/l

3.88

702

4509

Somnolence, stupor and coma

188

792

2.53

28.45

5.8

3.3

123.78

127.75

g/l

1.52

181

771

Dilated cardiomyopathy

482

2840

1.77

28.32

5.4

3.5

129.78

128.95

g/l

0.30

465

2767

Mental and behavioural disorders due to tobacco

323

1684

2.01

28.19

4.6

3.3

129.82

130.29

g/l

0.13

315

1642

Smoking dependency

323

1688

2.00

27.99

4.6

3.3

129.82

130.33

g/l

0.14

315

1646

Other necrotizing vasculopathies (FG)

266

1306

2.16

27.82

6.1

3.0

121.91

129.00

g/l

5.35

260

1280

Malignant neoplasm of bladder

314

1633

2.03

27.78

4.5

3.3

123.66

129.70

g/l

4.38

309

1593

Operations for atrial fibrillation

102

322

3.71

27.70

4.8

3.4

124.43

128.50

g/l

0.89

317

Other diseases of blood and blood-forming organs, wide

758

4995

1.56

27.63

6.1

3.5

121.83

129.19

g/l

12.11

737

4864

Immunodeficiencies

192

828

2.47

27.58

12.0

4.0

125.39

128.38

g/l

0.99

186

806

Malignant neoplasm of bladder, including Hilmo

505

3013

1.73

27.53

4.4

3.3

124.91

130.52

g/l

5.95

494

2929

DVT of lower extremities

712

4643

1.58

27.35

4.0

3.3

126.73

128.61

g/l

1.45

704

4540

Polyuria

802

5362

1.54

27.34

4.2

3.2

129.35

g/l

0.00

787

5216

Gonarthrosis,primary

3176

15893

1.25

27.30

3.0

3.4

129.20

128.60

g/l

0.75

3097

15526

Inflammatory bowel disease

992

6910

1.46

27.09

4.5

3.6

129.63

130.69

g/l

0.73

959

6756

Benign neoplasm: Ascending colon

535

3277

1.70

27.08

4.6

3.2

125.11

128.26

g/l

2.35

526

3196

Alzheimer disease, excluding more controls

644

2667

1.64

27.00

2.8

3.0

128.86

125.61

g/l

3.14

628

2604

Psoriasis

936

6461

1.48

26.98

3.7

3.5

129.50

130.05

g/l

0.31

919

6300

Disorders of synovium and tendon

1664

11020

1.34

26.80

3.7

3.1

129.85

129.50

g/l

0.26

1616

10776

Other symptoms and signs involving the circulatory and respiratory systems

227

1057

2.24

26.79

5.0

3.1

128.09

128.29

g/l

0.04

215

1022

Superficial injury of thorax

529

3231

1.69

26.76

4.1

3.4

128.54

129.83

g/l

0.68

518

3158

Papulosquamous disorders

1294

9465

1.39

26.70

3.7

3.5

129.14

129.29

g/l

0.08

1269

9244

Polycystic ovarian syndrome, consortium definition

1940

8806

1.32

26.61

3.8

2.9

127.64

127.51

g/l

0.09

1896

8608

ILD, hospital admissions

597

3773

1.64

26.58

4.6

3.3

126.19

127.85

g/l

1.04

578

3677

Other and unspecified nerve root and plexus disorders, also in other diseases

637

4072

1.61

26.53

3.7

3.4

131.76

130.33

g/l

0.88

608

3980

Injuries to unspecified part of trunk, limb or body region

384

2158

1.85

26.46

4.5

3.5

124.65

128.86

g/l

2.90

375

2102

Other disorders of skin and subcutaneous tissue, not elsewhere classified

525

3213

1.69

26.44

5.8

3.1

119.81

129.29

g/l

17.67

514

3129

Irregular menses

1139

6400

1.42

26.38

4.3

2.9

129.01

128.73

g/l

0.16

1113

6242

Disorders of vestibular function (Vertigo)

1595

11865

1.35

26.33

3.3

130.75

127.71

g/l

7.03

1560

11577

ILD, hospital admissions 1, main diag only

541

3350

1.68

26.26

4.5

3.3

126.61

127.71

g/l

0.54

525

3264

Alzheimer’s disease (Atypical or mixed), excluding more controls

361

1571

1.91

26.24

2.9

3.1

129.60

124.10

g/l

4.64

351

1536

Viral pneumonia (known virus, not influenza)

138

526

2.89

26.20

10.0

4.8

124.08

126.57

g/l

0.56

132

518

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1024

7178

1.44

26.10

3.9

3.6

132.77

131.70

g/l

0.83

1004

7009

Other arterial embolism and thrombosis

136

514

2.87

26.04

6.2

3.0

118.25

127.01

g/l

4.04

130

503

Hypopituitarism

263

1313

2.10

26.00

5.7

4.2

133.75

132.81

g/l

0.25

252

1282

Thyroiditis, ILD-related definition

361

1996

1.87

25.99

3.5

3.3

130.65

128.94

g/l

0.84

355

1946

Deforming dorsopathies

860

5879

1.49

25.94

3.9

3.4

128.59

128.49

g/l

0.04

840

5747

Chronic apical periodontitis

3798

17959

1.22

25.73

3.8

3.3

128.61

129.78

g/l

2.37

3698

17554

Cervical disc disorders

1173

8493

1.41

25.73

3.5

3.3

129.63

128.93

g/l

0.49

1138

8306

Emphysema

298

1564

2.00

25.67

3.9

3.3

129.47

127.87

g/l

0.52

289

1522

Bicuspidal aortic valve syndrome

160

659

2.61

25.61

5.2

4.2

120.44

131.67

g/l

7.25

154

644

Other interstitial pulmonary diseases

604

3862

1.62

25.60

4.7

3.3

126.19

127.81

g/l

1.00

585

3763

Other aneurysm

236

1144

2.19

25.56

5.7

3.0

122.72

128.99

g/l

3.28

226

1114

Interstitial lung disease

604

3865

1.62

25.51

4.7

3.3

126.19

127.82

g/l

1.01

585

3765

Interstitial lung disease endpoints

604

3865

1.62

25.51

4.7

3.3

126.19

127.82

g/l

1.01

585

3765

Dementia, including avohilmo

1738

9135

1.33

25.51

3.1

3.3

127.51

126.41

g/l

1.36

1697

8895

Chronic periodontitis, complicated

1846

14189

1.31

25.34

4.7

3.3

127.87

129.54

g/l

2.35

1802

13863

Any dementia

1518

7929

1.36

25.15

3.2

3.3

126.90

126.04

g/l

0.84

1489

7717

Anosmia

122

4.83

25.14

2.9

1.6

131.22

139.63

g/l

2.07

122

Dental operations

2330

9443

1.28

25.06

3.9

3.2

127.83

129.21

g/l

2.03

2265

9261

Exposure to other specified factors

2407

17680

1.26

25.01

3.7

3.5

129.39

130.09

g/l

0.76

2354

17269

Diseases of inner ear

1843

13844

1.31

24.93

3.4

3.3

130.73

128.03

g/l

6.25

1798

13518

Ovarian cyst

998

4007

1.46

24.90

3.2

3.0

128.66

126.65

g/l

2.28

967

3928

Benign neoplasm: Transverse colon

428

2535

1.77

24.80

4.1

3.3

124.51

128.40

g/l

2.67

423

2464

Subjective visual disturbances

808

5513

1.50

24.79

3.9

3.3

130.20

129.05

g/l

0.75

779

5391

Familial hypercholesterolemia

534

3335

1.65

24.76

3.7

3.0

125.24

127.98

g/l

1.91

523

3247

Fracture of foot, except ankle

725

4837

1.53

24.73

4.7

3.6

127.97

130.63

g/l

2.47

707

4722

Dermatophytosis

478

2910

1.70

24.70

4.2

3.4

129.22

129.62

g/l

0.14

467

2830

Psoriatic and enteropathic arthropathies

392

2258

1.79

24.66

4.0

3.3

130.11

130.91

g/l

0.29

383

2214

Fall on and from stairs and steps

859

5946

1.48

24.49

3.4

3.5

128.11

129.08

g/l

0.60

838

5809

Appendectomy

1961

14690

1.29

24.46

3.2

3.4

130.67

130.16

g/l

0.46

1919

14345

Radiculopathy

561

3559

1.62

24.29

3.9

3.4

129.57

127.40

g/l

1.38

545

3481

Cerebral palsy and other paralytic syndromes

394

2286

1.78

24.25

4.8

3.6

129.93

128.88

g/l

0.41

385

2224

Vascular dementia

393

2200

1.79

24.19

3.6

3.2

126.05

123.98

g/l

1.13

384

2145

Umbilical hernia

922

6488

1.45

24.07

4.7

3.3

128.65

131.01

g/l

2.33

907

6331

Coxarthrosis, primary

2146

14423

1.28

24.03

3.3

3.4

127.66

127.71

g/l

0.04

2101

14083

Osteoporosis with pathological fracture (FG)

301

1624

1.95

24.00

5.0

2.9

122.04

126.39

g/l

3.13

292

1592

Other epidermal thickening

184

830

2.36

23.93

5.1

3.2

124.73

128.29

g/l

1.33

179

811

Hepatic failure, not elsewhere classified

173

763

2.44

23.91

7.8

3.0

115.34

128.50

g/l

9.60

162

745

Other other unspecified disorders of the circulatory system

167

726

2.47

23.83

4.8

3.5

120.53

127.96

g/l

4.13

152

710

Seborrhoeic keratosis

793

5448

1.49

23.72

3.8

3.2

127.13

128.29

g/l

0.80

776

5317

Superficial injury of wrist and hand

588

3789

1.59

23.57

3.5

3.6

132.13

130.31

g/l

1.19

580

3699

Malignant neoplasm of pancreas, including Hilmo

345

1953

1.85

23.43

3.2

3.1

120.30

129.80

g/l

12.94

338

1902

Fracture of shoulder and upper arm

1212

8954

1.38

23.36

3.8

3.5

125.69

128.65

g/l

4.63

1180

8748

Benign neoplasm: Skin of other and unspecified parts of face

398

2347

1.76

23.27

4.2

3.1

128.05

127.86

g/l

0.06

389

2287

Cerebral aneurysm, nonruptured

312

1716

1.90

23.17

3.4

3.1

127.60

128.85

g/l

0.42

306

1667

Follow-up examination after treatment for conditions other than malignant neoplasms

1318

6471

1.36

23.17

3.4

2.8

128.13

130.27

g/l

2.91

1288

6324

Other congenital malformations of the digestive system

198

923

2.25

23.15

10.1

6.3

123.75

128.92

g/l

2.35

193

904

Intracerebral haemorrhage

490

3052

1.66

23.12

4.0

3.2

126.88

127.08

g/l

0.07

482

2978

Benign paroxysmal vertigo

978

7011

1.43

23.03

3.3

3.4

131.03

127.44

g/l

5.97

957

6844

Postprocedural disorders of digestive system, not elsewhere classified

147

613

2.58

23.00

5.5

3.7

121.34

128.15

g/l

2.46

142

602

Other diseases of stomach and duodenum

249

1278

2.05

22.93

4.5

2.9

121.53

128.63

g/l

4.89

241

1245

Degeneration of macula and posterior pole

1730

10705

1.31

22.83

3.7

3.2

126.04

127.36

g/l

1.65

1687

10444

Viral infections characterized by skin and mucous membrane lesions

2806

19692

1.23

22.78

4.2

3.5

128.43

129.61

g/l

2.07

2735

19242

Diabetic maculopathy

603

3742

1.59

22.77

6.2

3.7

117.50

129.45

g/l

31.41

585

3654

Other specific joint derangements/joint disorders

2235

11520

1.27

22.72

3.5

3.3

130.57

130.85

g/l

0.23

2177

11274

Other systemic involvement of connective tissue

903

6398

1.44

22.70

4.3

3.2

125.75

127.58

g/l

1.92

880

6245

Pyothorax

190

890

2.28

22.66

5.9

3.4

119.87

128.76

g/l

5.13

183

872

Crohn disease

405

2412

1.73

22.56

5.0

3.4

129.36

130.76

g/l

0.59

393

2346

Injuries to the elbow and forearm

2249

15883

1.26

22.54

3.7

3.5

128.79

129.34

g/l

0.57

2210

15511

Fall on same level involving ice and snow

1833

14416

1.29

22.52

3.4

128.79

129.06

g/l

0.20

1793

14081

Other and unspecified tonsillitis

895

5295

1.44

22.43

4.7

3.6

134.30

133.20

g/l

0.73

870

5186

Ulcer of oesophagus

283

1536

1.94

22.14

4.4

3.0

122.22

129.46

g/l

5.36

278

1491

Diplopia

457

2828

1.67

22.12

4.8

3.1

130.33

129.20

g/l

0.52

441

2753

Migraine without aura and triptan purchases

382

2246

1.74

22.04

3.6

133.15

130.45

g/l

1.77

371

2201

Disorders of sclera, cornea, iris and ciliary body

1734

13598

1.29

21.83

4.5

3.3

127.87

129.68

g/l

2.67

1685

13285

Pulmonary oedema

101

361

3.09

21.75

7.3

3.1

112.69

125.03

g/l

6.37

351

Cyst of kidney

290

1604

1.90

21.45

4.9

3.1

123.01

128.10

g/l

3.26

283

1560

Primary hyperparathyroidism

384

2301

1.73

21.22

3.7

3.1

126.16

127.24

g/l

0.45

374

2246

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1036

6567

1.39

21.22

3.9

3.0

126.89

128.83

g/l

2.14

1014

6414

Other joint disorders

2773

11991

1.23

21.12

3.7

3.4

131.21

130.75

g/l

0.49

2694

11733

Benign neoplasm: Adrenal gland

292

1625

1.88

21.08

3.7

3.0

127.56

128.38

g/l

0.23

280

1582

Other disorders of nervous system

250

1326

1.98

20.96

4.3

3.1

126.61

128.84

g/l

0.72

239

1291

Colorectal cancer

845

5876

1.44

20.95

3.0

3.3

120.95

129.95

g/l

22.95

823

5720

Neuromuscular dysfunction of bladder

322

1846

1.81

20.84

5.9

3.0

127.16

129.55

g/l

1.07

307

1793

Pruritus

358

2112

1.75

20.79

5.4

3.0

124.22

128.57

g/l

3.44

352

2053

Missing teeth due to accident, extraction or parodontitis

2010

15226

1.26

20.44

4.0

3.3

126.48

128.84

g/l

4.79

1949

14889

Haemorrhoids and perianal venous thrombosis

1026

7540

1.38

20.36

3.5

3.1

127.45

128.74

g/l

1.10

998

7358

Embedded and impacted teeth

628

3472

1.51

20.31

4.6

3.4

133.16

133.62

g/l

0.21

613

3393

Nonalcoholic fatty liver disease

317

1824

1.80

20.21

3.4

131.40

130.76

g/l

0.18

311

1780

Dementia

1603

8615

1.30

20.15

3.1

3.3

127.66

126.44

g/l

1.51

1567

8389

Pyogenic arthritis

260

1415

1.92

20.09

6.5

3.4

120.37

129.33

g/l

7.37

252

1386

Retinal vascular occlusion

463

2950

1.63

20.07

4.4

3.1

123.65

127.34

g/l

2.93

455

2866

Other shoulder lesions

297

1681

1.82

19.94

3.3

3.0

131.12

130.07

g/l

0.33

292

1636

Disorders of muscles

332

1942

1.76

19.89

4.7

3.2

128.25

129.79

g/l

0.61

321

1892

Thyrotoxicosis

753

5289

1.45

19.89

3.6

3.3

131.46

127.91

g/l

4.61

731

5164

Ulcerative colitis

742

5201

1.45

19.79

4.3

3.5

128.80

130.74

g/l

1.45

712

5083

Cardiac murmurs and other cardiac sounds

264

1426

1.88

19.74

6.0

4.5

125.02

128.55

g/l

1.52

252

1392

Psoriasis vulgaris

601

4054

1.52

19.74

3.9

3.5

129.60

130.14

g/l

0.22

588

3950

Corns and callosities

250

1353

1.93

19.71

5.3

2.9

121.72

129.25

g/l

5.74

242

1318

Diseases of pulp and periapical tissues, including avohilmo

3597

15758

1.19

19.69

3.8

3.4

129.18

129.16

g/l

0.02

3510

15406

Other mental disorders due to brain damage and dysfunction and to physical disease

436

2751

1.64

19.69

4.2

3.2

125.19

127.09

g/l

1.03

431

2671

Panniculitis affecting regions of neck and back

138

598

2.44

19.66

4.0

2.9

128.86

127.89

g/l

0.19

133

580

Diseases of male genital organs

1859

7435

1.28

19.42

4.4

3.8

131.80

132.12

g/l

0.21

1810

7278

Other and unspecified visual disturbances

346

2068

1.73

19.28

5.2

3.2

132.14

128.94

g/l

2.22

341

2016

Other disorders of bone

579

3891

1.52

19.26

3.6

3.2

131.29

131.15

g/l

0.05

563

3805

Allergic contact dermatitis

388

2383

1.67

19.22

3.7

3.2

131.57

129.92

g/l

0.96

383

2323

Other disorders of eyelid

1523

11377

1.29

19.20

3.9

3.3

127.73

127.24

g/l

0.39

1496

11097

Agranulocytosis

373

2276

1.69

19.20

6.4

3.3

114.45

129.22

g/l

28.52

363

2210

Multiple myeloma, including Hilmo

192

963

2.12

19.18

5.5

2.8

110.10

130.26

g/l

26.19

187

931

Arthropod-borne viral fevers and viral haemorrhagic fevers

335

1992

1.74

19.10

3.6

3.3

130.56

129.89

g/l

0.20

325

1937

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

297

1710

1.81

19.10

5.1

2.9

114.70

127.57

g/l

18.52

290

1665

Retinal vascular disorders

466

3008

1.60

19.09

4.4

3.1

123.55

127.31

g/l

3.03

458

2924

Contact with and exposure to communicable diseases

327

5401

0.59

19.07

7.0

3.8

129.96

132.20

g/l

1.00

310

5278

Other sleep disorders

364

2208

1.70

19.06

3.8

3.2

130.50

128.81

g/l

0.79

350

2157

Trochanteric bursitis

437

2773

1.62

19.00

3.1

2.9

128.58

127.03

g/l

0.82

428

2710

Excessive, frequent and irregular menstruation

1042

4194

1.38

18.99

3.9

3.1

128.29

126.81

g/l

1.43

1020

4105

Benign neoplasm of other and unspecified endocrine glands

441

2813

1.62

18.90

3.6

3.2

128.50

129.15

g/l

0.23

420

2737

Pregnancy hypertension

900

5861

1.39

18.89

4.1

3.0

127.09

129.09

g/l

2.00

881

5716

Melanocytic naevi

859

6227

1.40

18.88

4.2

3.4

128.27

129.89

g/l

1.30

839

6079

Malignant neoplasm of colon, including Hilmo

680

4745

1.47

18.80

3.2

120.29

129.81

g/l

19.68

665

4621

Disorders of ocular muscles, binocular movement, accommodation and refraction

1351

10373

1.31

18.75

5.1

3.7

129.58

129.98

g/l

0.28

1319

10132

Early complications of trauma

170

821

2.19

18.68

3.9

3.1

126.40

130.15

g/l

1.14

164

802

!Aliquae complicationes praecoces traumatis

170

821

2.19

18.68

3.9

3.1

126.40

130.15

g/l

1.14

164

802

Dislocation, sprain and strain of joints and ligaments at neck level

412

2588

1.63

18.60

2.8

3.3

134.43

131.28

g/l

2.21

405

2521

Acute posthaemorrhagic anaemia

150

693

2.30

18.55

4.9

2.8

109.98

128.89

g/l

14.61

145

676

Benign neoplasm: Stomach

353

2148

1.71

18.52

4.2

3.1

122.03

127.78

g/l

4.84

345

2093

Open wound of wrist and hand

1366

10375

1.30

18.49

3.5

3.6

133.19

131.04

g/l

2.95

1338

10128

Non-Hodgkin lymphoma, all, including Hilmo

473

3085

1.58

18.44

4.5

3.3

119.82

130.46

g/l

18.98

465

3001

1116

7371

1.35

18.21

3.4

3.1

125.03

126.45

g/l

1.43

1086

7183

Diseases of oral cavity, salivary glands and jaws

2205

9232

1.24

18.20

4.1

3.1

127.67

129.22

g/l

2.38

2143

9046

Abnormalities of gait and mobility

444

2868

1.60

18.17

5.1

3.6

127.04

127.71

g/l

0.26

433

2794

Viral haemorrhagic fevers, not elsewhere classified/unspecified

274

1567

1.82

18.01

3.6

3.2

130.78

130.04

g/l

0.21

269

1524

Psoriatic arthropathies

327

1959

1.72

18.01

3.9

3.2

130.06

130.40

g/l

0.10

321

1920

Specific development disorders of speech and language

192

944

2.03

17.78

4.4

6.9

130.41

129.85

g/l

0.12

186

921

Lesion of ulnar nerve

445

2890

1.58

17.57

3.8

3.3

129.91

130.17

g/l

0.08

435

2822

Abdominal aortic aneurysm (AAA)

383

2389

1.64

17.47

4.5

3.1

121.70

128.02

g/l

5.55

375

2332

Malignant neoplasm of colon

539

3656

1.52

17.44

3.1

3.2

119.51

129.62

g/l

17.67

526

3562

Endovascular or surgical operations to intracerebral aneurysms

225

1226

1.92

17.43

3.7

3.1

127.21

128.64

g/l

0.41

225

1195

Thyrotoxicosis, other and/or unspecified

580

3981

1.49

17.40

3.4

3.2

131.86

128.10

g/l

3.97

560

3895

Unspecified event, undetermined intent

100

397

2.69

17.38

3.9

3.6

132.24

131.12

g/l

0.17

100

390

Anorexia (incl.atypical)

161

778

2.13

17.31

5.1

3.1

129.21

129.56

g/l

0.08

155

765

Urticaria and erythema

1011

7617

1.35

17.26

4.5

3.7

129.94

129.27

g/l

0.44

983

7452

Other bursopathies

423

2731

1.59

17.16

3.7

3.2

127.06

129.05

g/l

1.06

418

2664

Other renal tubulo-interstitial diseases

335

2.83

17.15

6.4

2.5

117.02

127.81

g/l

4.05

328

Familial hypercholesterolemia, with ischemic heart disease

338

2078

1.69

17.06

4.1

2.8

124.18

129.22

g/l

3.81

331

2028

Hypothyroidism, strict autoimmune, 3 medication purchases required

2618

14792

1.21

17.05

3.6

3.3

127.54

128.54

g/l

1.48

2545

14464

Pneumonia derived septicemia

139

646

2.28

16.95

7.6

4.1

119.21

127.87

g/l

4.33

134

629

Use of biperiden

190

990

2.01

16.89

3.1

126.77

130.22

g/l

1.35

185

967

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

381

2418

1.63

16.89

4.7

3.2

118.61

130.55

g/l

18.02

376

2352

Fibromyalgia

235

1304

1.85

16.84

2.8

2.7

130.91

129.17

g/l

0.66

230

1276

Hyperplasia of prostate

1341

5926

1.31

16.82

4.1

3.4

130.01

130.31

g/l

0.17

1298

5807

Herpesviral [herpes simplex] infections

356

2221

1.65

16.73

5.2

3.2

126.98

129.21

g/l

1.09

347

2160

Paracetamol or NSAID medication

558

1881

1.52

16.68

4.2

3.9

129.82

130.93

g/l

0.49

547

1837

Car occupant injured in other and unspecified transport accidents

534

3638

1.50

16.66

3.2

3.4

132.98

130.78

g/l

1.39

523

3549

Stomatitis and related lesions

576

3985

1.48

16.64

6.7

3.4

127.46

129.70

g/l

1.61

564

3879

Other diseases of oesophagus

332

2042

1.68

16.63

3.7

3.1

124.02

128.71

g/l

2.92

322

1992

Discitis, unspecified

321

2.91

16.62

6.5

3.0

117.33

126.98

g/l

3.32

311

Polyarthrosis

671

4428

1.44

16.61

3.5

3.2

126.21

127.07

g/l

0.46

648

4347

Malignant neoplasm of pancreas

263

1529

1.79

16.47

3.2

3.0

119.97

129.69

g/l

10.41

256

1484

Injury of unspecified body region

272

1595

1.77

16.41

4.5

3.5

124.71

128.72

g/l

2.09

267

1550

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

897

6700

1.36

16.41

3.8

3.6

131.87

130.90

g/l

0.61

878

6540

Childhood asthma (age<16), excluding more controls

245

1079

1.81

16.22

3.4

3.6

133.50

137.78

g/l

2.18

239

1062

Malnutrition

408

2.63

16.14

7.9

5.2

121.04

126.48

g/l

1.55

400

Other enthesopathies

845

6268

1.37

16.11

3.3

3.2

130.94

129.06

g/l

1.66

822

6140

Extrapyramidal and movement disorders

1256

9865

1.29

15.96

3.5

3.4

128.77

127.87

g/l

0.78

1226

9620

Artrosis, including avohilmo

2775

12815

1.19

15.94

3.1

3.5

131.63

129.21

g/l

6.41

2702

12530

Orchitis and epididymitis

333

2076

1.66

15.85

5.3

3.7

130.75

g/l

0.00

325

2029

Appendicitis, broad definition

2240

16892

1.21

15.82

3.3

3.4

131.98

129.98

g/l

4.10

2191

16496

Right hemicolectomy

232

1319

1.84

15.80

4.1

3.0

117.98

127.23

g/l

7.55

227

1285

Disorders of lacrimal system

1291

10152

1.29

15.79

4.1

3.3

128.09

127.95

g/l

0.08

1256

9908

Pedal cyclist injured in other and unspecified transport accidents

349

2204

1.63

15.64

3.8

3.3

126.85

130.74

g/l

2.69

339

2149

Multiple myeloma and malignant plasma cell neoplasms

196

1064

1.95

15.62

5.6

3.1

110.31

127.36

g/l

20.34

190

1036

Malignant neoplasm of urinary organs

358

2284

1.62

15.57

4.8

3.2

117.89

130.47

g/l

18.61

353

2221

Invasive ventilation

256

1503

1.77

15.45

4.5

3.5

121.88

128.76

g/l

4.34

247

1459

Problems related to social environment

109

476

2.42

15.39

3.9

2.9

122.27

127.25

g/l

1.65

103

465

Traumatic subarachnoid haemorrhage

140

678

2.17

15.33

5.3

2.9

126.30

127.45

g/l

0.23

135

661

Diseases of appendix

2255

17006

1.21

15.33

3.3

3.4

131.95

129.94

g/l

4.13

2206

16608

Need for immunization against other single viral diseases

358

2.69

15.28

7.8

3.2

111.28

131.48

g/l

12.20

352

Superficial injury of ankle and foot

327

2044

1.64

15.19

4.4

3.5

130.96

131.19

g/l

0.06

318

1992

Cervicocranial syndrome

313

1939

1.66

15.15

4.3

3.3

131.01

128.04

g/l

1.86

308

1888

Symptoms and signs involving speech and voice

1017

7827

1.32

15.13

4.0

3.4

128.39

128.25

g/l

0.07

991

7636

Injuries involving multiple body regions

138

668

2.17

15.13

5.0

3.2

127.57

129.90

g/l

0.54

133

651

Acute appendicitis

2089

16252

1.21

15.10

3.2

3.5

132.16

130.10

g/l

4.07

2042

15871

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1630

8953

1.25

15.07

3.7

3.3

126.41

130.38

g/l

10.91

1585

8735

Thrombocytopenia, unspecified

257

1522

1.76

15.06

6.0

3.4

116.35

128.66

g/l

12.53

251

1479

Sequelae of injuries, of poisoning and of other consequences of external causes

696

5069

1.40

15.05

3.3

3.6

128.88

130.80

g/l

1.31

679

4953

Childhood asthma (age<16)

246

1111

1.77

15.03

3.4

3.7

133.40

137.31

g/l

1.89

240

1094

Benign neoplasm: Rectum

617

4418

1.43

15.00

3.7

3.4

125.40

128.43

g/l

2.45

600

4313

Other noninflammatory disorders of uterus, except cervix

670

3240

1.42

14.95

3.0

3.1

126.40

125.29

g/l

0.69

656

3180

Postmenopausal osteoporosis with pathological fracture

245

1440

1.78

14.90

3.9

2.6

122.09

125.70

g/l

1.96

239

1406

Other specified disorders of kidney and ureter

133

641

2.20

14.89

8.3

3.3

123.38

127.78

g/l

1.35

133

632

ILD-related respiratory insufficiency

148

745

2.13

14.89

6.2

3.2

123.59

126.33

g/l

0.70

135

727

Other fall from one level to another

683

4968

1.40

14.87

3.9

4.0

129.86

130.62

g/l

0.39

669

4854

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

195

1075

1.91

14.79

4.7

3.0

117.79

130.69

g/l

13.21

188

1041

Speech disturbances, not elsewhere classified

320

2013

1.64

14.78

4.5

3.1

128.03

127.61

g/l

0.13

315

1954

Adhesive capsulitis of shoulder

504

3482

1.48

14.77

3.7

3.2

129.24

128.84

g/l

0.15

488

3402

Pneumococcal septicemia

131

634

2.18

14.48

7.5

4.2

119.74

127.64

g/l

3.54

126

620

Reimbursement for rheumatic diseases

1739

14243

1.23

14.46

4.1

3.4

125.87

129.08

g/l

7.59

1692

13917

Conjunctivitis (acute, non atopic)

789

5884

1.36

14.25

4.1

4.0

131.21

129.68

g/l

1.15

771

5747

788

5554

1.36

14.25

3.4

3.1

124.37

126.12

g/l

1.54

764

5413

Other condition

435

2944

1.51

14.23

4.2

3.4

127.79

130.56

g/l

1.80

423

2864

Use of pramipexole

710

5251

1.38

14.09

5.0

3.3

126.19

127.72

g/l

1.07

691

5123

Acute suppurative otitis media

630

4244

1.40

14.09

5.4

3.7

130.54

133.30

g/l

2.24

619

4142

Subarachnoid haemorrhage

347

2248

1.59

14.06

3.2

3.0

126.75

128.12

g/l

0.53

340

2191

Fall involving bed

146

749

2.08

13.93

6.3

3.6

123.45

125.65

g/l

0.62

141

735

Rheumatoid arthritis

986

6844

1.31

13.86

3.6

3.1

124.02

128.58

g/l

8.85

961

6703

Nontoxic multinodular goitre

609

4406

1.41

13.85

3.1

3.0

129.13

126.16

g/l

3.00

591

4303

Disorders of optic nerve and visual pathways

283

1754

1.66

13.79

5.9

3.6

129.72

129.41

g/l

0.08

278

1706

Fracture at wrist and hand level

1001

7764

1.30

13.77

4.0

3.6

130.07

130.62

g/l

0.33

982

7578

Recurrent aphthous stomatitis , including avohilmo

425

2883

1.51

13.76

7.7

3.3

126.94

129.22

g/l

1.37

415

2807

Secondary uncertain malignant neoplasm

444

3043

1.50

13.74

3.7

3.2

118.94

130.37

g/l

22.95

438

2961

Open wound of forearm

308

1952

1.62

13.71

4.4

3.2

128.81

129.75

g/l

0.32

302

1906

Arthropathic psoriasis

344

2236

1.58

13.69

3.9

3.3

129.99

129.75

g/l

0.07

339

2173

Zoster [herpes zoster]

1575

12708

1.23

13.63

3.7

3.3

127.24

128.20

g/l

0.98

1533

12407

Examination and encounter for administrative purposes

170

919

1.93

13.59

3.3

3.0

131.30

129.52

g/l

0.46

163

893

Spondylolisthesis/Spondylolysis

530

3755

1.44

13.56

3.8

3.4

128.96

128.28

g/l

0.28

517

3668

Redundant prepuce, phimosis and paraphimosis

655

4760

1.39

13.55

4.5

3.6

132.27

133.42

g/l

0.59

641

4656

malignant neoplasm of female genital organs

458

3149

1.48

13.46

2.8

2.9

120.98

127.50

g/l

8.82

451

3069

Iridocyclitis

679

5020

1.38

13.45

4.9

3.3

126.42

129.84

g/l

3.56

664

4899

Retinal detachments and breaks

1160

9236

1.27

13.27

4.2

3.2

126.02

128.58

g/l

3.42

1138

9015

Fluid overload

6.66

13.24

8.2

3.2

122.63

128.70

g/l

0.50

Oligomenorrhoea

435

2.34

13.22

5.7

3.0

130.82

127.46

g/l

0.87

424

Benign neoplasm: Rectum, anus and anal canal

673

4992

1.38

13.19

3.6

3.5

125.39

128.38

g/l

2.65

654

4872

Other disorders of conjunctiva

465

3242

1.47

13.18

5.1

3.4

129.50

127.89

g/l

0.81

447

3164

Carbimazole or st.post thyroidectomy, condition for graves disease

563

4050

1.41

13.18

3.0

3.3

132.23

128.68

g/l

3.43

541

3948

Acute appendicitis, no complications

1563

12787

1.23

13.09

3.3

3.5

132.96

130.51

g/l

4.26

1530

12493

Other disorders of eye and adnexa

403

2733

1.51

13.06

3.9

3.5

130.33

129.28

g/l

0.45

391

2664

Sarcoidosis

408

2782

1.50

12.95

4.4

3.2

127.46

129.80

g/l

1.17

395

2711

1434

10736

1.24

12.94

3.6

3.3

126.34

126.74

g/l

0.30

1401

10463

Idiopathic pulmonary fibrosis

293

1869

1.63

12.93

4.2

3.1

127.61

126.82

g/l

0.24

283

1822

Burns and corrosions

405

2757

1.50

12.90

3.7

3.8

130.49

131.40

g/l

0.33

395

2688

Spondyloarthritis

528

3771

1.42

12.90

4.3

3.3

126.34

129.73

g/l

2.77

511

3680

Pedal cyclist injured in transport accident

632

4650

1.38

12.89

3.3

3.6

129.19

130.76

g/l

1.04

614

4545

Pre-eclampsia

417

2849

1.49

12.85

4.1

3.1

126.16

129.61

g/l

2.60

406

2775

Trigger finger

406

2768

1.50

12.80

3.9

3.1

128.20

129.16

g/l

0.36

394

2699

5-aminosalicylic acid

577

4186

1.40

12.80

4.2

3.2

130.23

131.89

g/l

0.94

555

4098

Psoriatic arthropathies, ICD10

319

2076

1.58

12.69

3.8

3.2

130.25

129.74

g/l

0.15

314

2021

Fibroblastic disorders

734

5543

1.35

12.65

3.4

3.2

128.19

128.47

g/l

0.12

719

5399

Pre-eclampsia or eclampsia

449

3123

1.46

12.61

4.1

3.2

125.99

129.34

g/l

2.61

437

3047

Strabismus

733

5526

1.34

12.48

5.1

4.0

129.47

129.91

g/l

0.21

717

5392

Fracture of neck

221

1328

1.73

12.41

3.3

3.2

124.87

128.42

g/l

1.45

216

1294

Nontoxic goitre/thyroid nodule

874

6780

1.31

12.38

3.1

129.23

126.71

g/l

2.95

854

6612

IBD patients in KELA-register

622

4597

1.37

12.32

4.1

3.6

130.74

131.53

g/l

0.36

600

4486

Suppurative and unspecified otitis media

910

6269

1.30

12.29

4.8

3.7

130.27

132.01

g/l

1.48

892

6126

Other benign neoplasms of skin

1159

9313

1.26

12.24

4.0

3.3

128.17

128.08

g/l

0.05

1134

9077

Crohn's disease NAS

194

1126

1.78

12.20

5.6

3.5

127.49

131.50

g/l

1.50

185

1098

Other psoriatic arthropathies

310

2024

1.57

12.17

3.8

3.2

130.33

129.81

g/l

0.15

305

1971

Pre-eclampsia or poor fetal growth

590

4311

1.38

12.14

4.2

3.1

126.59

129.82

g/l

3.11

573

4209

Melanocytic naevi of trunk

352

2361

1.53

12.14

4.0

3.2

126.40

129.81

g/l

2.08

342

2291

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

455

3208

1.45

12.06

4.0

3.1

124.30

129.13

g/l

4.96

444

3115

Seborrhoeic dermatitis

309

2022

1.57

12.05

3.8

3.4

128.99

129.84

g/l

0.27

298

1967

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1511

8532

1.23

12.02

3.5

3.3

126.23

130.26

g/l

10.27

1472

8325

Diseases of salivary glands

912

7137

1.29

12.02

3.3

3.4

129.56

129.03

g/l

0.31

897

6970

Gestational [pregnancy-induced] hypertension

494

3517

1.42

12.01

4.2

3.0

127.65

129.76

g/l

1.36

482

3425

Neuralgia and neuritis, unspecified

164

913

1.86

11.96

4.0

2.8

128.73

129.93

g/l

0.28

153

889

Vitamin B12 deficiency anaemia

359

2429

1.52

11.94

4.4

3.1

118.01

128.51

g/l

13.75

347

2371

Disorders of continuity of bone

276

1763

1.60

11.90

4.8

3.2

124.84

130.39

g/l

3.80

270

1721

Anterior Iridocyclitis

594

4396

1.37

11.77

5.1

3.3

126.26

129.80

g/l

3.34

580

4284

Inflammatory diseases of the central nervous system

256

1614

1.63

11.74

3.8

3.3

125.22

129.75

g/l

2.67

250

1570

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

747

5711

1.32

11.72

3.3

3.5

133.19

130.82

g/l

2.22

726

5577

Special screening examination for neoplasms

184

1066

1.78

11.68

3.3

2.9

132.35

130.35

g/l

0.50

177

1036

Osteonecrosis

203

1213

1.74

11.62

5.0

3.1

122.28

129.27

g/l

3.79

196

1186

Other disorders of the musculoskeletal system and connective tissue

457

3252

1.44

11.60

3.0

3.3

128.19

128.87

g/l

0.26

442

3165

Primary gonarthrosis, bilateral

1689

12129

1.21

11.48

3.0

3.4

128.43

127.70

g/l

0.69

1652

11847

Budesonide

384

2648

1.48

11.47

3.5

3.1

129.66

131.01

g/l

0.57

367

2583

Generalized epilepsy

129

674

1.99

11.46

4.4

4.9

129.13

129.78

g/l

0.11

121

659

Oxicams

902

3990

1.30

11.46

3.4

4.1

131.03

126.45

g/l

7.37

881

3907

Faecal incontinence

260

1654

1.61

11.44

3.4

2.8

126.39

126.72

g/l

0.10

252

1618

Glaucoma

1878

13677

1.19

11.44

3.6

3.3

125.64

127.66

g/l

3.45

1828

13348

conjunctival haemorrhage

262

1678

1.61

11.37

5.0

3.1

127.78

127.74

g/l

0.01

251

1633

Diabetes mellitus in pregnancy

553

2571

1.39

11.30

3.6

3.2

129.93

130.58

g/l

0.30

538

2506

Malignant neoplasm of skin

1618

9255

1.21

11.21

3.5

3.3

126.49

130.57

g/l

10.97

1572

9031

Pneumothorax

238

1494

1.65

11.21

4.4

3.2

127.60

128.81

g/l

0.30

230

1454

Other diseases of lip and oral mucosa

1147

9297

1.25

11.20

3.6

3.5

129.79

129.01

g/l

0.57

1120

9080

Acute and subacute iridocyclitis

557

4115

1.38

11.20

5.1

3.2

126.72

129.83

g/l

2.50

543

4012

Arterial embolism and thrombosis of lower extremity artery

136

732

1.95

11.19

7.1

3.1

121.16

128.44

g/l

2.73

130

715

Rare circulating lymphoid malignancy, including Hilmo

114

579

2.08

11.17

15.8

3.3

113.88

131.05

g/l

11.42

114

568

Sequelae of injuries of head

167

956

1.81

11.13

3.5

3.4

128.89

131.37

g/l

0.69

162

933

Lyme disease

510

6928

0.73

11.13

2.2

3.5

132.71

128.96

g/l

4.09

503

6755

Other disorders of lacrimal gland

1004

8028

1.27

11.11

4.4

3.3

127.49

128.18

g/l

0.47

974

7843

Vascular dementia (undefined)

159

891

1.83

11.02

4.3

3.1

125.12

122.96

g/l

0.64

154

864

Coeliac disease

339

2302

1.50

11.02

5.1

3.3

125.56

130.39

g/l

3.99

330

2241

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

470

2.17

10.98

9.5

6.9

129.86

131.05

g/l

0.18

462

Colorectal adenocarcinoma

656

4974

1.34

10.96

2.7

3.2

121.38

130.03

g/l

16.37

635

4842

Disturbance of activity and attention

235

1439

1.63

10.95

4.9

132.75

134.64

g/l

0.69

228

1407

Wet age-related macular degeneration

642

4727

1.35

10.88

3.3

3.1

125.34

126.05

g/l

0.36

628

4612

Hypertrophic cardiomyopathy

155

882

1.84

10.71

5.5

3.4

129.28

128.49

g/l

0.14

150

860

Other and unspecified vascular occlusions

331

2259

1.51

10.68

4.7

3.1

123.73

127.41

g/l

2.27

325

2198

Lung cancer and mesothelioma

588

3770

1.36

10.64

3.7

2.7

122.65

129.38

g/l

10.77

578

3683

Inflammatory bowel disease, strict (require KELA)

622

4705

1.34

10.63

4.1

3.6

130.74

131.52

g/l

0.36

600

4597

Adult respiratory distress syndrome

246

2.69

10.58

6.5

3.3

116.79

127.10

g/l

2.06

241

Caries of enamel

1996

16798

0.85

10.57

4.1

3.4

129.98

130.41

g/l

0.35

1967

16386

Inflammatory disease of uterus

305

2041

1.52

10.57

2.9

3.1

130.12

128.52

g/l

0.68

300

1996

Keratitis

1027

8280

1.25

10.56

4.3

3.4

128.15

129.78

g/l

1.45

997

8096

Other/unspecified synovitis and tenosynovitis

320

2167

1.51

10.55

3.4

3.1

129.10

129.06

g/l

0.01

313

2107

Other maltreatment syndromes

439

2.18

10.54

3.8

3.2

136.33

133.72

g/l

0.49

431

Need for other prophylactic measures

186

1116

1.72

10.51

8.9

3.5

124.44

130.05

g/l

2.65

186

1083

Other spirochaetal diseases

521

6992

0.74

10.51

2.3

3.5

132.53

129.00

g/l

3.76

513

6817

Fissure and fistula of anal and rectal regions

663

5072

1.32

10.46

3.3

3.2

129.99

130.23

g/l

0.10

647

4956

Burns and corrosions of external body surface, specified by site

312

2110

1.51

10.40

3.7

3.8

130.41

131.10

g/l

0.20

307

2052

Spirochaetal infections, other/unspecified

521

6980

0.74

10.39

2.2

3.5

132.77

128.98

g/l

4.28

513

6805

Presence of other devices

434

5948

0.72

10.35

3.8

2.8

124.04

128.43

g/l

3.65

410

5818

Personal history of other diseases and conditions

248

1588

1.58

10.32

7.6

3.4

124.83

132.40

g/l

5.93

242

1550

Somnolence

201

2.84

10.32

4.9

4.2

123.57

129.20

g/l

1.23

196

Coxarthrosis, primary, with hip surgery

1571

12388

1.20

10.31

3.3

3.4

127.09

127.27

g/l

0.12

1536

12083

Chronic sinusitis

1218

10010

1.23

10.31

3.6

3.4

130.38

129.30

g/l

0.96

1183

9770

Atypical facial pain

160

926

1.79

10.30

2.8

130.64

127.20

g/l

1.30

152

908

Other specified/unspecified bacterial intestinal infections

217

1362

1.65

10.28

6.1

3.0

123.59

128.61

g/l

2.60

212

1325

Skin changes due to chronic exposure to nonionizing radiation

1341

10281

1.22

10.26

3.7

3.3

126.04

126.62

g/l

0.45

1309

10018

Follicular cysts of skin and subcutaneous tissue

534

3978

1.37

10.23

4.0

3.4

128.32

130.06

g/l

0.98

519

3882

Later onset COPD

1021

6571

1.26

10.22

4.4

3.2

125.70

126.72

g/l

0.71

991

6395

Mycoses

2608

19848

1.15

10.18

4.1

3.4

128.33

129.82

g/l

2.70

2549

19387

Actinic keratosis

1311

10081

1.22

10.14

3.7

3.3

126.00

126.63

g/l

0.49

1280

9823

Gingivitis and periodontal diseases

3432

15705

1.13

10.11

3.9

3.3

128.71

129.57

g/l

1.36

3335

15362

Persistent delusional disorders

234

1501

1.60

10.06

2.5

3.2

131.19

129.13

g/l

0.74

228

1464

Hypoplasia of dental enamel, prenatal

6.49

10.05

52.6

18.4

116.35

123.15

g/l

0.60

Abscess of anal and rectal regions

238

1531

1.59

10.03

3.8

3.4

127.77

133.03

g/l

2.71

228

1495

Other and unspecified disorders of vitreous body

1252

10226

1.22

9.97

3.3

3.4

130.65

127.68

g/l

5.17

1224

9985

Enthesopathies of lower limb, excluding foot

583

4412

1.34

9.96

4.4

3.4

130.78

129.25

g/l

0.90

567

4312

Other general symptoms and signs

129

698

1.88

9.95

3.2

3.4

126.31

130.10

g/l

1.04

120

680

Hyperkinetic disorders

250

1589

1.56

9.94

4.8

5.1

133.11

134.29

g/l

0.38

243

1556

Nondiabetic hypoglycaemic coma

5.22

9.91

4.0

3.9

127.36

132.85

g/l

0.41

Abnormal results of function studies

257

1691

1.56

9.84

5.0

3.6

126.65

129.42

g/l

1.17

252

1642

Other inflammatory liver diseases

205

1284

1.65

9.79

3.4

3.1

124.98

129.19

g/l

1.68

198

1251

Exposure to other and unspecified inanimate mechanical forces

216

1369

1.62

9.77

4.0

3.7

129.08

130.69

g/l

0.47

211

1333

Other enthesopathy of foot (+metatarsalgia)

266

1767

1.54

9.67

3.3

3.1

130.41

129.05

g/l

0.46

259

1722

Other spirochaetal diseases

537

7086

0.75

9.66

2.3

3.5

132.65

129.03

g/l

4.07

528

6908

Postprocedural musculoskeletal disorders, not elsewhere classified

235

1527

1.59

9.65

3.0

3.1

126.27

127.83

g/l

0.49

225

1490

Bell's palsy

345

2418

1.46

9.61

3.7

3.2

127.91

129.11

g/l

0.43

334

2357

Sulfasalazine

783

6190

1.28

9.59

3.6

3.1

126.91

130.27

g/l

4.01

759

6054

Temporomandibular joint disorders, including avohilmo

1035

8314

1.24

9.57

3.5

3.4

131.04

129.98

g/l

0.95

1006

8125

Inguinal hernia

1944

11166

1.17

9.56

3.9

3.4

129.41

130.96

g/l

2.11

1904

10898

Congenital malformations and deformations of the musculoskeletal system

272

1811

1.52

9.49

5.1

5.0

131.39

130.47

g/l

0.29

267

1765

Pain associated with micturition

333

2324

1.46

9.49

5.3

3.2

127.86

128.68

g/l

0.29

326

2259

Urticaria

755

5950

1.28

9.47

4.6

3.6

131.10

129.71

g/l

0.98

737

5812

Collagenous colitis

270

1812

1.53

9.46

4.7

3.3

123.92

128.53

g/l

2.96

265

1763

Fracture of forearm

1613

12559

1.19

9.44

3.7

3.4

127.86

128.72

g/l

0.83

1587

12269

Diffuse brain injury

105

548

1.98

9.41

2.7

3.1

126.75

129.88

g/l

0.74

100

538

Outcome of delivery

115

1290

0.54

9.38

2.0

3.0

135.23

130.59

g/l

2.08

115

1262

Blepharochalasis

907

7323

1.26

9.38

3.6

3.3

128.59

126.89

g/l

1.59

888

7142

Anomalies of dental arch relationship, including avohilmo

479

3197

1.37

9.38

4.4

3.8

131.37

130.94

g/l

0.16

471

3118

Impingement syndrome of shoulder

682

5323

1.30

9.34

3.6

3.2

131.67

129.43

g/l

1.78

653

5202

Rheumatism, unspecified

351

2480

1.44

9.30

3.2

2.9

128.39

127.33

g/l

0.41

335

2424

Metatarsalgia

249

1648

1.54

9.25

3.3

3.1

130.60

128.71

g/l

0.70

244

1604

Hydrocephalus

256

1712

1.54

9.21

3.0

3.3

129.94

127.26

g/l

1.23

249

1665

Viral warts

549

4170

1.33

9.19

5.4

3.4

128.37

130.97

g/l

1.88

534

4070

Alkalosis

7.92

9.17

9.7

1.5

121.00

125.73

g/l

0.32

Weight loss

311

2162

1.47

9.14

4.2

3.6

126.69

127.76

g/l

0.38

297

2107

Hyperaldosteronism

104

552

1.98

9.07

3.7

3.4

133.49

128.06

g/l

1.50

104

542

Congenital malformations of the musculoskeletal system, not elsewhere classified

202

2.65

9.02

10.1

5.2

131.59

130.15

g/l

0.20

197

Mandibular retrognathia

163

981

1.70

8.95

3.0

4.1

135.98

131.41

g/l

2.18

158

955

Ulcerative colitis, NAS

377

2719

1.41

8.91

4.9

3.5

127.45

130.95

g/l

2.15

361

2647

Dislocation, sprain and strain of joints and ligaments of head

113

616

1.89

8.90

6.0

3.8

132.44

130.46

g/l

0.48

113

600

Right bundle-branch block

112

611

1.90

8.85

6.5

2.4

129.81

128.42

g/l

0.30

107

592

Dermatitis due to substances taken internally

160

968

1.70

8.80

4.6

3.2

125.52

128.63

g/l

0.96

155

943

Injury of eye and orbit

377

2724

1.41

8.80

4.2

3.6

132.36

131.35

g/l

0.37

372

2656

Anxious personality disorder

235

2.49

8.77

4.9

2.9

130.71

134.37

g/l

0.52

230

Acute nasopharyngitis (common cold)

327

2292

1.44

8.76

3.7

3.4

132.59

133.41

g/l

0.25

315

2239

188

1182

1.63

8.73

3.8

2.7

126.91

125.79

g/l

0.29

183

1150

Inflammatory diseases of female pelvic organs

1457

9064

1.19

8.73

3.5

3.0

128.65

127.47

g/l

1.38

1426

8856

Maternal care for other conditions predominantly related to pregnancy

353

2474

1.41

8.63

3.3

129.93

130.33

g/l

0.14

343

2413

Superficial injury of shoulder and upper arm

326

2309

1.44

8.61

4.1

3.3

129.85

130.20

g/l

0.10

320

2248

Basal cell carcinoma, including avohilmo

1465

8565

1.19

8.58

3.4

3.3

126.53

130.28

g/l

8.72

1424

8356

Alzheimer’s disease (Atypical or mixed)

380

2751

1.41

8.57

2.9

3.2

129.30

124.22

g/l

4.58

369

2684

Visual field defects

266

1823

1.50

8.48

3.9

3.2

128.27

127.99

g/l

0.07

256

1773

Acute pharyngitis

355

2532

1.41

8.46

5.9

4.0

132.79

132.65

g/l

0.04

344

2481

Accidental poisoning by and exposure to alcohol

271

2.36

8.46

6.8

3.4

133.13

131.06

g/l

0.31

264

Effects of foreign body entering through natural orifice

698

5545

1.27

8.34

3.6

3.8

131.57

131.29

g/l

0.12

681

5411

Gonarthrosis, primary, with knee surgery

1879

12993

1.16

8.34

3.1

3.4

126.74

127.67

g/l

1.01

1840

12691

Ventricular septal defect, a heart condition

364

2.15

8.31

10.0

11.3

133.24

127.84

g/l

0.94

359

Malignant neoplasm of endocrine gland

197

1272

1.59

8.31

5.6

3.0

125.23

131.14

g/l

3.02

190

1231

Disorders of refraction and accommodation

661

5201

1.28

8.22

5.8

4.0

129.75

130.51

g/l

0.40

643

5078

Hypoplasia of dental enamel, prenatal , including avohilmo

4.02

8.21

48.0

15.5

118.60

124.79

g/l

0.63

Basal cell carcinoma

1413

8309

1.19

8.18

3.4

3.3

126.17

130.10

g/l

9.22

1374

8108

Colon adenocarcinoma

390

2880

1.38

8.13

2.8

3.1

119.72

129.78

g/l

12.45

378

2806

Malignant neoplasm of thyroid gland, including Hilmo

203

1327

1.57

8.10

3.0

2.9

126.91

131.08

g/l

1.77

197

1285

Malignant neoplasm of ovary, including Hilmo

181

1156

1.61

8.05

2.9

2.8

117.82

128.67

g/l

8.94

176

1124

Striking against or struck by other objects

902

7398

1.23

7.94

4.1

3.9

131.67

131.41

g/l

0.13

878

7227

Squamous cell neoplasms and carcinomas of the skin

292

2069

1.45

7.83

4.0

3.1

123.36

128.50

g/l

3.70

286

2007

Other intracranial haemorrhages

123

722

1.78

7.78

5.0

3.3

125.89

127.17

g/l

0.23

118

707

Parkinson's disease, including avohilmo

527

4090

1.31

7.78

3.3

127.88

127.32

g/l

0.25

513

3987

Dislocation, sprain and strain of joints and ligaments of knee

1606

12778

1.17

7.77

3.1

3.4

134.12

130.98

g/l

6.42

1569

12487

Renal agenesis and other reduction defects of kidney

3.66

7.75

7.0

12.0

118.37

126.78

g/l

0.94

Bronchiectasis

253

1753

1.48

7.69

3.4

3.2

124.63

127.01

g/l

1.00

248

1710

Otitis externa, unspecified

298

2124

1.43

7.64

3.3

3.6

132.05

129.76

g/l

0.95

287

2067

Congenital malformations of the musculoskeletal system, not elsewhere classified

183

2.58

7.62

11.2

5.5

132.16

130.34

g/l

0.25

178

Assault by other specified means

120

3.01

7.59

2.8

3.6

132.53

132.97

g/l

0.03

120

Sequelae of injuries of lower limb

255

1772

1.47

7.55

3.5

3.3

127.79

130.40

g/l

0.96

248

1730

Intentional self-harm by smoke, fire and flames

7.92

7.52

5.2

5.0

128.12

130.07

g/l

0.10

Other strabismus

541

4207

1.30

7.48

5.3

4.0

130.62

130.36

g/l

0.10

529

4105

Hypogonadotropic hypogonadism

486

1.93

7.45

3.0

3.4

142.31

135.06

g/l

1.69

478

Abnormal weight loss

281

2000

1.44

7.37

3.8

3.6

127.25

127.72

g/l

0.13

268

1947

Menorrhagia

856

3876

1.24

7.36

4.1

3.1

127.63

126.28

g/l

1.09

837

3796

Diseases of pulp and periapical tissues and dental caries

2331

10563

1.14

7.36

3.9

3.3

128.05

128.81

g/l

0.84

2273

10338

Viral agents as the cause of diseases classified to other chapters

370

2.07

7.32

3.8

4.3

124.90

128.95

g/l

0.70

364

Polyp of the female genital tract

795

3705

1.24

7.30

2.9

3.1

128.63

126.18

g/l

2.66

774

3631

Chondropathies

400

3013

1.35

7.26

3.3

132.67

130.71

g/l

0.98

388

2935

Other symptoms and signs involving the nervous and musculoskeletal systems

1169

9915

1.19

7.26

4.5

3.6

130.97

128.83

g/l

2.76

1128

9682

Behavioural syndromes associated with physiological disturbances and physical factors

2716

17253

1.12

7.23

3.4

3.5

131.90

129.45

g/l

7.14

2655

16844

Malignant neoplasm of rectum, including Hilmo

391

2945

1.35

7.19

2.8

3.3

123.04

130.27

g/l

8.09

380

2869

Viral agents as the cause of diseases classified to other chapters

421

1.98

7.19

3.6

4.1

125.96

129.44

g/l

0.62

412

Crohn's disease of large intestine

135

826

1.68

7.18

3.9

3.2

127.80

131.62

g/l

1.09

130

806

In situ neoplasms

1123

9510

1.19

7.17

3.7

3.2

125.30

127.16

g/l

2.13

1090

9281

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

4.72

7.14

10.0

2.4

114.61

129.14

g/l

1.40

Occlusion and stenosis of arteries, not leading to stroke

253

2.30

7.14

2.7

3.1

122.93

126.03

g/l

0.45

246

Other specified/unspecified necrotizing vasculopathies

274

2.26

7.12

7.2

3.2

115.78

127.28

g/l

3.21

268

Otitis externa

593

4717

1.27

7.09

3.7

3.6

130.83

129.83

g/l

0.49

576

4609

Glaucoma suspect

1109

9410

1.19

6.97

3.5

3.4

126.22

127.56

g/l

1.18

1075

9180

Lateral epicondylitis

319

2341

1.38

6.88

3.3

3.1

132.08

130.42

g/l

0.69

310

2285

Primary coxarthrosis, bilateral

922

7712

1.21

6.88

3.3

127.14

126.96

g/l

0.09

898

7535

Noninflammatory disorders of female genital tract

1016

4258

1.21

6.80

3.1

129.20

126.84

g/l

3.13

990

4166

Herpesviral [herpes simplex] infections

582

4641

1.27

6.79

4.2

3.3

128.08

130.17

g/l

1.51

570

4524

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1519

12844

1.16

6.75

4.2

3.5

130.52

129.74

g/l

0.65

1471

12541

Parkinson's disease

496

3897

1.30

6.72

3.3

127.62

127.37

g/l

0.10

482

3802

Suggestive for eosinophilic asthma

263

1886

1.42

6.63

3.7

3.1

133.20

129.00

g/l

2.36

258

1834

Scleritis and episcleritis

158

1025

1.58

6.62

5.6

3.2

128.12

130.15

g/l

0.59

152

1001

Vascular dementia (mixed)

407

1.97

6.61

2.6

2.9

125.14

123.12

g/l

0.34

394

Malignant neoplasm of thyroid gland

177

1178

1.54

6.60

3.1

2.9

126.55

130.88

g/l

1.67

171

1142

Retinal haemorrhage

508

1.85

6.58

4.7

3.0

125.09

128.13

g/l

0.69

497

Otitis media, unspecified

266

1755

1.42

6.56

6.3

4.4

129.70

131.26

g/l

0.54

254

1713

Injury of muscle and tendon at wrist and hand level

374

2836

1.34

6.56

2.7

3.5

133.10

130.11

g/l

1.74

363

2763

Central retinal artery occlusion

495

1.87

6.56

4.0

3.1

123.93

125.57

g/l

0.25

481

Other extrapyramidal and movement disorders in other diseases

684

5586

1.24

6.52

3.5

128.77

128.45

g/l

0.14

671

5454

Burn and corrosion of hip and lower limb, except ankle and foot

401

1.95

6.47

5.1

3.6

130.51

129.48

g/l

0.14

393

Necrosis of pulp, including avohilmo

1544

13476

1.15

6.37

4.1

3.4

131.67

130.68

g/l

0.98

1504

13163

Early lumbar disc prolapse, operated

197

1347

1.48

6.34

3.8

3.2

134.65

134.71

g/l

0.01

185

1318

Paralytic strabismus

217

1519

1.46

6.33

4.5

3.2

127.62

128.64

g/l

0.27

212

1473

Calcinosis cutis

7.11

6.29

43.9

3.8

104.13

130.12

g/l

3.08

Parkinson's disease, strict definition

461

3622

1.30

6.29

3.3

128.17

127.28

g/l

0.43

448

3533

Syndactyly

4.52

6.29

5.4

2.9

129.19

136.95

g/l

0.78

Superficial injury of neck

280

2.11

6.23

2.2

3.8

136.33

132.43

g/l

0.81

275

Meniscus derangement

1683

9970

1.14

6.18

3.3

3.2

131.46

130.20

g/l

1.43

1642

9768

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

331

2485

1.35

6.16

3.2

3.1

128.59

128.58

g/l

0.00

322

2432

Benign neoplasm of mouth and pharynx

308

2295

1.37

6.15

3.5

3.2

128.98

128.81

g/l

0.04

301

2229

Diseases of middle ear and mastoid

1508

10800

1.15

6.04

4.3

3.6

130.57

130.59

g/l

0.01

1477

10537

Polymyalgia rheumatica

427

3342

1.30

6.03

3.7

3.1

123.58

126.86

g/l

2.85

418

3257

Mixed connective tissue disease

170

1147

1.52

5.99

3.6

3.0

123.62

127.55

g/l

1.64

164

1120

Seropositive rheumatoid arthritis

695

5715

1.22

5.96

3.5

3.2

123.16

128.23

g/l

8.08

679

5593

Contact with heat and hot substances

147

964

1.56

5.93

3.2

3.9

129.86

129.58

g/l

0.05

142

943

Complications predominantly related to the puerperium

479

3797

1.27

5.91

3.0

3.2

130.91

128.96

g/l

1.37

469

3712

Other specified and unspecified retinal disorders

113

701

1.67

5.86

5.6

2.9

127.40

127.35

g/l

0.01

107

687

Contact with sharp object, undetermined intent

372

1.92

5.82

3.8

3.5

130.35

131.77

g/l

0.20

365

UC patients in KELA-register (code 208), prior to 1994

132

853

1.59

5.76

4.4

3.2

127.80

129.76

g/l

0.39

123

834

Schizoid personality disorder

292

2.04

5.64

2.3

3.1

129.04

132.07

g/l

0.46

287

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

15.04

5.59

5.8

3.3

116.44

132.67

g/l

—

Acute laryngitis and tracheitis

249

1789

1.38

5.57

4.2

4.1

131.98

132.74

g/l

0.21

241

1755

Other diseases of upper respiratory tract

3591

17200

1.09

5.56

3.6

3.5

130.06

128.77

g/l

2.71

3507

16810

Nontoxic single thyroid nodule

190

1332

1.46

5.52

3.4

3.0

130.35

127.55

g/l

1.07

190

1307

Other coagulation defects

193

1358

1.45

5.49

5.7

3.3

123.88

128.94

g/l

2.20

187

1324

Vulvovaginal ulceration/inflammation in other diseases

120

764

1.60

5.48

3.9

2.6

130.30

129.48

g/l

0.17

115

745

Congenital malformation of biliary tract

3.99

5.46

22.8

15.7

118.94

126.98

g/l

0.59

Thyrotoxicosis with diffuse goitre

322

2456

1.33

5.46

3.6

3.2

131.42

128.33

g/l

1.81

314

2401

Perforation of tympanic membrane

275

2054

1.36

5.46

4.9

3.2

128.66

129.33

g/l

0.17

268

2000

Hydrocele

364

2833

1.31

5.38

4.3

3.7

125.35

129.72

g/l

2.78

355

2770

Artificial joint operation, meniscal resection

2932

17396

1.10

5.38

3.2

3.4

129.14

129.03

g/l

0.09

2870

16993

Voice disturbances

707

5910

1.21

5.37

3.8

3.4

128.49

128.51

g/l

0.01

684

5772

Other keratitis

290

2187

1.35

5.37

4.7

3.3

127.99

130.51

g/l

1.05

283

2133

Nummular dermatitis

238

1745

1.39

5.36

4.7

3.1

125.66

129.39

g/l

1.67

232

1690

Palmar fascial fibromatosis [Dupuytren]

475

3819

1.26

5.36

3.4

3.3

128.37

128.49

g/l

0.04

467

3715

Other obstetric conditions, not elsewhere classified

487

2471

1.26

5.36

4.3

2.9

130.29

131.86

g/l

0.93

470

2417

Benign lipomatous neoplasm

822

6968

1.19

5.34

4.0

3.5

130.66

128.91

g/l

1.49

793

6800

Other maternal disorders predominantly related to pregnancy

1135

6149

1.16

5.32

3.2

3.1

130.59

128.46

g/l

2.87

1105

6013

Other and unspecified injuries of wrist and hand

102

631

1.66

5.32

3.7

3.8

126.23

128.21

g/l

0.32

617

Calcific tendinitis of shoulder

148

996

1.52

5.32

3.8

3.0

133.81

129.68

g/l

1.41

142

971

Autoimmune thyroiditis

256

2.07

5.32

3.2

3.5

131.06

127.65

g/l

0.56

251

Medullary cystic kidney disease, nephronophthisis

6.60

5.28

11.9

2.5

100.85

133.21

g/l

3.13

Rash and other nonspecific skin eruption

258

1920

1.37

5.26

3.9

3.5

129.54

128.16

g/l

0.51

252

1873

Mantle cell lymphoma, including Hilmo

295

2.01

5.22

4.0

2.8

116.55

131.64

g/l

4.06

289

Spondylopathies (FG)

336

2599

1.31

5.17

3.8

3.3

130.50

131.66

g/l

0.41

329

2550

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

447

3581

1.26

5.17

4.3

3.6

130.63

131.21

g/l

0.20

427

3501

Hallux valgus (acquired)

917

5636

1.18

5.15

2.8

3.1

127.94

128.00

g/l

0.03

892

5524

Intentional self-harm by jumping from a high place

3.32

5.05

3.9

3.5

136.74

136.57

g/l

0.01

Demyelinating diseases of the central nervous system

188

1338

1.43

5.02

4.6

3.0

132.72

130.71

g/l

0.69

183

1305

Spontaneous rupture of synovium and tendon

224

1646

1.39

4.98

3.8

3.1

130.00

128.88

g/l

0.30

215

1596

Inflammatory diseases of prostate (prostatitis)

388

3078

1.28

4.97

3.3

3.5

134.01

130.90

g/l

1.84

381

3002

Other disorders of the genitourinary system

341

2663

1.30

4.95

4.1

3.0

126.91

126.46

g/l

0.14

334

2595

Haemorrhage in early pregnancy

504

3996

1.24

4.94

2.8

3.2

130.67

128.83

g/l

1.23

494

3898

Sexual assault by bodily force

5.30

4.92

3.9

2.7

128.86

131.67

g/l

0.17

Ulcerative colitis (strict definition, require KELA)

413

3299

1.27

4.92

4.3

3.5

130.32

131.34

g/l

0.38

394

3223

Persons encountering health services in circumstances related to reproduction

1164

8959

0.87

4.90

4.7

3.9

130.32

131.99

g/l

1.60

1125

8768

Corneal ulcer

472

3831

1.25

4.88

4.4

3.2

128.58

130.70

g/l

1.20

459

3738

Preterm labour and delivery

479

3888

1.24

4.88

3.1

3.3

128.63

128.29

g/l

0.14

469

3806

Degenerative macular diseases

372

2945

1.28

4.88

3.7

3.0

129.08

127.25

g/l

0.85

363

2873

Orthopaedic devices associated with adverse incidents

395

0.29

4.87

3.2

2.9

119.67

125.36

g/l

0.27

388

Immunodeficiency associated with other major defects

3.79

4.85

20.6

14.2

127.81

128.58

g/l

0.05

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

398

3172

1.27

4.85

4.3

3.5

130.41

131.29

g/l

0.31

382

3098

Biological medication for rheuma

386

3068

1.27

4.80

3.7

130.24

131.57

g/l

0.54

375

3002

Injury of muscle and tendon at shoulder and upper arm level

1057

9221

1.16

4.79

3.2

3.4

131.17

129.88

g/l

1.06

1028

8998

Spondylopathies in diseases classified elsewhere

227

2.09

4.75

6.7

2.9

120.18

126.18

g/l

0.95

219

Colonic or urogenital fistula

732

6214

1.19

4.73

3.5

129.13

129.67

g/l

0.26

714

6063

Injury of heart

4.73

4.71

4.7

3.0

127.67

129.16

g/l

0.06

Viral infections of the central nervous system

197

1432

1.40

4.71

4.2

3.3

126.97

130.06

g/l

1.13

192

1396

Viral infections of the central nervous system

186

1340

1.41

4.69

4.3

3.2

126.22

130.13

g/l

1.58

181

1308

Benign neoplasm of urinary organs

140

961

1.49

4.66

4.5

3.1

124.52

127.25

g/l

0.72

135

935

Acute appendicitis, with complications

526

4342

1.22

4.64

3.1

3.6

129.78

129.72

g/l

0.02

512

4244

Left hemicolectomy

494

1.71

4.63

4.3

3.1

117.28

126.38

g/l

2.65

485

200

2.10

4.60

5.1

2.6

124.61

132.74

g/l

1.30

195

Trigeminal neuralgia

157

1104

1.45

4.57

3.3

2.9

130.86

127.95

g/l

0.99

152

1081

Food allergy

5.13

4.54

3.5

136.23

132.32

g/l

0.30

Other symptoms and signs involving the urinary system

290

2246

1.31

4.54

3.9

3.3

126.95

129.35

g/l

1.10

284

2180

Alzheimer’s disease (Late onset), excluding more controls

435

2301

1.25

4.53

2.5

3.0

127.18

125.33

g/l

0.97

424

2251

Failure of sterile precautions during surgical operation

3.72

4.52

2.8

4.1

123.93

127.22

g/l

0.27

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

465

2394

1.24

4.51

4.4

2.9

130.34

131.90

g/l

0.89

448

2340

Motor disorders

236

2.01

4.51

5.4

14.9

131.96

128.68

g/l

0.43

231

Specific developmental disorder of motor function

232

2.01

4.49

5.4

15.4

131.96

128.64

g/l

0.44

225

Other and unspecified disorders of binocular movement

2.84

4.48

4.2

7.6

130.68

129.40

g/l

0.10

Adalimumab

215

1597

1.36

4.48

3.5

130.90

132.15

g/l

0.33

206

1560

Cerebral palsy

231

2.02

4.46

6.8

7.6

130.78

130.00

g/l

0.09

226

Other specified/unspecified systemic involvement of connective tissue

146

1018

1.46

4.46

3.6

2.9

123.84

127.55

g/l

1.33

141

995

Maternal care for known or suspected fetal abnormality and damage

131

1634

0.68

4.44

2.3

3.4

131.49

130.24

g/l

0.28

126

1593

Other abnormal uterine and vaginal bleeding

573

3416

1.21

4.44

3.1

3.0

127.46

125.74

g/l

1.23

558

3351

Myopia

269

2066

1.32

4.42

5.3

3.7

130.30

131.30

g/l

0.31

261

2013

Other peripheral vertigo

259

1986

1.33

4.40

3.4

3.1

133.04

127.59

g/l

4.20

253

1935

Meningitis

131

898

1.49

4.39

2.9

3.1

125.55

130.62

g/l

1.90

131

877

Oter anti-inflammatory and antirheumatic agents, non-steroids

799

3772

1.18

4.39

3.1

3.9

128.55

126.15

g/l

2.10

780

3694

Other peripheral vascular diseases

202

1493

1.37

4.38

3.7

2.8

124.42

129.53

g/l

2.69

193

1455

Nonsuppurative otitis media

513

3669

1.22

4.36

5.5

3.8

130.31

131.52

g/l

0.58

504

3577

Cryoglobulinemia

5.53

4.35

6.7

4.1

112.83

128.46

g/l

1.86

Enteropathogenic Escherichia coli infection

3.32

4.33

5.2

5.7

126.00

128.47

g/l

0.18

Open wound of shoulder and upper arm

350

1.80

4.32

4.7

3.0

126.31

130.60

g/l

0.71

342

Brachial plexus disorders

199

1469

1.37

4.32

3.1

131.45

130.44

g/l

0.24

190

1434

Impacted cerumen

170

2330

0.72

4.31

3.4

128.24

128.00

g/l

0.05

164

2265

Atopic dermatitis, strict definition with reimbursement

640

5226

1.19

4.28

3.5

4.0

132.45

131.66

g/l

0.41

626

5098

Rheumatoid arthritis, including avohilmo

1059

9315

1.14

4.28

3.5

3.3

124.48

128.01

g/l

6.05

1032

9096

Dental caries, including avohilmo

2511

11783

1.09

4.20

4.0

3.3

128.30

128.97

g/l

0.72

2448

11527

Episcleritis

126

865

1.49

4.19

5.5

3.2

128.14

129.87

g/l

0.40

120

845

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

325

1.83

4.18

3.9

3.1

112.95

128.27

g/l

5.48

314

Malignant neoplasm of vulva, including Hilmo

261

1.93

4.12

3.8

2.4

122.67

127.57

g/l

0.79

252

Peritonsillar abscess

495

4112

1.21

4.12

3.3

3.5

132.97

131.10

g/l

1.12

487

4018

Hypertrophy of breast in women and men

411

3354

1.24

4.09

3.2

129.91

128.76

g/l

0.49

401

3260

Rheumatoid lung disease

2.81

4.09

4.5

4.0

133.38

127.73

g/l

0.56

Plantar fascial fibromatosis

225

1708

1.33

4.09

2.8

3.0

130.39

129.06

g/l

0.45

219

1665

Achilles tendinitis

255

1973

1.31

4.04

4.1

3.6

131.89

129.09

g/l

1.11

245

1918

Dentofacial anomalies [including malocclusion]

1733

12606

1.11

4.04

3.7

3.5

131.36

130.32

g/l

1.26

1693

12316

Peptic ulcer

178

2.13

4.04

5.1

3.0

121.39

126.85

g/l

0.69

173

Malignant neoplasm of ovary

123

850

1.48

4.00

3.0

2.9

117.81

128.63

g/l

6.09

118

825

Tumor necrosis factor alpha inhibitors

338

2709

1.26

3.99

3.5

3.7

130.26

131.71

g/l

0.55

327

2649

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

145

1014

1.43

3.99

6.2

5.5

131.59

131.61

g/l

0.00

140

989

APECED

14.96

3.97

8.2

12.8

126.50

132.60

g/l

—

Use of levodopa decarboxylase inhibitor

426

3512

1.23

3.95

3.1

3.2

127.34

127.23

g/l

0.04

414

3426

Nightmares

5.75

3.95

3.5

3.0

130.70

126.89

g/l

—

Peripheral retinal degeneration

562

1.59

3.93

3.1

2.8

134.54

128.12

g/l

1.90

551

Premature rupture of membranes

220

2060

0.76

3.88

2.6

3.2

131.88

129.97

g/l

0.76

212

2011

Benign neoplasm: Heart

3.08

3.87

8.5

3.0

125.94

128.74

g/l

0.18

Other hammer toe(s) (acquired)

490

3778

1.21

3.86

3.4

3.1

126.04

126.91

g/l

0.40

476

3706

Other/unspecified enthesopathies of lower limb, excluding foot

160

1165

1.39

3.85

5.8

3.2

130.12

128.69

g/l

0.34

155

1132

Mixed conductive and sensorineural hearing loss

344

2781

1.25

3.84

4.0

3.3

126.58

128.16

g/l

0.66

337

2709

Other congenital musculoskeletal deformities

4.47

3.82

4.3

14.2

125.42

131.93

g/l

0.54

Methotrexate

350

2833

1.25

3.82

3.5

3.0

124.51

129.44

g/l

4.12

340

2761

Sleep disorders

2499

16667

1.09

3.82

3.2

3.4

132.22

129.45

g/l

8.42

2445

16272

Spinal osteochondrosis

168

2.11

3.81

2.4

2.6

130.97

130.82

g/l

0.01

163

Selective deficiency of immunoglobulin M [IgM]

13.76

3.78

10.5

130.83

113.67

g/l

—

Erosion of teeth , including avohilmo

562

4767

1.19

3.75

5.3

3.7

128.95

131.12

g/l

1.36

549

4656

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

289

2299

1.28

3.74

2.5

3.2

123.88

130.61

g/l

5.58

280

2231

Localized swelling, mass and lump of skin and subcutaneous tissue

842

7371

1.15

3.72

5.2

3.4

128.06

129.07

g/l

0.65

821

7187

Kyphoscoliotic heart disease

6.22

3.71

4.1

2.9

126.33

127.29

g/l

—

Childhood allergy (age < 16)

242

1546

1.30

3.66

4.2

6.2

132.88

134.03

g/l

0.37

237

1515

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

11.89

3.65

1.7

11.0

126.67

123.50

g/l

—

Other inflammation of eyelid

347

2825

1.24

3.63

3.8

3.3

130.14

128.52

g/l

0.69

339

2746

Deep bite

255

1753

1.29

3.62

7.2

4.4

129.57

130.76

g/l

0.42

250

1702

Other noninflammatory disorders of vulva and perineum

198

1505

1.33

3.60

2.8

3.1

128.98

126.34

g/l

1.07

198

1475

Marfan's syndrome

2.70

3.59

3.6

3.3

136.05

131.07

g/l

0.29

Other and unspecified urticaria

446

3724

1.21

3.58

4.8

3.7

130.07

129.63

g/l

0.16

435

3631

Hidradenitis suppurativa

487

1.59

3.54

3.6

3.1

129.50

131.74

g/l

0.36

479

Sicca syndrome [Sjögren]

208

1602

1.32

3.49

5.5

3.0

125.02

127.77

g/l

1.07

201

1564

Autoimmune polyglandular failure

6.53

3.49

7.4

17.4

119.75

125.93

g/l

—

Carcinoma in situ of skin of other and unspecified parts of face

271

2165

1.27

3.46

3.7

3.1

123.28

126.17

g/l

1.40

259

2114

Distal bite

535

1.55

3.44

6.4

7.0

133.44

131.12

g/l

0.49

517

Dislocation, sprain and strain of joints and ligaments of thorax

613

1.52

3.43

4.0

3.1

132.01

129.14

g/l

0.70

603

Other and specified injuries of hip and thigh

438

1.62

3.43

4.2

3.0

125.87

126.99

g/l

0.18

429

Other congenital musculoskeletal deformities

3.67

3.42

4.2

11.1

127.23

129.82

g/l

0.17

Salpingitis and oophoritis

367

3024

1.22

3.41

4.3

3.1

127.71

127.40

g/l

0.11

358

2955

Postmenopausal bleeding

715

3307

1.16

3.38

3.2

3.1

126.85

125.32

g/l

1.08

695

3245

Bronchitis, not specified as acute or chronic

222

1733

1.30

3.37

5.0

3.2

127.73

129.52

g/l

0.55

217

1692

Malignant neoplasm of vulva

192

1.98

3.36

3.3

2.5

121.67

127.75

g/l

0.80

187

Ganglion

465

3922

1.19

3.36

3.5

3.0

131.65

129.74

g/l

1.05

451

3838

Hereditary angioödema type 1

7.54

3.35

60.4

2.8

129.43

123.18

g/l

—

Other disorders of bladder

334

2736

1.24

3.35

4.9

3.2

127.56

129.29

g/l

0.71

322

2657

Radial styloid tenosynovitis [de Quervain]

117

829

1.43

3.35

2.5

2.7

132.07

129.84

g/l

0.52

111

811

Disorders of optic nerve, not elsewhere classified

426

1.63

3.33

6.1

3.2

123.10

126.77

g/l

0.53

419

Disorders of copper metabolism

7.40

3.33

3.9

9.4

126.00

131.91

g/l

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

5.42

3.33

5.4

2.7

113.67

129.35

g/l

—

Malignant neoplasm of rectum

277

2226

1.26

3.33

2.7

3.2

122.60

130.64

g/l

7.28

268

2161

Maternal care related to the fetus and amniotic cavity and possible delivery problems

623

4241

0.86

3.33

3.0

3.2

130.88

129.32

g/l

1.13

609

4136

Multiple sites

7.96

3.32

5.1

6.6

122.57

133.00

g/l

—

Crowding of teeth, including avohilmo

174

1085

1.34

3.29

8.8

5.2

132.27

132.32

g/l

0.01

168

1061

Idiopathic progressive neuropathy

4.63

3.27

3.5

3.0

133.10

121.88

g/l

—

Diseases of external ear

930

8272

1.13

3.26

3.7

129.53

129.12

g/l

0.22

904

8073

Testicular hypofunction

589

1.51

3.23

4.4

3.8

135.28

135.40

g/l

0.01

577

Mental and behavioural disorders due to use of volatile solvents

3.72

3.22

4.7

2.3

132.58

136.94

g/l

0.31

Abrasion of teeth

643

7385

0.87

3.22

3.0

3.4

130.23

129.40

g/l

0.44

623

7215

D07AA Corticosteroids, weak (group I)

348

2867

1.22

3.21

4.2

4.3

129.56

129.94

g/l

0.11

339

2797

Unspecific neurodegenerative disorder

1392

8641

1.11

3.20

2.7

3.3

127.97

125.95

g/l

3.05

1358

8422

Bullous pemphigoid

479

1.58

3.20

3.0

3.1

119.89

125.22

g/l

1.53

466

Testicular dysfunction

681

1.47

3.19

4.2

3.7

136.67

135.06

g/l

0.23

667

Other and unspecified diseases of spleen

2.69

3.17

9.3

2.5

117.18

131.84

g/l

1.45

Rapidly progressive nephritic syndrome

3.69

3.16

10.1

4.6

113.08

123.42

g/l

1.05

Flat foot [pes planus] (acquired)

229

1811

1.28

3.16

3.1

3.2

126.45

128.58

g/l

0.79

224

1777

Caries of dentine, including avohilmo

2630

12512

1.08

3.15

3.9

3.4

128.54

128.94

g/l

0.39

2562

12249

Injury of muscle and tendon at hip and thigh level

240

1913

1.27

3.11

3.6

3.5

129.30

130.76

g/l

0.44

233

1867

Dental pulpitis, including avohilmo

2468

14910

1.08

3.08

3.4

3.5

133.43

130.33

g/l

9.59

2402

14573

Malignant neoplasm of testis, including Hilmo

332

1.68

3.08

3.5

2.8

124.89

136.82

g/l

2.48

325

Other and unspecified glaucoma

211

1662

1.29

3.06

3.5

2.9

125.00

126.78

g/l

0.57

206

1623

Pyoderma

317

1.69

3.06

7.1

3.6

123.69

129.06

g/l

0.97

310

Malignant neoplasm of testis

279

1.74

3.06

3.1

2.8

126.02

137.07

g/l

1.85

273

Other/unspecified enthesopathies, not elsewhere classified

216

1705

1.28

3.05

3.3

3.0

130.60

128.75

g/l

0.55

210

1657

Adenocarcinoma and papilloma adenocarcinoma of rectum

272

2207

1.25

3.04

2.5

3.2

123.95

130.58

g/l

5.04

263

2143

Single spontaneous delivery

801

4802

0.88

3.03

2.5

3.2

128.56

126.01

g/l

2.96

773

4696

3.04

3.02

4.6

3.5

115.38

134.50

g/l

1.36

Glycosuria

5.19

3.02

3.0

12.5

132.13

123.71

g/l

—

Other disorders of prostate

105

748

1.44

3.02

3.7

3.2

128.90

128.57

g/l

0.05

105

731

Early lumbar disc prolapse operation

202

1582

1.29

3.00

3.7

3.3

135.13

135.78

g/l

0.15

190

1551

Malignant neoplasm of cervix uteri, including Hilmo

373

1.62

2.99

5.0

2.8

123.24

128.33

g/l

1.07

359

Other and unspecified mononeuropathies, also in other diseases

575

1.50

2.99

4.0

2.9

126.84

127.74

g/l

0.14

563

Ethmoidectomy

207

2612

0.78

2.97

2.9

3.3

132.24

130.42

g/l

0.56

194

2545

Lichen planus

327

2711

1.22

2.95

3.9

3.2

127.60

127.98

g/l

0.12

319

2634

Drug-induced dystonia

3.40

2.95

3.7

2.6

126.00

123.87

g/l

0.11

Bitten or struck by other mammals

241

1935

1.26

2.93

3.7

3.4

131.47

130.62

g/l

0.23

230

1890

Nonspecific lymphadenitis

134

997

1.36

2.92

8.0

3.3

129.40

130.18

g/l

0.15

129

975

Vasomotor and allergic rhinitis

892

7821

1.12

2.91

3.7

3.8

133.38

130.21

g/l

4.39

875

7642

Nephropathy induced by other drugs, medicaments and biological substances

3.71

2.90

13.3

3.7

110.36

130.26

g/l

2.25

Tooth eruption problems

253

1991

1.25

2.90

8.1

4.0

128.05

132.60

g/l

2.72

239

1949

Pemphigoid

598

1.48

2.87

3.2

3.1

122.23

125.15

g/l

0.69

585

Abscess of mediastinum

3.90

2.84

2.4

3.0

130.20

127.48

g/l

—

Other menopausal disorders

474

3117

0.85

2.83

2.8

3.1

130.21

126.16

g/l

4.24

462

3057

Benign neoplasm: Liver/bile ducts (ICD-9)

7.04

2.83

2.0

2.5

117.00

128.30

g/l

—

Fibrosis and sclerosis of liver

6.97

2.82

2.7

3.0

114.33

135.60

g/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

984

5719

1.12

2.82

2.5

3.1

124.64

129.15

g/l

9.34

963

5581

Malignant neoplasm of breast, including Hilmo

984

5719

1.12

2.81

2.5

3.1

124.64

129.15

g/l

9.34

963

5581

Whooping cough

145

1.98

2.80

6.3

2.5

123.46

133.68

g/l

1.62

140

FESS (DNB20)

197

2481

0.79

2.80

2.5

3.3

132.13

130.43

g/l

0.50

185

2417

Abnormal findings on diagnostic imaging of breast

241

1.76

2.80

3.7

2.5

123.20

128.04

g/l

0.91

235

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1106

11851

0.90

2.80

3.2

3.4

130.87

129.35

g/l

1.57

1079

11589

Benign neoplasm: Hypopharynx

2.44

2.79

3.4

3.0

124.39

127.27

g/l

0.16

Other congenital malformations

274

2244

1.23

2.78

6.3

4.2

130.37

130.13

g/l

0.06

268

2190

Pedestrian injured in transport accident

168

1304

1.31

2.75

3.4

3.2

128.97

129.49

g/l

0.10

160

1271

Absence of one kidney

2.76

2.73

7.8

12.5

121.71

125.91

g/l

0.24

Separation of retinal layers (serosa)

107

779

1.40

2.73

5.3

3.0

132.03

131.34

g/l

0.10

102

764

Drug-induced Cushing's syndrome

5.29

2.71

1.3

2.6

123.57

132.00

g/l

—

Rat-bite fevers

6.59

2.69

6.5

3.5

127.17

124.18

g/l

—

Abuse of non-dependence-producing substances

4.53

2.69

5.3

2.7

131.63

122.80

g/l

—

Bladder disorders in in diseases classified elsewhere

6.32

2.66

2.5

3.3

137.33

121.27

g/l

—

Syndactyly

4.33

2.64

7.6

2.7

126.50

137.10

g/l

—

Victim of lightning

7.97

2.62

2.2

1.9

128.80

117.43

g/l

—

Ankyloglossia

207

1.78

2.60

8.3

10.9

133.58

130.17

g/l

0.37

202

Q fever

8.91

2.60

3.6

8.5

135.40

140.13

g/l

—

Malignant otitis externa

3.83

2.59

5.0

2.3

117.56

132.58

g/l

—

Melanoma in situ of lip

8.65

2.58

3.4

1.9

109.20

132.00

g/l

—

Fall on and from ladder

216

1746

1.26

2.58

3.2

3.4

132.58

129.73

g/l

1.19

211

1701

Benign mammary dysplasia

331

2788

1.20

2.56

3.3

3.0

126.18

126.26

g/l

0.02

321

2722

Aortic hypoplasia

3.90

2.56

7.9

26.5

120.22

121.15

g/l

—

Convalescence

115

856

1.36

2.55

7.3

2.5

120.53

130.74

g/l

4.04

109

830

Hyperchylomicronaemia

3.45

2.55

6.0

2.3

110.80

134.00

g/l

—

Glucosamine medication

1466

10789

1.09

2.53

2.9

3.3

127.58

126.65

g/l

0.89

1432

10531

Osteogenesis imperfecta

3.40

2.53

5.0

9.9

129.50

130.50

g/l

—

Visual impairment including blindness (binocular or monocular)

186

1483

1.27

2.50

5.9

3.3

123.43

127.17

g/l

1.55

180

1447

Congenital mitral valve regurgitation

3.70

2.50

9.8

15.2

125.00

132.74

g/l

—

Excessive attrition of teeth

1404

12942

1.09

2.49

4.5

3.5

131.23

130.37

g/l

0.75

1371

12641

Pediculosis, acariasis and other infestations

356

3024

1.19

2.49

3.7

3.6

131.78

131.40

g/l

0.12

346

2953

Allergic conjunctivitis

1176

12512

0.91

2.48

3.2

3.4

130.93

129.48

g/l

1.54

1148

12230

Digeorge syndrome

5.10

2.48

6.9

25.8

138.00

120.89

g/l

—

Ebstein's anomaly

4.07

2.47

2.6

9.5

115.75

132.27

g/l

—

Nanophthalmos, microphthalmos and macrophthalmos

5.98

2.47

3.5

18.5

135.33

124.31

g/l

—

Other and unspecified rosacea

202

1628

1.26

2.46

6.0

3.0

131.51

128.95

g/l

0.91

196

1590

Other disorders of white blood cells

139

1071

1.32

2.46

5.0

3.1

122.78

128.80

g/l

2.04

134

1044

Mental and behavioural disorders of puerperium, not classified elsewhere

110

2.05

2.45

2.1

2.9

128.09

129.33

g/l

0.09

105

L02BB Anti-androgens

285

2384

1.21

2.45

3.3

3.6

118.89

128.01

g/l

9.72

278

2319

Polyglandular dysfunction

3.28

2.45

6.1

9.0

118.10

128.88

g/l

—

Thalassaemia

2.76

2.43

5.8

5.4

128.42

125.72

g/l

0.19

Malignant neoplasm of breast, HER2-negative

953

5641

1.11

2.42

2.5

3.1

124.41

129.11

g/l

9.75

933

5506

Supervision of normal pregnancy

249

1729

0.82

2.42

2.0

3.0

134.44

130.15

g/l

2.99

241

1692

Isolated patent ductus arteriosus

3.86

2.42

2.5

3.2

123.88

134.45

g/l

—

Interstitial emphysema and related conditions originating in the perinatal period

3.62

2.42

15.3

23.6

118.44

123.39

g/l

—

Drug-induced acute pancreatitis

3.57

2.42

54.4

2.3

116.33

129.32

g/l

—

Tracheo-bronchomalasia

3.75

2.39

4.3

5.2

127.37

136.50

g/l

—

Female genital prolapse

710

3574

1.13

2.37

2.8

3.1

127.45

125.75

g/l

1.46

692

3504

Q fever

7.06

2.37

3.6

7.7

135.40

142.22

g/l

—

Endocrine disorders, other/unspecified

316

0.46

2.36

22.5

3.5

128.67

128.62

g/l

0.00

311

Endometriosis

752

3943

1.12

2.34

2.9

3.0

128.90

126.58

g/l

2.55

743

3864

Murder, homicide, or other assault by handgun discharge

6.79

2.34

1.0

5.7

117.60

121.22

g/l

—

Degenerative diseases of the nervous system

1163

7831

1.10

2.34

2.8

3.3

127.62

125.78

g/l

2.14

1137

7631

Other disorders of veins

1063

9659

1.10

2.34

3.5

3.2

128.85

128.43

g/l

0.25

1044

9434

Rat-bite fevers

6.72

2.34

6.8

2.7

128.20

126.78

g/l

—

Carcinoma in situ of skin of scalp and neck

609

1.42

2.31

4.2

3.2

119.67

124.97

g/l

1.28

595

Failure in dosage during surgical and medical care

3.81

2.30

4.4

3.3

119.00

131.29

g/l

—

Rickettsioses

3.35

2.30

2.6

4.0

138.44

129.62

g/l

—

Atopic dermatitis, strict definition

593

5148

1.13

2.30

3.6

4.3

132.62

131.56

g/l

0.57

582

5028

Traumatic amputation of forearm

5.22

2.30

5.8

3.0

114.67

123.79

g/l

—

Unspecified urinary incontinence

218

1788

1.23

2.29

3.2

2.9

126.15

126.97

g/l

0.22

206

1739

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

2.56

2.28

5.0

2.8

125.46

133.09

g/l

0.57

Other disorders of penis

259

2162

1.21

2.27

4.4

4.5

131.24

131.17

g/l

0.02

254

2116

Drug phototoxic response

5.03

2.27

1.2

5.1

142.83

126.07

g/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

679

6080

1.12

2.27

3.4

3.3

123.29

127.77

g/l

6.38

663

5934

Varicose veins

1817

12814

1.07

2.26

3.2

127.69

128.17

g/l

0.41

1758

12518

Delivery

824

4818

0.90

2.25

2.6

3.2

128.59

126.02

g/l

3.03

793

4711

Benign lipomatous neoplasm of other sites/unspecified

235

1947

1.22

2.25

3.2

3.1

129.34

127.80

g/l

0.51

225

1897

Etanercept

136

1060

1.30

2.22

3.8

3.6

126.02

131.03

g/l

1.60

131

1035

All dysplastic lesions of the cervix uteri, vagina or vulva

482

4163

1.15

2.22

3.5

3.1

128.87

129.45

g/l

0.26

475

4059

Sacrococcygeal disorders, not elsewhere classified

426

1.48

2.22

2.8

2.7

128.02

128.57

g/l

0.07

413

Hypertrophy of breast

314

2670

1.18

2.21

2.8

3.1

130.60

128.14

g/l

1.29

307

2597

Other specified/unspecified hearing loss

225

1860

1.22

2.21

4.7

3.3

126.46

127.85

g/l

0.39

225

1810

Carcinoma in situ of lip, oral cavity and pharynx

2.66

2.20

5.3

3.1

129.33

129.04

g/l

0.02

Persons with potential health hazards related to communicable diseases

647

7161

0.89

2.19

7.7

3.8

125.59

131.78

g/l

9.51

627

6993

Ulcerative colitis (strict definition, all Crohn cases excluded)

326

2785

1.18

2.18

4.0

3.5

131.69

131.22

g/l

0.13

314

2718

Benign neoplasm of meninges

260

2181

1.20

2.18

3.7

3.0

126.96

127.46

g/l

0.15

253

2123

malignant neoplasm of male genital organs

916

5074

1.11

2.17

3.5

127.33

132.98

g/l

10.08

894

4955

Toxic colitis

2.42

2.17

6.6

3.7

117.93

129.06

g/l

0.96

Other (seronegative) rheumatoid arthritis, wide

488

4299

1.14

2.16

3.6

3.2

124.57

127.76

g/l

2.56

476

4190

Other abnormal products of conception

498

2893

1.14

2.16

2.3

3.3

131.23

130.07

g/l

0.62

487

2813

Familial erythrocytosis

2.18

2.14

3.6

2.8

150.88

129.98

g/l

1.94

Intentional self-harm by crashing of motor vehicle

5.55

2.14

2.8

3.3

143.40

129.00

g/l

—

Disorders of breast

1084

9037

1.09

2.13

3.3

3.1

128.29

127.24

g/l

0.96

1060

8838

Benign neoplasm: Skin, unspecified

728

1.35

2.12

4.8

3.0

128.21

128.17

g/l

0.01

712

Exposure to high and low air pressure and changes in air pressure

4.40

2.11

1.0

2.3

128.83

136.40

g/l

—

Inflammation of lacrimal passages (acute and unspecified)

310

1.55

2.09

4.1

2.9

126.47

126.51

g/l

0.00

304

Frostbite involving multiple body regions and unspecified frostbite

3.02

2.07

4.6

139.33

123.66

g/l

—

Allergic rhinitis

644

5715

1.12

2.06

4.1

133.50

131.25

g/l

1.83

635

5585

Drug-induced autoimmune haemolytic anaemia

3.71

2.05

6.0

2.3

127.57

127.81

g/l

—

Rosacea

259

2186

1.19

2.04

6.6

3.1

130.81

129.00

g/l

0.71

252

2126

Myasthenia gravis, drug-induced

3.65

2.04

4.1

3.4

115.29

128.67

g/l

—

Crushing injury of head

3.31

2.03

1.6

3.8

122.50

121.96

g/l

—

Autoimmune hyperthyroidism

129

1012

1.29

2.03

3.2

2.7

132.12

130.13

g/l

0.47

122

986

Traumatic secondary and recurrent haemorrhage

3.28

2.02

1.3

2.0

140.75

127.52

g/l

—

Injury of blood vessels at forearm level

2.50

2.02

6.5

4.5

123.50

132.71

g/l

0.64

Carcinoma in situ of oral cavity

2.77

2.02

2.2

2.5

135.00

129.41

g/l

—

Bartonellosis

5.18

2.02

4.0

1.6

118.80

139.55

g/l

—

Congenital malposition of the kidney

4.21

2.02

4.3

4.1

109.83

128.63

g/l

—

Rickettsioses

3.23

2.01

2.8

4.3

139.38

128.78

g/l

—

Occupational exposure to risk-factors

667

1.36

2.00

3.5

3.3

131.77

129.69

g/l

0.38

652

Bacterial agents resistant to antibiotics

3.69

2.00

4.6

3.0

129.29

134.27

g/l

—

Malignant neoplasm of other and unspecified female genital organs

266

1.59

1.99

3.1

2.4

115.93

127.02

g/l

2.64

253

Other specified/unspecified disorders of bone/cartilage

505

1.41

1.98

4.1

3.0

129.80

130.83

g/l

0.14

499

Other/unspecified rheumatoid arthritis

319

2748

1.17

1.98

3.9

3.0

123.03

127.11

g/l

3.05

314

2674

Malignant neoplasm of breast

952

5683

1.10

1.98

2.5

3.1

124.60

129.13

g/l

9.15

932

5545

Lumbosacral root disorders, not elsewhere classified

227

0.43

1.98

2.4

3.0

123.90

128.29

g/l

—

221

Maternal care for (suspected) damage to fetus from alcohol

3.09

1.97

7.9

2.6

134.88

128.78

g/l

—

Absence of one kidney

2.49

1.97

8.6

13.2

118.42

125.87

g/l

0.44

Tooth agenesis EXCLUDE clefts and syndromes

462

1.42

1.97

4.6

5.0

131.50

131.16

g/l

0.05

445

Hereditary nephropathy, not elsewhere classified

2.49

1.96

25.8

2.9

122.17

131.42

g/l

1.05

Torsion of testis

266

1.57

1.96

3.8

4.8

145.90

137.88

g/l

1.13

261

Other/unspecified seropositive rheumatoid arthritis

688

6225

1.11

1.95

3.5

3.3

123.13

127.72

g/l

6.78

672

6076

Neurofibromatosis, type 2

3.42

1.94

2.6

6.9

142.57

130.27

g/l

—

Chronic laryngitis and laryngotracheitis

256

3009

0.84

1.92

4.3

3.3

127.40

128.24

g/l

0.23

243

2926

Insomnia

2363

16299

1.06

1.92

3.2

3.4

132.37

129.41

g/l

9.08

2313

15908

Myocardial infarction, unclassifiable

708

5731

1.11

1.90

4.8

3.3

121.52

126.63

g/l

7.85

677

5590

Urethral discharge

3.87

1.90

5.0

3.3

146.33

129.35

g/l

—

Cysts of oral region, not elsewhere classified

141

1132

1.26

1.88

3.5

3.3

128.25

129.80

g/l

0.30

132

1101

Seropositive rheumatoid arthritis, wide

695

6309

1.11

1.86

3.5

3.4

123.16

127.71

g/l

6.74

679

6159

Nutritional marasmus

2.99

1.86

3.5

4.2

128.25

124.62

g/l

—

Congenital malformations of eye, ear, face and neck

132

1052

1.27

1.86

5.6

4.5

130.51

130.91

g/l

0.07

127

1029

Dementia in Alzheimer disease

546

4131

1.12

1.85

2.6

3.3

127.17

124.70

g/l

1.99

535

4024

Relapsing polychondritis

2.94

1.84

2.8

128.13

133.48

g/l

—

Poor fetal growth

164

1339

1.23

1.83

4.4

3.2

128.09

131.31

g/l

1.08

156

1306

Ankylosis of teeth

2.68

1.82

7.0

3.6

125.00

130.26

g/l

—

Sequelae of injuries of neck and trunk

539

1.38

1.82

2.3

3.1

129.92

130.02

g/l

0.01

530

Other operation for atrial fibrillation

110

1.93

1.82

3.3

3.5

124.75

127.45

g/l

0.21

110

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

3.69

1.81

4.5

2.4

120.33

123.39

g/l

—

Congenital absence, atresia and stenosis of small intestine

3.68

1.81

15.8

14.4

120.67

131.06

g/l

—

Other disorders of patella

364

3188

1.15

1.80

3.3

3.2

132.38

130.99

g/l

0.56

354

3130

Other congenital malformations of spinal cord

3.62

1.80

24.5

7.7

123.17

130.83

g/l

—

Single ventricle heart

3.19

1.79

15.1

21.9

134.14

123.67

g/l

—

Other conditions originating in the perinatal period

4.33

1.78

11.8

25.6

112.40

125.38

g/l

—

Congenital malformations of genital organs

162

1319

1.23

1.78

4.1

4.8

128.48

130.16

g/l

0.48

157

1286

Other hypertrichosis

2.61

1.78

1.8

2.5

117.33

129.75

g/l

—

HSIL lesion of the vulva

274

1.53

1.76

3.2

2.6

123.39

128.57

g/l

0.95

268

Benign neoplasm of middle ear and respiratory system

203

1705

1.20

1.76

3.3

3.2

126.65

128.78

g/l

0.69

198

1657

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

322

2805

1.16

1.76

3.9

3.4

131.39

129.29

g/l

1.00

311

2729

Internal derangement of knee

959

8813

1.09

1.75

3.1

3.3

130.57

130.44

g/l

0.06

932

8636

Malignant neoplasm of cervix uteri

210

1.61

1.75

3.1

2.5

124.39

128.75

g/l

0.51

204

Pedal cyclist injured in noncollision transport accidents

258

2211

1.18

1.75

3.0

3.5

130.30

131.01

g/l

0.21

252

2155

Glaucoma secondary to drugs

2.32

1.74

4.3

3.2

136.08

132.85

g/l

0.16

Uterine polyps

203

1705

1.20

1.74

2.7

3.1

129.53

125.56

g/l

2.13

197

1671

Lethal midline granuloma

4.44

1.73

8.0

2.9

114.20

129.79

g/l

—

Aortic arch syndrome [Takayasu]

2.78

1.72

3.4

4.5

123.38

126.55

g/l

—

Use of antiglaucoma preparations and miotics

229

1950

1.19

1.71

4.8

2.9

123.18

126.74

g/l

1.53

218

1905

Assault by drugs, medicaments and biological substances

3.03

1.71

4.1

4.2

132.43

127.96

g/l

—

Alzheimer’s disease, strict definition

672

6071

0.91

1.70

2.4

3.2

126.55

125.22

g/l

0.91

654

5924

Benign neoplasm: Cerebral meninges

232

1978

1.18

1.70

3.5

3.1

127.52

127.51

g/l

0.00

226

1928

Kissing spine

2.99

1.70

2.3

3.8

138.14

126.68

g/l

—

Contraceptive management

765

5857

0.91

1.69

4.5

3.5

131.44

132.41

g/l

0.57

743

5740

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

2.54

1.68

4.0

2.5

120.10

127.81

g/l

—

Porphyria cutanea tarda

3.98

1.67

1.8

2.1

121.20

128.64

g/l

—

Contact with machinery

286

2483

1.16

1.67

3.7

133.09

131.43

g/l

0.55

278

2424

Abnormal findings in peritoneal fluid saliva

2.17

1.65

4.6

2.9

130.85

128.06

g/l

0.23

Benign neoplasm: Skin of upper limb, including shoulder

354

1.44

1.63

3.0

2.9

127.44

128.31

g/l

0.09

348

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

223

1904

1.18

1.62

3.6

3.1

128.79

128.63

g/l

0.03

218

1857

Ménière disease

239

2052

1.18

1.62

3.1

3.0

128.66

127.61

g/l

0.34

232

1998

Retinal detachment with retinal break

343

3022

1.14

1.62

4.6

3.3

125.84

129.08

g/l

1.81

336

2950

Tonsillectomy and adenotomy

1211

7865

1.07

1.62

3.8

4.0

133.78

132.05

g/l

1.93

1178

7676

Secondary sideroblastic anaemia

2.40

1.60

5.0

3.0

112.20

126.27

g/l

—

Behçet disease

2.40

1.60

2.4

3.1

126.00

129.77

g/l

—

Alzheimer’s disease (Late onset)

622

5737

0.91

1.60

2.3

3.3

126.56

124.94

g/l

1.16

605

5598

Injury of blood vessels at shoulder and upper arm level

2.61

1.59

2.9

3.6

113.88

127.33

g/l

—

Acetic acid derivatives and related substances

884

4230

1.09

1.59

2.9

4.1

131.60

126.81

g/l

7.99

853

4143

Alzheimer’s disease (Early onset)

1023

0.76

1.58

2.5

3.0

126.92

125.55

g/l

0.28

998

Disorders of puberty

176

1.62

1.57

4.4

6.9

133.50

132.88

g/l

0.06

169

Chronic rhinitis, nasopharyngitis and pharyngitis

766

7048

1.09

1.57

3.8

3.6

131.63

129.46

g/l

2.06

758

6884

Carcinoma in situ of skin of upper limb, including shoulder

599

1.33

1.57

3.9

3.1

124.28

124.89

g/l

0.09

585

Burn and corrosion of respiratory tract

3.61

1.56

2.2

12.1

105.20

137.73

g/l

—

Motor- or nonmotor-vehicle accident in traffic area

1.91

1.54

5.1

3.7

138.50

131.23

g/l

0.66

Disorders of conjunctiva

2257

17264

1.05

1.53

3.8

3.6

130.84

129.33

g/l

2.63

2198

16872

Other female pelvic inflammatory diseases

318

2799

1.14

1.52

3.8

2.9

129.34

127.58

g/l

0.83

311

2733

Myasthenia gravis

326

1.44

1.52

4.5

3.3

129.48

127.19

g/l

0.31

320

120

971

1.24

1.52

2.6

3.0

132.70

131.80

g/l

0.20

120

947

Rhabdomyosarcoma

3.49

1.49

30.4

17.9

111.20

133.06

g/l

—

Malignant neoplasm of rectosigmoid junction

336

1.43

1.49

3.3

2.9

124.77

129.76

g/l

0.74

330

Disorders of sexual preference

2.47

1.48

3.3

4.3

128.11

132.23

g/l

—

Other sideroblastic anaemias

2.13

1.48

4.5

2.9

122.25

126.46

g/l

0.27

Radiodermatitis

2.46

1.48

2.1

2.5

125.11

130.97

g/l

—

Other specified/unspecified disorders of middle ear and mastoid

2.45

1.48

3.1

4.6

130.44

128.85

g/l

—

Artificial joint re-operation

184

1562

1.19

1.48

4.0

3.0

121.09

127.57

g/l

3.71

177

1525

Essential (haemorrhagic) thrombocythaemia

745

1.28

1.47

2.2

2.7

128.73

130.88

g/l

0.42

720

Neuromyelitis optica

2.43

1.47

10.1

2.3

132.78

135.62

g/l

—

Other nonautoimmune haemolytic anaemias

2.43

1.47

4.9

3.0

106.00

124.90

g/l

—

Vestibular neuronitis

217

1867

1.17

1.46

3.4

3.2

130.29

128.58

g/l

0.55

212

1819

Nasal polyp

508

4609

1.11

1.46

3.2

3.5

132.62

129.60

g/l

2.51

497

4489

Ulcer of vagina/vulva

388

1.39

1.44

3.3

2.9

125.36

127.44

g/l

0.33

378

Ulcerative rectosigmoiditis

178

1508

1.19

1.44

4.8

3.1

130.33

131.16

g/l

0.18

171

1468

Supervision of high-risk pregnancy

242

1682

0.86

1.44

2.3

3.0

133.49

129.84

g/l

2.10

234

1647

Other puerperal infections

104

834

1.25

1.44

2.3

3.1

133.67

131.09

g/l

0.68

815

Dyslexia and other symbolic dysfunctions, not elsewhere classified

2.16

1.42

5.0

4.5

137.64

128.17

g/l

1.16

Other orthopaedic follow-up care

114

927

1.24

1.42

3.5

2.7

131.90

131.45

g/l

0.07

109

900

Disorders of vagus nerve

2.86

1.42

25.8

5.3

123.00

121.70

g/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

117

955

1.24

1.42

4.4

3.0

132.59

129.77

g/l

0.71

111

927

Need for immunization against other single infectious diseases

2.85

1.42

4.0

6.8

128.33

127.13

g/l

—

Dextrocardia

3.24

1.41

5.0

16.6

124.00

130.94

g/l

—

Malignant neoplasm of other endocrine glands and related structures

2.79

1.40

20.5

3.3

104.33

132.30

g/l

—

Embedded teeth, including avohilmo

152

1273

1.20

1.40

5.6

3.6

125.94

132.94

g/l

3.52

141

1246

Pectus carinatum

3.14

1.39

7.2

9.3

125.40

132.76

g/l

—

Injury of muscle and tendon at lower leg level

372

3331

1.12

1.39

3.9

3.5

130.82

130.67

g/l

0.04

360

3258

Mental and behavioural disorders due to cocaine

3.10

1.38

2.8

5.7

109.80

127.24

g/l

—

Juvenile Open Angle Glaucoma

1.93

1.38

7.2

3.6

122.71

133.89

g/l

0.90

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

163

1380

1.19

1.37

2.7

3.1

132.46

129.27

g/l

1.00

155

1345

Malignant neoplasm of breast, ER-positive, including Hilmo

729

5193

1.09

1.36

2.5

3.1

124.77

128.90

g/l

6.35

708

5069

Other osteochondropathies

151

1269

1.20

1.36

2.8

3.5

133.37

131.57

g/l

0.40

143

1240

Endometriosis ASRM stages 1,2

293

2588

1.14

1.36

2.8

3.2

131.55

129.12

g/l

1.38

288

2518

Pulmonary artery stenosis

2.75

1.36

4.2

19.0

130.50

121.38

g/l

—

Other disorders of skin and subcutaneous tissue related to radiation

2.55

1.35

2.1

3.0

128.13

130.59

g/l

—

Photocontact dermatitis [berloque dermatitis]

2.68

1.34

4.3

5.2

135.67

121.83

g/l

—

Disorders of synovium and tendon in diseases classified elsewhere

377

1.38

1.34

3.5

2.9

127.24

131.59

g/l

0.64

368

Diaper [napkin] dermatitis

2.66

1.34

10.8

16.4

132.67

131.79

g/l

—

Erythrasma

2.50

1.33

4.8

126.13

129.71

g/l

—

Palatinal maxillary operation

1.84

1.33

7.5

8.6

129.53

129.55

g/l

0.00

Malignant neoplasm of head and neck

205

1772

1.17

1.33

2.7

3.2

123.30

131.02

g/l

4.73

199

1724

Malignant neoplasm of breast, HER-positive

716

5161

1.09

1.32

2.5

3.1

124.74

128.87

g/l

6.25

695

5037

Benign neoplasm: Penis

2.45

1.32

1.7

3.1

143.88

127.51

g/l

—

Internuclear ophthalmoplegia

2.09

1.31

2.5

3.4

118.82

129.73

g/l

0.88

Other and unspecified hypertrophic disorders of skin

1.77

1.31

1.8

2.7

135.12

130.94

g/l

0.36

Crohn's disease (strict) with PSC

2.91

1.31

10.2

12.0

131.20

141.06

g/l

—

Medical treatment for female infertility

218

2490

0.87

1.30

2.5

3.3

131.73

130.82

g/l

0.28

210

2429

Malignant neoplasm of prostate

879

4902

1.08

1.29

3.5

127.23

132.60

g/l

8.91

857

4789

Seropositive rheumatoid arthritis, strict definition

352

3158

1.12

1.29

3.3

3.1

123.94

128.65

g/l

3.77

344

3072

Use of peginterferon beta-1a

2.36

1.29

2.5

3.7

139.88

134.60

g/l

—

Other hereditary haemolytic anaemias

1.80

1.29

3.2

3.6

135.56

128.27

g/l

0.41

Atrophy of thyroid (acquired)

2.58

1.28

3.8

3.3

124.00

125.76

g/l

—

Other hearing loss

792

7215

1.08

1.28

3.5

3.3

126.37

126.91

g/l

0.27

769

7044

Disorders of tooth development and eruption

344

2491

1.12

1.28

5.9

3.0

129.68

132.24

g/l

1.25

337

2440

Long labour

283

2731

0.88

1.26

3.4

3.3

132.36

129.65

g/l

1.51

270

2672

Alcoholic myopathy

2.88

1.26

4.8

3.4

140.20

130.89

g/l

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

2.86

1.25

5.4

2.2

124.80

135.16

g/l

—

Non-neuropathic heredofamilial amyloidosis

2.82

1.25

5.0

2.4

107.40

127.26

g/l

—

Carcinoma in situ of skin

238

2093

1.15

1.25

3.6

3.1

124.90

127.41

g/l

0.99

231

2037

Delivery, wide proxy

727

4163

0.92

1.25

2.5

3.1

128.35

125.58

g/l

3.04

698

4069

Burn and corrosion of wrist and hand

619

1.27

1.24

3.5

3.6

134.49

131.54

g/l

0.60

604

Other and unspecified thalassaemias

2.77

1.24

3.8

7.9

140.00

131.05

g/l

—

Complications specific to multiple gestation

2.22

1.23

1.1

2.7

138.50

129.27

g/l

—

Postpartum care and examination

143

1073

0.84

1.23

6.0

2.8

130.54

131.36

g/l

0.21

136

1048

Malignant neoplasm of prostate, including Hilmo

906

5036

1.07

1.23

3.4

3.5

127.39

132.78

g/l

9.06

885

4919

Leiomyoma of uterus

1455

7817

1.06

1.23

3.1

127.97

126.80

g/l

1.30

1419

7639

Family history of malignant neoplasm

192

1662

1.16

1.23

2.8

2.5

130.11

131.94

g/l

0.55

183

1620

Gestational diabetes (for exclusion)

526

3349

1.09

1.22

3.2

131.99

130.52

g/l

0.95

515

3264

Operations 1 for CAVS

2.05

1.22

5.7

10.4

122.91

122.35

g/l

0.03

Bilateral sagittal split ramus osteotomy operation

435

1.32

1.22

2.4

3.1

138.12

132.39

g/l

1.33

426

Heterophoria

160

1368

1.18

1.21

6.5

3.6

130.47

130.03

g/l

0.09

154

1334

Myeloproliferative diseases

215

1882

1.15

1.21

2.7

3.0

126.45

127.99

g/l

0.39

205

1831

Alzheimer disease

1015

6985

1.07

1.20

2.6

3.2

127.80

125.25

g/l

3.47

989

6806

Donors of organs and tissues

181

1.52

1.20

2.9

2.3

130.56

133.12

g/l

0.23

176

Malignant neoplasm of oropharynx, including Hilmo

438

1.33

1.20

4.2

3.0

125.95

131.59

g/l

1.02

428

Obstructed labour due to malposition and malpresentation of fetus

250

2636

0.88

1.19

3.1

3.3

132.79

129.81

g/l

1.59

239

2580

Patellar tendinitis

206

1.48

1.19

2.9

3.4

134.47

132.56

g/l

0.17

199

Diseases of thymus

2.15

1.18

5.4

3.6

133.13

129.92

g/l

—

Use of memantine

863

6699

1.07

1.18

2.4

3.2

128.28

125.06

g/l

4.71

840

6531

Use of other anti-dementia drugs

863

6699

1.07

1.18

2.4

3.2

128.28

125.06

g/l

4.71

840

6531

Endometriosis ASRM stages 3,4

442

4034

1.10

1.18

3.0

3.1

128.59

127.71

g/l

0.43

436

3939

Mouth breathing

1044

9832

1.06

1.18

4.0

3.9

131.67

130.51

g/l

0.87

1014

9599

Epidermolysis bullosa

2.65

1.18

8.4

14.6

114.60

126.40

g/l

—

Dysplastic lesion of the vulva of unknown severity

2.64

1.17

5.0

2.0

126.40

126.75

g/l

—

Defect, injury or illness of lumbar spine

2.12

1.17

2.0

3.2

134.38

131.15

g/l

—

Kaposi sarcoma, including Hilmo

2.63

1.17

4.6

2.3

131.60

132.55

g/l

—

Congenital retinoschisis

2.12

1.16

12.5

6.2

125.12

129.63

g/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

816

6591

0.93

1.16

3.0

3.1

129.04

128.61

g/l

0.23

790

6449

Chronic drug-induced interstitial lung disorders

2.45

1.15

2.1

3.2

132.29

128.71

g/l

—

Use of galantamine

178

2046

0.86

1.15

2.1

3.1

130.79

125.39

g/l

2.98

170

1999

Lesion of sciatic nerve

115

963

1.21

1.14

3.0

126.60

126.39

g/l

0.03

110

941

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

251

1.42

1.13

4.2

3.2

138.34

134.96

g/l

0.37

246

Lichen planus, including avohilmo

451

4132

1.10

1.13

3.5

3.3

128.07

128.24

g/l

0.06

443

4026

Other secondary gonarthrosis

133

1130

1.19

1.12

3.4

3.1

125.93

128.24

g/l

0.59

128

1104

Parapsoriasis

346

1.35

1.12

2.9

3.7

137.46

128.86

g/l

2.02

339

Disorders of orbit

791

1.23

1.12

3.0

3.1

130.33

128.28

g/l

0.44

766

Pleural plaque

282

2527

1.12

3.5

3.3

129.56

127.19

g/l

1.06

275

2455

Other zoonotic bacterial diseases, not elsewhere classified

2.55

1.12

2.4

2.9

137.80

119.05

g/l

—

General autosomal fish scale disease

2.54

1.12

3.4

4.6

133.40

133.10

g/l

—

Iliotibial band syndrome

160

1.53

1.12

6.0

2.9

120.62

128.90

g/l

0.98

154

Scabies

270

2411

1.12

1.11

3.6

3.7

132.38

132.05

g/l

0.09

263

2353

Restless leg syndrome

312

2811

1.12

1.11

3.3

3.1

131.23

128.62

g/l

1.32

305

2736

Other prurigo

202

1.47

1.11

6.6

3.0

122.55

128.73

g/l

0.66

197

Malignant neoplasm of other connective and soft tissue, including Hilmo

103

857

1.22

1.10

4.2

3.0

121.88

131.08

g/l

4.14

834

Benign neoplasm: Pineal gland

2.46

1.10

1.8

4.9

134.00

132.57

g/l

—

2.46

1.10

14.0

4.4

129.60

138.38

g/l

—

Procedures for purposes other than remedying health state

312

1.36

1.10

2.7

2.3

129.52

129.91

g/l

0.04

304

Disorders of puberty, all

202

1.45

1.09

4.2

7.8

132.93

130.86

g/l

0.23

194

Fourth [trochlear] nerve palsy

454

1.30

1.08

4.3

3.2

129.40

127.17

g/l

0.27

446

Acne varioliformis

2.21

1.08

4.7

2.2

105.00

127.61

g/l

—

Caries in Clefts patients

113

1.62

1.07

13.1

7.6

122.56

131.04

g/l

0.66

113

Carcinoma in situ of oral cavity and pharynx

2.21

1.07

2.4

3.0

133.86

130.32

g/l

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

2.48

1.07

2.6

3.0

129.00

133.68

g/l

—

Use of donepezil

619

5516

1.08

1.07

2.7

3.2

128.94

125.05

g/l

5.34

602

5377

Atopic dermatitis

1198

10337

0.95

1.07

3.6

3.7

131.49

131.00

g/l

0.34

1172

10093

Unspecified severe protein-energy malnutrition

2.18

1.06

5.7

5.3

122.71

125.97

g/l

—

Malignant cancer of tonsil and base of tongue, including Hilmo

509

1.28

1.06

4.1

2.9

125.08

132.27

g/l

1.62

495

Mumps

440

0.72

1.05

3.5

2.9

132.63

131.78

g/l

0.08

433

Pectus carinatum

2.38

1.05

7.2

7.9

125.40

131.41

g/l

—

Toxic erythema

2.37

1.05

2.4

2.2

118.60

129.09

g/l

—

Infections with a predominantly sexual mode of transmission

564

5227

1.08

1.04

4.1

3.4

128.07

131.87

g/l

3.90

553

5103

Colitis due to radiation

214

1.44

1.03

5.3

3.2

124.37

125.98

g/l

0.17

208

Alzheimer disease, including avohilmo

1163

7778

1.06

1.02

2.6

3.3

127.68

125.55

g/l

2.85

1133

7586

Procreative management

702

5476

1.07

1.02

5.7

4.0

129.12

132.15

g/l

2.77

676

5351

Thyroiditis, unspecified

240

1.40

1.01

3.5

2.7

132.27

127.60

g/l

0.54

234

Other cranial nerve disorders in other disorders

1.95

1.01

2.1

3.4

128.20

130.06

g/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

524

4866

1.08

0.99

3.3

128.76

128.42

g/l

0.13

513

4746

Other diseases of hard tissues of teeth

1832

9095

1.04

0.98

4.0

3.1

129.23

129.34

g/l

0.06

1777

8913

Congenital deformities of feet

354

1.31

0.98

3.8

4.9

126.54

129.98

g/l

0.50

348

Selective deficiency of immunoglobulin A [IgA]y

1.83

0.97

6.9

7.4

118.00

129.24

g/l

0.69

Hyperfunction of pituitary gland, other and/or unspecified

2.36

0.96

4.5

3.2

118.50

125.48

g/l

—

Cyst of spleen

2.33

0.96

11.0

3.6

119.83

135.78

g/l

—

Disease of hard tissues of teeth, NOS

1569

8568

0.96

0.95

3.3

3.1

131.76

129.79

g/l

2.75

1524

8392

Coxibs

859

4265

1.06

0.95

2.7

4.0

131.42

126.84

g/l

7.11

831

4176

Maternal care for cervical incompetence

567

0.77

0.95

2.0

2.6

135.16

128.35

g/l

1.55

553

All dysplastic lesions of the vagina

401

1.29

0.94

3.8

2.6

125.57

127.90

g/l

0.40

390

All dysplastic lesions of the cervix uteri

384

3499

1.09

0.93

3.3

3.1

128.85

129.82

g/l

0.41

378

3406

Erectile dysfunction

225

2018

1.12

0.93

6.3

3.6

125.73

128.77

g/l

1.04

217

1966

Obstructed labour due to maternal pelvic abnormality

264

2385

1.11

0.93

2.8

3.3

132.56

127.94

g/l

3.43

258

2334

Polypectomy (DHB20)

165

1452

1.15

0.92

3.2

3.3

130.83

129.74

g/l

0.25

159

1415

Malignant neoplasm of oropharyng

2.18

0.92

4.0

2.6

135.83

129.79

g/l

—

therapeutic use

619

0.78

0.92

4.4

2.8

123.27

127.77

g/l

0.70

608

Glaucoma, exfoliation

309

2818

1.10

0.92

3.5

3.1

126.58

126.01

g/l

0.17

295

2755

Rhabdomyosarcoma, including Hilmo

2.17

0.92

25.7

10.8

112.83

130.17

g/l

—

Onychogryphosis

1.99

0.91

2.9

2.5

122.38

127.52

g/l

—

Intermittent hydrarthrosis

2.15

0.91

8.5

4.3

137.17

133.83

g/l

—

Primary open-angle glaucoma

937

8598

1.06

0.91

3.4

3.3

125.32

126.60

g/l

0.98

909

8392

Ovarian hyperstimulation (induction)

168

1.44

0.91

2.1

3.5

125.54

133.10

g/l

0.91

163

Major anomalies of jaw size

421

1.27

0.90

4.2

3.8

132.08

130.02

g/l

0.29

413

Arteriovenous malformation of peripheral vessels

1.69

0.90

6.5

6.9

127.38

128.01

g/l

0.04

Exposure to ignition or melting of other clothing and apparel

1.94

0.90

3.3

4.3

140.13

130.09

g/l

—

Carcinoma in situ of larynx

2.11

0.89

2.2

3.3

136.50

123.80

g/l

—

Hereditary lymphedema

2.09

0.89

6.3

3.1

128.00

131.03

g/l

—

Cleft lip and cleft lip and palate

1.64

0.89

11.1

5.8

121.93

130.97

g/l

0.57

Use of anticholinesterases

1076

8083

1.05

0.89

2.5

3.3

128.53

125.54

g/l

5.15

1051

7873

N06DA Anticholinesterases

1076

8083

1.05

0.89

2.5

3.3

128.53

125.54

g/l

5.15

1051

7873

Effects of air pressure and water pressure

1.76

0.88

1.6

3.8

133.27

133.75

g/l

0.02

Other diseases of blood and blood-forming organs

162

1431

1.14

0.87

4.6

3.1

137.66

129.36

g/l

3.00

155

1389

Infections with a predominantly sexual mode of transmission

740

6505

1.06

0.87

3.8

3.3

129.80

132.18

g/l

2.17

727

6346

Maternal care for other known or suspected fetal problems

325

1881

1.10

0.86

3.1

3.2

131.00

130.81

g/l

0.06

313

1839

LeFortI or BSSO operation

533

1.23

0.85

2.4

3.2

139.40

132.03

g/l

2.21

521

Other sexually transmitted chlamydial diseases

745

0.82

0.84

2.8

2.9

130.54

136.16

g/l

1.17

726

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1221

10096

0.96

0.84

3.2

3.4

129.56

128.74

g/l

0.68

1181

9863

Osteochondrodysplasia with defects of growth of tubular bones and spine

1.95

0.84

1.2

10.0

129.50

129.56

g/l

—

Calcium deposit in bursa

1.95

0.83

5.2

3.4

99.33

131.94

g/l

—

Pityriasis rubra pilaris

1.94

0.83

3.5

3.1

122.00

128.66

g/l

—

Triptan medication for migraine, min. 3 purchases

1128

8221

1.05

0.83

3.1

3.4

132.73

130.47

g/l

3.49

1103

8032

Maxillary retrognathism

249

1.34

0.83

2.2

5.5

142.58

132.88

g/l

1.71

241

Sequelae of tuberculosis

365

1.28

0.82

4.6

3.0

121.43

122.93

g/l

0.20

356

Postpartum hemorraghe, parous women as controls

308

2858

0.92

0.82

2.9

130.40

131.01

g/l

0.20

300

2793

Spontaneous abortion

868

5554

1.06

0.82

3.0

3.1

128.92

128.06

g/l

0.59

844

5427

Use of bromocriptine

0.00

0.81

0.0

2.8

—

126.80

—

Infection due to other mycobacteria

277

1.32

0.81

13.1

2.4

126.58

128.79

g/l

0.25

271

Non-seminoma of testis

1.72

0.81

5.9

3.5

131.13

137.44

g/l

—

Spasmodic torticollis

528

1.22

0.80

3.0

3.3

135.66

128.14

g/l

2.16

517

Habitual aborter

173

1.40

0.79

3.0

3.6

126.46

129.33

g/l

0.22

168

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

2.31

0.79

4.0

12.4

130.80

130.35

g/l

—

Benign neoplasm of ovary

364

3372

1.08

0.78

2.8

3.1

125.60

126.42

g/l

0.32

352

3292

Perioral dermatitis

287

1.30

0.78

11.1

3.3

133.00

127.77

g/l

1.17

282

Cardiovascular devices associated with adverse incidents

2.26

0.78

2.6

4.3

127.80

133.46

g/l

—

Qualitative platelet defects

1.70

0.77

1.9

3.4

128.36

132.72

g/l

0.31

Other sexually transmitted chlamydial diseases

104

1201

0.86

0.77

2.8

3.1

132.90

135.79

g/l

0.60

104

1173

Other hyperalimentation

1.75

0.77

2.1

2.7

124.00

130.89

g/l

—

Complications of labour and delivery

1133

6582

0.96

0.77

2.9

3.1

129.81

127.79

g/l

2.66

1106

6443

Congenital malformations of spine and bony thorax

1.58

0.77

30.6

7.9

131.21

131.07

g/l

0.01

Mandibular retrognathia AND surgery (BSSO)

341

1.27

0.77

2.1

3.2

140.77

131.84

g/l

2.48

334

Brain glioblastoma and astrocytoma

306

1.29

0.77

2.1

2.7

137.90

133.12

g/l

0.95

300

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

1.64

0.77

2.9

3.1

137.17

130.01

g/l

0.87

Cleft lip and palate

1.68

0.76

11.8

4.3

120.64

132.87

g/l

0.64

Injury of blood vessels of thorax

1.71

0.76

1.9

3.9

120.56

129.80

g/l

—

Bacterial meningitis

642

1.19

0.76

3.3

3.1

125.54

129.57

g/l

0.80

629

Need for immunization against single bacterial diseases

1.91

0.75

35.6

22.2

133.86

127.37

g/l

—

Optic atrophy

334

1.28

0.75

7.8

4.8

130.64

127.95

g/l

0.37

329

Subclinical iodine-deficiency hypothyroidism

2.11

0.75

3.6

3.3

145.20

123.56

g/l

—

Exposure to uncontrolled fire in building or structure

125

1.47

0.74

2.9

3.2

130.50

130.29

g/l

0.01

125

Cyst of iris, ciliary body and anterior chamber

2.08

0.74

1.4

2.6

150.60

136.40

g/l

—

Eclampsia

2.05

0.74

4.4

1.8

115.80

140.72

g/l

—

Myeloproliferative diseases (CML excluded)

188

1698

1.11

0.73

2.7

3.0

127.84

127.88

g/l

0.01

179

1654

Traumatic subcutaneous emphysema

2.03

0.73

4.0

4.8

136.40

129.81

g/l

—

Other disorders of amniotic fluid and membranes

145

1590

0.89

0.73

3.2

3.3

132.79

130.19

g/l

0.97

140

1551

L02BA Anti-estrogens

290

3143

0.92

0.72

2.6

3.1

124.57

127.14

g/l

1.50

284

3073

Optic atrophy

354

1.26

0.72

7.8

4.7

130.86

127.17

g/l

0.60

349

Traumatic amputation of lower leg

1.78

0.72

15.9

2.9

114.86

128.85

g/l

—

Other specified and unspecified disorders of eye and adnexa

702

1.18

0.71

4.2

3.1

130.94

127.56

g/l

0.75

686

Allergic colitis

291

1.28

0.71

12.6

8.8

129.49

130.96

g/l

0.18

284

Benign lipomatous neoplasm of of intra-abdominal organs

1.70

0.71

2.6

3.0

118.20

129.74

g/l

—

Crushing injury of ankle and foot

1.69

0.70

1.5

4.0

132.20

129.67

g/l

—

Lipodystrophy, not elsewhere classified

1.93

0.70

1.2

2.0

126.20

136.52

g/l

—

Traumatic spondylopathy

1.72

0.70

2.7

2.8

136.57

126.81

g/l

—

conjunctival scars

1.93

0.70

3.8

7.5

136.20

128.67

g/l

—

Other disorders of cornea

218

1989

1.10

0.70

3.8

3.0

124.60

129.08

g/l

1.96

210

1939

Other congenital malformations of respiratory system

1.92

0.70

4.4

12.7

135.00

125.37

g/l

—

Posteruptive colour changes of dental hard tissues

1.70

0.69

17.1

2.4

118.71

130.02

g/l

—

Assault by other and unspecified firearm discharge

1.85

0.67

2.8

4.3

134.60

131.75

g/l

—

Tuberous sclerosis 1

1.84

0.67

3.2

9.1

129.80

127.86

g/l

—

Toxic encephalopathy

1.65

0.67

4.1

2.9

139.14

125.73

g/l

—

Severe mental retardation

1.64

0.67

1.4

14.9

136.29

125.50

g/l

—

Benign neoplasm: Connective and other soft tissue of abdomen

1.63

0.66

2.7

3.5

127.71

129.64

g/l

—

Pollen allergy

281

2996

0.92

0.66

4.6

4.4

134.74

132.20

g/l

1.23

273

2938

Exfoliative dermatitis

216

1.32

0.65

3.4

129.79

129.20

g/l

0.04

211

Cholera

1.78

0.65

5.4

3.2

115.20

127.97

g/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

104

1.48

0.64

3.7

4.0

138.13

132.73

g/l

0.45

104

Congenital retinoschisis

1.69

0.64

12.5

5.3

125.13

129.65

g/l

—

Postpartum hemorraghe, all women as controls

308

3257

0.93

0.63

2.9

3.2

130.40

130.36

g/l

0.01

300

3184

Postpartum haemorrhage

308

2787

0.93

0.63

2.9

3.2

130.40

129.75

g/l

0.21

300

2730

Malignant neoplasm of oropharynx

334

1.24

0.63

3.2

2.9

129.78

131.62

g/l

0.21

325

Functional disorders of polymorphonuclear neutrophils

0.00

0.63

0.0

3.6

—

135.40

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

343

1.24

0.63

1.7

2.8

118.55

129.42

g/l

2.81

336

Acanthosis nigricans

1.64

0.62

2.9

2.4

132.13

132.96

g/l

—

Tinnitus

557

5286

1.06

0.62

3.6

3.5

131.90

129.24

g/l

2.19

544

5161

Maternal care for known or suspected malpresentation of fetus

204

1616

0.91

0.62

2.8

3.3

131.53

130.72

g/l

0.24

199

1577

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

1.71

0.62

13.6

4.0

140.00

132.10

g/l

—

Carcinoma in situ of anus and anal canal

0.00

0.62

0.0

3.5

—

126.95

—

Malignant neoplasm of trachea, including Hilmo

0.00

0.62

0.0

2.5

—

131.26

—

Pemphigus foliaceus

0.00

0.62

0.0

2.2

—

129.81

—

Familial chondrocalcinosis

0.00

0.62

0.0

3.0

—

127.33

—

Polydactyly

0.00

0.62

0.0

23.2

—

122.68

—

Sequelae of infectious and parasitic diseases

161

1460

1.11

0.61

4.9

3.1

125.81

129.67

g/l

1.42

161

1423

Other inflammation of vagina/vulva

444

1.20

0.61

2.0

2.9

130.81

129.69

g/l

0.15

436

Brain mixed glioma

0.00

0.61

0.0

2.8

—

133.86

—

Other predominantly sexually transmitted diseases, not elsewhere classified

338

3162

1.07

0.60

3.3

3.2

129.62

132.50

g/l

1.52

332

3089

Special screening examination for other diseases and disorders

220

2024

1.09

0.60

4.0

2.9

125.79

130.97

g/l

2.84

211

1969

Antenatal screening

298

1799

0.93

0.60

2.6

3.0

132.99

130.12

g/l

1.73

290

1757

Mucosal proctocolitis

257

2383

1.08

0.59

4.8

3.3

126.58

131.43

g/l

2.45

250

2327

Other and/or unspecified nontoxic goitre

173

1578

1.10

0.59

2.7

3.0

128.98

126.71

g/l

0.64

167

1545

Foreign body on external eye

340

3187

1.07

0.59

3.8

3.7

134.72

132.51

g/l

1.04

329

3118

Hereditary spherocytosis

1.76

0.59

1.7

5.7

135.67

127.43

g/l

—

Pregnancy examination and test

217

1239

1.09

0.58

2.5

3.0

132.41

131.11

g/l

0.46

208

1210

Benign neoplasm: Spinal cord

247

1.27

0.58

2.6

3.4

128.19

127.20

g/l

0.09

242

Gonococcal infection

506

0.82

0.57

2.5

2.9

126.95

132.01

g/l

0.88

494

Adult-onset Still disease

1.56

0.56

5.3

2.1

113.33

132.78

g/l

—

Seronegative rheumatoid arthritis

263

2450

1.08

0.56

3.2

3.1

125.20

128.50

g/l

1.58

254

2401

Malignant neoplasm of tonsil

294

1.24

0.56

3.2

2.9

128.58

131.62

g/l

0.35

288

Lipomatosis, not elsewhere classified

1.61

0.55

10.5

2.1

119.50

131.18

g/l

—

Spermatocele

196

1807

1.09

0.55

3.8

3.7

130.19

129.62

g/l

0.12

188

1763

L01XX Other antineoplastic agents

142

1291

1.11

0.54

3.3

3.0

121.32

127.82

g/l

2.38

133

1257

Cardiomyopathy due to drugs and other external agents

1.58

0.54

8.0

3.4

119.67

127.33

g/l

—

False labour

431

2541

1.06

0.54

2.5

3.3

133.19

130.07

g/l

2.81

421

2481

Effects of other deprivation

1.57

0.54

5.7

3.6

123.67

133.00

g/l

—

Early syphilis

215

0.73

0.54

3.5

3.3

122.44

132.68

g/l

0.95

209

Balanced rearrangements and structural markers, not elsewhere classified

1.56

0.53

3.7

3.9

138.33

131.21

g/l

—

Chondromalacia

470

1.18

0.53

3.7

3.2

136.60

129.87

g/l

1.56

464

Other and unspecified disease of Bartholin gland

501

0.83

0.53

5.0

2.7

127.05

127.31

g/l

0.03

489

Type 1 diabetes, wide definition, subgroup 2

260

0.76

0.53

10.0

4.3

123.05

124.96

g/l

0.11

255

Dysplasia of cervi uteri

410

2806

1.06

0.53

3.2

3.1

128.20

127.62

g/l

0.22

404

2748

Carcinoma in situ of other and unspecified genital organs

305

1.23

0.53

3.5

2.5

120.41

128.29

g/l

1.53

300

Scar conditions and fibrosis of skin

629

1.15

0.53

4.4

3.3

127.28

129.04

g/l

0.33

614

216

2006

1.08

0.52

4.5

3.5

116.72

129.16

g/l

9.96

210

1959

Medicines for HER+ breast cancer

773

7611

0.96

0.52

2.7

3.1

124.55

126.81

g/l

2.39

752

7447

Fenamates

375

2692

0.94

0.51

3.7

4.1

129.01

125.67

g/l

2.18

364

2636

Varicose veins of other sites

146

1334

1.10

0.51

2.7

3.4

131.05

131.27

g/l

0.04

138

1302

L02BG Aromatase inhibitors

626

6516

0.96

0.50

2.7

3.1

124.01

126.55

g/l

2.39

608

6374

Other and unspecified cicatricial alopecia

1.56

0.49

1.6

2.6

123.43

129.20

g/l

—

Gonococcal infection

540

0.85

0.49

2.4

3.0

127.22

132.03

g/l

0.88

525

Persons encountering health services in other circumstances

929

8933

1.04

0.49

4.5

3.2

128.26

129.45

g/l

0.84

892

8703

Epiphora

410

1.18

0.48

2.4

3.0

134.79

126.41

g/l

3.01

399

Other articular cartilage disorders

466

1.17

0.48

2.5

3.4

129.72

129.73

g/l

0.00

457

Unspecified lump in breast

268

2852

0.94

0.47

4.3

3.0

126.90

127.06

g/l

0.04

262

2785

Other congenital malformations of skin

126

1381

0.91

0.47

4.9

3.8

132.15

129.74

g/l

0.65

121

1350

Respiratory tuberculosis, not confirmed

873

1.12

0.47

4.0

3.1

122.37

125.63

g/l

0.78

852

Aphakia

282

1.22

0.47

3.5

2.9

127.41

127.81

g/l

0.04

275

Malignant neoplasm of tonsil, including Hilmo

357

1.19

0.46

3.5

2.9

125.98

131.68

g/l

0.81

349

Other and unspecified heterotropia

1.43

0.46

2.6

6.7

128.43

128.36

g/l

—

Lagophthalmos

265

1.22

0.46

3.3

3.2

122.31

125.99

g/l

0.37

259

Traumatic amputation of shoulder and upper arm

1.69

0.44

34.6

3.0

122.00

132.00

g/l

—

Early syphilis

230

0.77

0.44

3.3

3.2

121.89

132.73

g/l

1.18

223

Dermatophytosis

1552

15879

0.98

0.44

3.3

3.4

130.04

130.05

g/l

0.01

1517

15500

Drug-induced aplastic anaemia

1.67

0.44

6.8

2.5

117.60

127.65

g/l

—

Enterohaemorrhagic Escherichia coli infection

1.66

0.44

11.4

2.6

117.20

130.81

g/l

—

Graves disease, strict definition

182

1693

1.08

0.44

2.7

3.0

132.73

128.87

g/l

1.65

176

1646

Other haemoglobinopathies

1.60

0.43

5.6

2.8

149.20

126.47

g/l

—

Sequelae of other and unspecified infectious and parasitic diseases

102

926

1.11

0.43

5.4

3.2

126.07

131.93

g/l

1.86

102

909

Hydatidiform mole

173

0.75

0.42

2.5

3.5

130.62

128.21

g/l

0.24

168

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

623

1.13

0.42

4.5

3.1

120.77

125.11

g/l

1.02

610

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

0.42

0.0

2.7

—

131.12

—

Other congenital malformations of integument

0.00

0.42

0.0

8.9

—

131.93

—

Hypothyroidism, autoimmune, DX-based

1.40

0.42

3.7

141.13

130.95

g/l

—

Intentional self-harm by drowning and submersion

1.55

0.42

5.8

2.8

126.00

132.52

g/l

—

Schistosomiasis [bilharziasis]

0.00

0.42

0.0

6.0

—

130.40

—

Unspecified pneumoconiosis

0.00

0.42

0.0

5.5

—

118.44

—

Other superficial mycoses

183

1707

1.07

0.42

3.4

3.2

133.07

131.86

g/l

0.32

178

1664

Chronic bullous disease of childhood

0.00

0.41

0.0

2.7

—

133.00

—

Benign neoplasm of mesothelial tissue

0.00

0.41

0.0

4.2

—

128.35

—

Other specified diseases of spinal cord, drug-induced

0.00

0.41

0.0

3.6

—

125.17

—

Malignant neoplasm of tongue

380

1.17

0.41

2.5

2.9

119.59

130.52

g/l

2.00

373

Pemphigus erythematosus

0.00

0.41

0.0

3.1

—

125.50

—

Pedestrian injured in collision with heavy transport vehicle or bus

1.35

0.41

3.3

3.5

133.50

126.72

g/l

—

Other disorders of breast

220

2067

1.07

0.41

2.7

3.0

130.90

127.29

g/l

1.92

214

2018

Congenital cataract

1.35

0.41

8.9

6.9

128.75

131.08

g/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1812

12010

1.02

0.40

3.3

3.5

132.50

130.44

g/l

3.86

1768

11742

Triptan medication for migraine, single purchase ok

1812

12010

1.02

0.40

3.3

3.5

132.50

130.44

g/l

3.86

1768

11742

Yaws

1.33

0.40

9.1

4.0

129.00

131.69

g/l

—

Acquired stenosis of external ear canal

204

0.77

0.40

5.9

3.6

121.50

129.46

g/l

0.52

199

Drug-induced interstitial lung disorders, unspecified

1.46

0.40

3.0

4.0

139.80

129.20

g/l

—

Medical abortion

1406

7441

1.03

0.40

3.1

3.0

128.61

127.17

g/l

1.72

1370

7269

Oher contracture of tendon (sheath)

1.39

0.39

4.3

2.7

128.22

127.59

g/l

—

Deviated nasal septum

864

8379

1.03

0.39

3.6

3.5

132.99

130.33

g/l

2.98

845

8173

Oesophagitis, drug-induced

1.41

0.39

4.6

3.7

122.80

125.83

g/l

—

Chronic inflammatory disorders of orbit

1.41

0.39

1.6

4.2

144.20

128.03

g/l

—

Congenital malformations of spine and bony thorax

107

1.33

0.38

30.6

7.0

131.21

131.17

g/l

0.00

107

Benign neoplasm: Skin of eyelid, including canthus

367

3510

1.05

0.38

3.9

3.3

128.72

127.76

g/l

0.34

358

3417

Congenital lens malformations

1.32

0.38

8.4

6.2

125.44

130.70

g/l

—

Diving or jumping into water causing injury other than drowning or submersion

1.41

0.37

2.3

5.4

144.40

131.64

g/l

—

Primary open-angle glaucoma, strict

740

7159

1.03

0.37

3.3

3.2

125.10

126.63

g/l

1.05

719

6992

Other mosquito-borne viral fevers

1.50

0.37

1.3

3.2

125.67

128.71

g/l

—

Benign neoplasm of eye and adnexa

207

2193

0.94

0.36

3.7

3.1

126.28

128.15

g/l

0.61

201

2132

Torsion of ovary, ovarian pedicle and fallopian tube

263

1.18

0.36

2.4

3.4

127.29

127.10

g/l

0.02

255

Ectopic pregnancy

274

2606

1.05

0.36

2.5

3.4

127.96

128.19

g/l

0.06

265

2547

Non-small cell lung cancer

256

2414

1.06

0.35

3.6

3.3

122.51

129.62

g/l

5.52

251

2349

Retrobulbar neuritis in diseases classified elsewhere

1.38

0.35

47.7

3.3

136.67

134.50

g/l

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.32

0.33

3.5

3.6

123.00

132.72

g/l

—

Other acquired deformities of ankle and foot

137

1.25

0.32

3.5

3.0

129.71

127.46

g/l

0.22

132

Cleft hard palate NOS

1.29

0.32

6.2

12.6

124.00

132.38

g/l

—

Multiple system atrophy (rare forms of Parkinsonism)

1.37

0.32

1.6

3.1

116.29

126.04

g/l

—

Pleural plaque with presence of asbestos

180

1903

0.94

0.31

3.7

3.6

128.53

127.31

g/l

0.32

174

1853

Femoral hernia, bilateral

1.34

0.31

3.6

2.9

126.86

129.30

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

171

1614

1.06

0.31

6.2

3.2

130.70

128.90

g/l

0.50

164

1574

Reiter disease

0.70

0.31

3.0

3.7

126.14

129.19

g/l

—

Viral infections of central nervous system, not elsewhere classified/unspecified

230

1.18

0.31

1.9

3.4

129.93

130.76

g/l

0.06

225

Glaucoma-related operations

126

1344

0.93

0.30

3.4

3.0

128.40

126.43

g/l

0.41

119

1310

Chalazion

237

2263

1.05

0.29

3.0

3.3

131.67

129.51

g/l

0.78

227

2201

Single delivery by caesarean section

244

1466

0.95

0.28

2.6

3.8

131.65

128.49

g/l

1.58

235

1427

Excessive earwax

1489

14778

0.98

0.28

3.0

3.5

129.85

128.57

g/l

1.41

1453

14439

Generalized pustular psoriasis

1.25

0.27

2.4

4.4

132.13

131.38

g/l

—

Malignant neoplasm of bronchus and lung, including Hilmo

575

4679

1.03

0.27

3.7

3.3

122.64

130.17

g/l

13.40

563

4551

Enterobiasis

226

0.84

0.27

3.2

5.6

138.63

131.11

g/l

1.18

219

Chronic diseases of tonsils and adenoids

2007

12868

0.98

0.27

3.6

132.27

129.90

g/l

4.75

1959

12572

Acute hepatitis B

1.32

0.27

2.3

3.6

122.80

129.84

g/l

—

Congenital hypothyroidism without goiter

0.66

0.26

1.4

5.4

128.00

131.24

g/l

—

Congenital malformations of anterior segment of eye

132

1.22

0.26

4.3

4.8

131.19

129.31

g/l

0.11

127

Overjet

346

1.13

0.26

19.4

7.3

124.69

129.27

g/l

0.75

336

Postmenopausal atrophic vaginitis

603

3239

1.03

0.26

3.0

3.1

128.17

125.51

g/l

2.47

588

3179

Dislocation of lens

322

1.13

0.24

3.6

2.9

123.11

127.21

g/l

0.52

314

Respiratory tuberculosis, clinically confirmed

246

1.15

0.24

2.6

3.4

125.36

125.70

g/l

0.02

240

Benign neoplasm: Respiratory system, unspecified

1.37

0.24

4.6

3.2

133.40

131.14

g/l

—

Type 1 diabetes, strict definition, subgroup 2

1.37

0.24

17.8

14.4

136.40

131.41

g/l

—

Other obstetric trauma

542

1.09

0.24

3.3

2.9

131.44

130.23

g/l

0.18

528

Other assisted single delivery

201

0.84

0.24

2.6

3.2

127.24

129.17

g/l

0.13

195

Malignant cancer of tonsil and base of tongue

418

1.11

0.24

2.9

123.91

132.67

g/l

1.53

408

Female infertility

487

2875

1.03

0.24

2.8

3.1

129.90

127.76

g/l

1.35

478

2814

Benign neoplasm: Ribs, sternum and clavicle

1.34

0.23

1.0

5.3

134.40

127.61

g/l

—

Traumatic amputation of ankle and foot

1.33

0.23

1.0

2.7

122.00

131.63

g/l

—

Crushing injury of lower leg

1.33

0.23

3.2

2.5

131.40

127.21

g/l

—

Small kidney of unknown cause

1.30

0.23

8.2

3.7

116.60

129.77

g/l

—

Non-small cell lung cancer, including Hilmo

392

3585

1.03

0.23

3.4

3.2

122.67

130.29

g/l

9.36

387

3492

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

115

1087

1.06

0.23

2.5

2.9

128.70

126.90

g/l

0.37

107

1064

Pregnancy, childbirth and the puerperium

715

3817

0.98

0.23

2.5

3.2

126.36

125.46

g/l

0.55

692

3727

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.22

0.0

3.1

—

135.27

—

Plague

0.00

0.22

0.0

3.7

—

140.30

—

Acquired keratosis follicularis

0.00

0.22

0.0

7.7

—

127.30

—

Inhalation of gastric contents

1.23

0.22

5.4

3.0

156.40

132.73

g/l

—

Cleft palate

116

1.21

0.22

8.6

8.7

124.86

129.42

g/l

0.41

116

Carcinoma in situ of other/unspecified male genital organs

0.00

0.22

0.0

3.7

—

120.42

—

Toxic myoneural disorders

0.00

0.22

0.0

3.0

—

130.90

—

Malignant neoplasm of bronchus and lung

464

3952

0.97

0.22

3.6

3.2

122.48

130.29

g/l

11.21

454

3848

Malignant neoplasm of meninges

0.00

0.22

0.0

3.4

—

124.80

—

Intestinal helminthiases, other/unspecified

0.00

0.22

0.0

2.6

—

123.18

—

Fetal blood loss

0.00

0.22

0.0

13.4

—

127.73

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.22

0.0

3.2

—

129.20

—

Echinococcosis

0.00

0.22

0.0

7.1

—

122.30

—

Glanders and melioidosis

0.00

0.22

0.0

2.2

—

130.64

—

Coccidioidomycosis

0.00

0.22

0.0

2.5

—

125.09

—

Benign neoplasm: Ureter

0.00

0.22

0.0

4.4

—

127.27

—

Chlamydial lymphogranuloma (venereum)

0.00

0.22

0.0

4.7

—

126.18

—

Acquired ichthyosis

0.00

0.22

0.0

3.1

—

146.00

—

Lichen ruber moniliformis

0.00

0.22

0.0

1.8

—

131.92

—

Benign neoplasm: Cranial nerves

575

0.92

0.22

3.9

3.0

133.58

128.06

g/l

1.22

564

Congenital syphilis

0.00

0.22

0.0

1.8

—

130.27

—

Linear scleroderma

0.00

0.22

0.0

2.8

—

133.10

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

0.21

0.0

5.1

—

132.67

—

Plasmodium vivax malaria

0.00

0.21

0.0

3.5

—

131.85

—

Hydroxyapatite deposition disease

0.00

0.21

0.0

3.2

—

121.54

—

Other specified/unspecified disorders of ear

1.26

0.20

15.3

3.3

119.67

129.29

g/l

—

Other obstructed labour

108

1025

1.06

0.20

3.1

3.2

127.29

128.45

g/l

0.23

103

1003

Changes in corneal membranes

1.19

0.20

2.3

2.6

129.33

125.96

g/l

—

Raynaud syndrome

146

1524

0.96

0.19

3.0

3.1

130.42

129.16

g/l

0.30

140

1484

Meningitis, viral

1.13

0.17

2.0

3.5

129.43

130.89

g/l

—

Vasomotor rhinitis (mode)

134

1396

0.96

0.17

3.0

3.1

132.55

128.53

g/l

1.61

128

1357

Alzheimer’s disease (Early onset), excluding more controls

704

1.06

0.17

2.5

2.8

126.92

124.63

g/l

0.51

681

Osteochondrosis of ankle, juvenile

1.18

0.17

1.8

5.0

137.00

130.50

g/l

—

Malignant neoplasm of breast, HER-negative

397

3983

0.98

0.16

2.6

3.0

123.65

128.04

g/l

4.22

390

3880

Malignant neoplasm, without specification of site

669

0.94

0.16

3.3

2.8

121.92

128.46

g/l

1.89

655

Hallux rigidus

299

3066

0.97

0.16

2.4

3.3

128.49

127.95

g/l

0.18

291

3004

Malignant neoplasm of breast, ER-negative, including Hilmo

461

4307

1.02

0.15

2.6

3.0

123.82

128.18

g/l

4.81

453

4200

Discontinuity and dislocation of ear ossicles

1.12

0.15

3.1

3.2

130.56

129.10

g/l

—

Lesion of plantar nerve

120

1155

1.04

0.14

5.5

2.9

131.96

127.82

g/l

1.53

112

1134

Chronic conjunctivitis

518

1.06

0.14

6.6

3.8

126.02

128.47

g/l

0.37

509

Contact with lifting and transmission devices, not elsewhere classified

326

0.92

0.14

3.2

3.3

141.27

129.72

g/l

1.81

321

Benign neoplasm: Peripheral nerves and autonomic nervous system

286

1.09

0.13

2.6

3.1

131.00

126.71

g/l

0.73

281

Injury of nerves and spinal cord at thorax level

1.18

0.13

2.8

3.7

131.18

131.04

g/l

0.01

Other predominantly sexually transmitted diseases, not elsewhere classified

268

2619

1.02

0.13

3.3

3.0

128.42

132.06

g/l

1.84

262

2555

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

374

1.07

0.13

5.5

3.0

115.90

124.54

g/l

2.23

369

Maternal care for known or suspected abnormality of pelvic organs

341

2368

0.98

0.13

3.3

3.2

133.71

129.78

g/l

3.47

332

2312

Malignant melanoma

332

3385

0.98

0.12

2.8

3.2

127.39

130.47

g/l

1.56

321

3295

Other benign neoplasms of connective and other soft tissue

200

1950

1.03

0.12

3.3

3.1

125.55

129.12

g/l

1.42

192

1898

Spinal enthesopathy

589

1.05

0.12

3.4

2.9

118.64

123.96

g/l

1.16

575

Sudden idiopathic hearing loss

224

2189

1.02

0.12

3.6

3.3

127.93

129.01

g/l

0.28

216

2128

Endometriosis of intestine

143

1.12

0.11

1.9

3.5

134.63

129.82

g/l

0.49

138

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

236

0.92

0.10

7.3

18.3

124.77

125.27

g/l

0.04

231

Presbycusis

364

3662

0.98

0.10

2.6

3.1

124.87

125.71

g/l

0.32

348

3583

Macular pucker

388

3824

1.02

0.10

4.4

3.2

126.45

127.75

g/l

0.55

378

3720

Other effects of reduced temperature

1.09

0.10

5.6

4.5

138.00

129.61

g/l

—

Other conditions related to polyarteritis nodosa

1.09

0.10

4.2

2.7

128.20

123.59

g/l

—

Calcaneal spur

227

0.92

0.09

3.8

2.7

130.24

129.13

g/l

0.10

222

Benign neoplasm: Other parts of oropharynx

155

1.10

0.09

5.7

3.6

129.88

130.10

g/l

0.01

155

Atypical mycobacterium lung infection

236

0.93

0.08

17.8

3.1

127.41

125.57

g/l

0.15

231

Anti-inflammatory and antirheumatic products, non-steroids

888

4427

1.01

0.08

3.1

4.3

129.68

126.96

g/l

2.78

869

4333

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

429

0.95

0.08

4.8

3.0

123.41

126.54

g/l

0.42

421

Haemorrhagic and haematological disorders of fetus and newborn

308

1.06

0.08

19.9

17.0

122.76

126.72

g/l

0.49

299

Cholinergic urticaria

1.04

0.07

1.8

3.1

132.88

131.87

g/l

—

Propionic acid derivatives

874

4426

0.99

0.07

3.0

4.3

130.72

126.96

g/l

5.02

854

4332

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

828

1.03

0.07

2.9

3.0

122.39

129.31

g/l

1.93

810

Benign neoplasm: Bronchus and lung

256

1.06

0.06

4.6

3.1

128.15

128.05

g/l

0.01

251

Malignant melanoma of skin, including Hilmo

343

3395

1.01

0.06

3.0

3.2

127.16

130.60

g/l

1.96

333

3305

Malignant melanoma of skin

248

2510

0.99

0.06

3.0

3.1

126.69

130.51

g/l

1.74

239

2435

Complications following abortion and ectopic and molar pregnancy

577

0.97

0.05

2.4

3.1

123.63

127.20

g/l

0.52

563

Malignant melanoma, including Hilmo

418

4145

1.01

0.05

2.9

3.2

127.70

130.39

g/l

1.53

406

4032

Use of rivastigmine

420

4221

0.99

0.05

2.2

3.2

127.00

125.31

g/l

0.98

412

4113

Noise effects on inner ear

868

0.98

0.05

3.9

3.4

133.60

129.99

g/l

0.70

847

Follow-up examination after treatment for malignant neoplasms

219

2210

0.99

0.03

3.2

3.0

122.79

127.62

g/l

2.41

207

2151

Retinal breaks without detachment

355

3527

1.01

0.03

3.8

3.3

128.68

129.31

g/l

0.21

348

3434

Conjunctivitis

1873

15603

1.00

0.03

3.6

130.94

129.37

g/l

2.44

1827

15242

Neonatal jaundice from other and unspecified causes

251

0.96

0.03

26.1

18.7

122.12

126.24

g/l

0.45

244

Benign neoplasm: Skin of trunk

779

1.01

0.02

3.8

3.0

126.68

128.56

g/l

0.31

761

Abnormal spermatozoa

319

3206

0.99

0.02

3.3

3.9

131.23

129.12

g/l

1.02

308

3129

Female infertility, cervical, vaginal, other or unspecified origin

432

2797

1.00

0.02

2.8

3.1

130.17

127.80

g/l

1.47

424

2739

Disorders of lacrimal system and orbit in diseases classified elsewhere

412

1.02

0.01

3.2

3.0

133.05

128.40

g/l

0.69

401

Other and unspecified degenerative diseases of nervous system

572

1.01

0.01

2.9

3.2

130.41

125.40

g/l

1.00

557

Normotensive glaucoma

207

2060

1.01

0.01

2.8

2.9

125.30

127.17

g/l

0.56

198

2011

Pregnancy with abortive outcome

1449

7554

1.00

0.00

2.8

3.0

127.91

127.16

g/l

0.66

1416

7380

Other protozoal intestinal diseases

304

1.02

0.00

4.2

4.0

137.39

129.28

g/l

1.37

298

Injury of muscle and tendon at ankle and foot level

384

1.02

0.00

3.2

3.4

133.00

129.69

g/l

0.45

377

Labour and delivery complicated by fetal stress [distress]

277

1813

1.00

0.00

2.8

3.1

131.83

131.01

g/l

0.28

268

1776

Other disorders of breast and lactation associated with childbirth

163

0.98

0.00

2.1

2.7

132.81

131.80

g/l

0.09

158

Infliximab

227

1.01

0.00

2.3

3.2

137.78

135.19

g/l

0.27

222

Disorders of acoustic nerve

534

0.99

0.00

3.8

3.1

133.36

128.60

g/l

1.00

521

Benign neoplasm: Vulva

353

0.99

0.00

4.3

2.5

121.57

127.02

g/l

0.79

345

Malignant neoplasm of respiratory system and intrathoracic organs

544

4527

1.00

0.00

3.6

3.3

122.50

130.28

g/l

12.62

528

4405

Benign neoplasm: Prostate

146

1.03

0.00

2.3

3.3

132.80

126.84

g/l

0.48

141

Exposure to excessive heat of man-made origin

154

0.97

0.00

11.7

4.4

119.93

127.20

g/l

0.53

149

Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons

0.00

0.0

1.0

—

154.00

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.0

2.8

—

127.25

—

Malignant neoplasm of placenta

0.00

0.0

1.8

—

134.60

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

0.0

5.8

—

128.20

—

Blastomycosis

0.00

0.0

2.0

—

114.20

—

Immobility syndrome (paraplegic)

0.00

0.0

1.6

—

133.60

—

Other drug-induced osteomalacia in adults

0.00

0.0

6.8

—

138.56

—

Bilateral

0.00

0.0

3.0

—

136.83

—

Diastrofic dysplasy

0.00

0.0

1.8

—

127.00

—

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

-0.00

0.0

2.8

—

132.33

—

Chronic thyroiditis

0.96

-0.00

6.0

2.7

127.14

130.25

g/l

—

Familial dysautonomia

0.00

-0.00

0.0

5.4

—

133.33

—

Chronic constrictive pericarditis

0.98

-0.00

3.0

4.4

121.60

126.59

g/l

—

Scarlet fever

1.01

-0.00

4.3

3.8

124.57

140.09

g/l

—

Deformity of orbit

0.00

-0.00

0.0

2.0

—

138.40

—

Scleritis and episcleritis (ICD-9) only

0.00

-0.00

0.0

4.8

—

125.50

—

Rabies

0.00

-0.00

0.0

7.0

—

122.44

—

Malignant neoplasm of trachea

0.00

-0.00

0.0

1.3

—

140.63

—

Injury of blood vessels at neck level

0.95

-0.00

2.8

3.5

120.33

133.32

g/l

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

2.1

—

137.43

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

-0.00

0.0

2.0

—

132.80

—

Trichuriasis

0.00

-0.00

0.0

3.0

—

125.43

—

Neurological devices associated with adverse incidents

0.00

-0.00

0.0

4.3

—

140.56

—

Disorders of other visual pathways

0.00

-0.00

0.0

14.2

—

135.00

—

Spotted fever [tick-borne rickettsioses]

0.00

-0.00

0.0

2.1

—

126.88

—

Congenital edentulism

0.00

-0.00

0.0

4.9

—

120.89

—

Pedal cyclist injured in collision with train or tram

0.00

-0.00

0.0

2.1

—

138.00

—

Ascariasis

0.00

-0.00

0.0

4.4

—

129.57

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

3.2

—

118.67

—

Anhidrosis

0.00

-0.00

0.0

3.0

—

130.89

—

Delta-beta thalassaemia

0.00

-0.00

0.0

5.5

—

129.88

—

Other neonatal haemorrhages

0.00

-0.00

0.0

13.1

—

126.43

—

Drug-induced chorea

0.00

-0.00

0.0

2.4

—

120.25

—

Pulmonary haemorrhage originating in the perinatal period

0.00

-0.00

0.0

3.0

—

134.17

—

Alcohol-induced pseudo-Cushing syndrome

0.00

-0.00

0.0

1.6

—

124.20

—

Strongyloidiasis

0.00

-0.00

0.0

8.1

—

123.00

—

Congenital pneumonia

0.00

-0.00

0.0

11.8

—

127.00

—

Intrauterine hypoxia

0.00

-0.00

0.0

3.6

—

125.00

—

Heredofamilial amyloidosis, unspecified

0.00

-0.00

0.0

1.8

—

130.60

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

10.4

—

124.80

—

Other fluke infections

0.00

-0.00

0.0

3.1

—

127.33

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

-0.00

0.0

4.3

—

129.14

—

Use of tolcapone

0.00

-0.00

0.0

3.9

—

136.13

—

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

0.00

-0.00

0.0

1.4

—

150.60

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

-0.00

0.0

9.5

—

128.25

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hemoglobin [Mass/volume] in Venous blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS